Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 905 |
| Prevention | 184 |
| Diagnostic | 62 |
| Other | 58 |
| Supportive Care | 58 |
| Health Services Research | 24 |
| Screening | 14 |
| Basic Science | 12 |
| Device Feasibility | 3 |
regCOVID
Craig Mayer, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
_See the full regCOVID repository with detailed results at https://github.com/lhncbc/r-snippets-bmi/tree/master/regCOVID —
Study Status
| overall_status | Study_Count |
|---|---|
| Active, not recruiting | 220 |
| Approved for marketing | 1 |
| Available | 18 |
| Completed | 384 |
| Enrolling by invitation | 112 |
| No longer available | 4 |
| Not yet recruiting | 816 |
| Recruiting | 1804 |
| Suspended | 19 |
| Terminated | 22 |
| Withdrawn | 52 |
Study Types
| Type | Study_count |
|---|---|
| Total_Studies | 2542 |
| interventional | 1320 |
| Observational | 1044 |
| Registry | 178 |
Studies over Time
Total studies by type over time
```
Interventional Trials
Intervention Type
| intervention_type | Study_Count |
|---|---|
| Drug | 341 |
| Drug|placebo | 244 |
| Other | 122 |
| Biological | 117 |
| Behavioral | 73 |
| Biological|placebo | 69 |
| Device | 65 |
| Drug|Other | 54 |
| Diagnostic Test | 48 |
| Procedure | 25 |
| Biological|Drug | 21 |
| Biological|Other | 19 |
| Dietary Supplement | 11 |
| Radiation | 10 |
| Device|Other | 9 |
| Dietary Supplement|Drug | 9 |
| Combination Product | 8 |
| Dietary Supplement|placebo | 7 |
| Drug|Other|placebo | 7 |
| Behavioral|Other | 5 |
| Other|placebo | 5 |
| Combination Product|Drug | 3 |
| Device|Drug|Procedure | 3 |
| Device|placebo | 3 |
| Dietary Supplement|Drug|placebo | 3 |
| Dietary Supplement|Other | 3 |
| Other|Procedure | 3 |
| Behavioral|Biological | 2 |
| Biological|Device|Other | 2 |
| Biological|Diagnostic Test | 2 |
| Biological|Drug|placebo | 2 |
| Biological|Other|placebo | 2 |
| Device|Drug | 2 |
| Device|Drug|Radiation | 2 |
| Device|Procedure | 2 |
| Drug|Procedure | 2 |
| Behavioral|Diagnostic Test | 1 |
| Behavioral|Drug | 1 |
| Behavioral|placebo | 1 |
| Biological|Combination Product|Drug|placebo | 1 |
| Biological|Drug|Procedure | 1 |
| Biological|Genetic|Other | 1 |
| Combination Product|placebo | 1 |
| Diagnostic Test|Dietary Supplement | 1 |
| Diagnostic Test|Drug|Other|placebo | 1 |
| Diagnostic Test|Other | 1 |
| Dietary Supplement|Drug|Other | 1 |
| Drug|placebo|Procedure | 1 |
| Drug|placebo|Radiation | 1 |
| Other|Radiation | 1 |
| placebo|Procedure | 1 |
Count of Studies by Intervention (normalized and mapped)
Interventions over Time
Weekly studies for each interventionStudies by Country
| Country | Study_Count |
|---|---|
| United States | 386 |
| France | 111 |
| China | 70 |
| Spain | 57 |
| Brazil | 48 |
| Canada | 45 |
| Mexico | 39 |
| United Kingdom | 39 |
| Egypt | 33 |
| Italy | 33 |
| Russian Federation | 25 |
| Pakistan | 24 |
| Turkey | 23 |
| Germany | 21 |
| Argentina | 18 |
| Belgium | 18 |
| Iran, Islamic Republic of | 18 |
| Denmark | 15 |
| India | 15 |
| Sweden | 13 |
| Australia | 12 |
| Netherlands | 12 |
| Saudi Arabia | 10 |
| Switzerland | 10 |
| Bangladesh | 9 |
| Greece | 9 |
| Israel | 9 |
| Korea, Republic of | 8 |
| Colombia | 7 |
| Hong Kong | 7 |
| South Africa | 7 |
| Indonesia | 6 |
| Poland | 5 |
| Singapore | 5 |
| United States|Canada | 5 |
| United States|Puerto Rico | 5 |
| Chile | 4 |
| Japan | 4 |
| Qatar | 4 |
| United States|Brazil | 4 |
| Austria | 3 |
| Iraq | 3 |
| Malaysia | 3 |
| Norway | 3 |
| Romania | 3 |
| Bahrain | 2 |
| Belarus | 2 |
| French Guiana | 2 |
| Guinea | 2 |
| Guinea-Bissau | 2 |
| Hungary | 2 |
| Kazakhstan | 2 |
| Kuwait | 2 |
| North Macedonia | 2 |
| Taiwan | 2 |
| Thailand | 2 |
| Ukraine | 2 |
| United States|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom | 2 |
| Vietnam | 2 |
| Argentina|Brazil|Chile|Mexico|Russian Federation | 1 |
| Argentina|Brazil|Denmark|Germany|Hungary|India|Netherlands|Peru|Russian Federation|South Africa|Spain | 1 |
| Argentina|France|Germany|Italy|Spain|Turkey | 1 |
| Australia|Netherlands|Spain | 1 |
| Austria|Belgium|France|Luxembourg | 1 |
| Austria|Denmark|Germany|Russian Federation|United Kingdom | 1 |
| Austria|Germany | 1 |
| Bahrain|Egypt|Jordan|United Arab Emirates | 1 |
| Belgium|Brazil|France|Germany|Italy|Mexico|Spain|United Kingdom | 1 |
| Belgium|France | 1 |
| Belgium|France|Monaco | 1 |
| Belgium|Germany | 1 |
| Bosnia and Herzegovina | 1 |
| Brazil|Canada|Chile|Colombia|Ecuador|Egypt|India|Pakistan|Philippines|Russian Federation|Saudi Arabia|United Arab Emirates | 1 |
| Brazil|Italy | 1 |
| Bulgaria|Germany | 1 |
| Canada|Argentina|Brazil|Chile|France|Germany|Israel|Italy|Japan|Russian Federation|Spain | 1 |
| Canada|Mongolia | 1 |
| China|Indonesia | 1 |
| China|Italy | 1 |
| Czechia | 1 |
| Dominican Republic | 1 |
| Ecuador | 1 |
| Finland | 1 |
| France|Monaco | 1 |
| French Guiana|Guadeloupe|New Caledonia | 1 |
| Germany|Netherlands|Spain | 1 |
| Germany|Sweden | 1 |
| Gibraltar | 1 |
| Honduras | 1 |
| Iceland | 1 |
| India|Denmark|Sweden|Switzerland | 1 |
| India|Israel | 1 |
| India|United Kingdom | 1 |
| Indonesia|Italy|Lao People’s Democratic Republic|Pakistan|Thailand|United Kingdom | 1 |
| Ireland | 1 |
| Israel|Mexico|Russian Federation | 1 |
| Italy|Spain | 1 |
| Jordan | 1 |
| Kenya | 1 |
| Kyrgyzstan | 1 |
| Moldova, Republic of|Romania|United Kingdom | 1 |
| NA | 1 |
| Peru | 1 |
| Philippines | 1 |
| Puerto Rico | 1 |
| Rwanda | 1 |
| Senegal | 1 |
| Slovenia | 1 |
| Uganda | 1 |
| United Arab Emirates | 1 |
| United States|Argentina|Belgium|Brazil|Canada|Chile|France|India|Japan|Mexico|Netherlands|Peru|Poland|Russian Federation|South Africa|Spain|United Kingdom | 1 |
| United States|Argentina|Brazil|Canada|Colombia|France|Germany|Italy|Mexico|Peru|Russian Federation|Spain|Turkey|United Kingdom | 1 |
| United States|Argentina|Brazil|Chile|Colombia|Mexico|Peru|Philippines|South Africa|Ukraine | 1 |
| United States|Argentina|Brazil|Germany|Italy|Japan|Korea, Republic of|Mexico|Puerto Rico|Russian Federation|Spain|United Kingdom | 1 |
| United States|Argentina|Brazil|Russian Federation|South Africa|Spain | 1 |
| United States|Argentina|Brazil|South Africa|Turkey | 1 |
| United States|Australia | 1 |
| United States|Australia|Brazil|Spain | 1 |
| United States|Australia|Philippines|Romania | 1 |
| United States|Austria|Belgium | 1 |
| United States|Austria|France|Israel|Spain|United Kingdom | 1 |
| United States|Belgium|Brazil|France | 1 |
| United States|Belgium|Brazil|Moldova, Republic of|Romania|South Africa|Ukraine | 1 |
| United States|Belgium|France|Netherlands | 1 |
| United States|Brazil|Canada|Mexico | 1 |
| United States|Brazil|Canada|South Africa|Spain | 1 |
| United States|Brazil|Chile|Peru|South Africa | 1 |
| United States|Brazil|Kenya|Mexico|Peru|South Africa | 1 |
| United States|Brazil|Mexico | 1 |
| United States|Brazil|Mexico|Spain | 1 |
| United States|Brazil|Russian Federation | 1 |
| United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom | 1 |
| United States|Canada|Ghana|Ireland|Netherlands|South Africa|Uganda|United Kingdom|Zambia|Zimbabwe | 1 |
| United States|Denmark|Germany|Greece|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom | 1 |
| United States|Denmark|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom | 1 |
| United States|Denmark|Singapore | 1 |
| United States|France|Italy|Russian Federation|Spain|United Kingdom | 1 |
| United States|France|Japan|Spain|United Kingdom | 1 |
| United States|Italy | 1 |
| United States|Japan|Korea, Republic of|Mexico|Singapore | 1 |
| United States|New Zealand | 1 |
| United States|Spain | 1 |
| United States|Spain|United Kingdom | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 848 |
| 2 | 109 |
| 3 | 55 |
| 4 | 43 |
| 5 | 30 |
| 6 | 19 |
| 7 | 26 |
| 8 | 19 |
| 9 | 21 |
| 10 | 14 |
| 11 | 16 |
| 12 | 8 |
| 13 | 9 |
| 14 | 8 |
| 15 | 4 |
| 16 | 6 |
| 17 | 4 |
| 18 | 4 |
| 19 | 2 |
| 20 | 4 |
| 21 | 2 |
| 22 | 3 |
| 23 | 1 |
| 24 | 3 |
| 25 | 4 |
| 26 | 4 |
| 27 | 1 |
| 28 | 2 |
| 29 | 3 |
| 30 | 2 |
| 31 | 3 |
| 33 | 2 |
| 34 | 2 |
| 35 | 1 |
| 39 | 2 |
| 40 | 4 |
| 47 | 3 |
| 49 | 2 |
| 51 | 1 |
| 53 | 1 |
| 54 | 1 |
| 55 | 1 |
| 59 | 1 |
| 60 | 1 |
| 61 | 1 |
| 62 | 1 |
| 65 | 1 |
| 67 | 1 |
| 69 | 2 |
| 71 | 3 |
| 77 | 1 |
| 78 | 1 |
| 90 | 1 |
| 92 | 1 |
| 95 | 1 |
| 100 | 1 |
| 116 | 1 |
| 118 | 1 |
| 166 | 1 |
| 183 | 1 |
| 184 | 1 |
| 243 | 1 |
Phase
| Phase | Study_Count |
|---|---|
| N/A | 443 |
| Phase 2 | 343 |
| Phase 3 | 198 |
| Phase 2/Phase 3 | 97 |
| Phase 1/Phase 2 | 79 |
| Phase 1 | 77 |
| Phase 4 | 64 |
| Early Phase 1 | 19 |
Number of Arms
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 226 |
| 2 | 827 |
| 3 | 121 |
| 4 | 73 |
| 5 | 19 |
| 6 | 18 |
| 7 | 4 |
| 8 | 7 |
| 9 | 3 |
| 10 | 2 |
| 11 | 2 |
| 12 | 1 |
| 13 | 1 |
| 14 | 1 |
| 15 | 1 |
| 17 | 1 |
| 21 | 1 |
| 24 | 1 |
| NA | 11 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 295 |
| 2 | 363 |
| 3 | 261 |
| 4 | 164 |
| 5 | 81 |
| 6 | 41 |
| 7 | 27 |
| 8 | 19 |
| 9 | 11 |
| 10 | 14 |
| 11 | 10 |
| 12 | 5 |
| 13 | 7 |
| 14 | 5 |
| 15 | 3 |
| 16 | 1 |
| 17 | 1 |
| 18 | 4 |
| 19 | 2 |
| 20 | 1 |
| 21 | 1 |
| 22 | 1 |
| 24 | 1 |
| 29 | 1 |
| 99 | 1 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 3100 | 1025 | 3.024390 |
| Contacts/Locations | 1852 | 814 | 2.275184 |
| None (earliest Version on record) | 1320 | 1320 | 1.000000 |
| Recruitment Status | 888 | 744 | 1.193548 |
| Outcome Measures | 595 | 443 | 1.343115 |
| Eligibility | 512 | 346 | 1.479769 |
| Study Design | 453 | 346 | 1.309249 |
| Study Description | 448 | 345 | 1.298551 |
| Oversight | 417 | 389 | 1.071979 |
| Study Identification | 408 | 316 | 1.291139 |
| Arms | 364 | 275 | 1.323636 |
| Interventions | 364 | 275 | 1.323636 |
| Sponsor/Collaborators | 166 | 141 | 1.177305 |
| Conditions | 134 | 117 | 1.145299 |
| References | 57 | 47 | 1.212766 |
| IPDSharing | 54 | 52 | 1.038461 |
| Documents | 32 | 24 | 1.333333 |
| Results | 7 | 7 | 1.000000 |
| Results Submission Events | 4 | 4 | 1.000000 |
| 2020Recruitment Status | 2 | 2 | 1.000000 |
| Reported Adverse Events | 2 | 1 | 2.000000 |
| 2020 Outcome Measures | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: August 18 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: September 10 | 1 | 1 | 1.000000 |
| Quality Control Review has not concludedReturned: September 3 | 1 | 1 | 1.000000 |
Enrollment Metrics by Phase
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 9.00000 | 4.000 | 5.00000 | 5.0000 | 5.0000 | 7.000 | 1.000 | 10.0000 |
| 1st Qu. | 10.00000 | 41.000 | 24.00000 | 30.0000 | 51.0000 | 120.000 | 200.000 | 79.0000 |
| Median | 50.00000 | 117.000 | 48.00000 | 58.0000 | 100.0000 | 300.000 | 445.000 | 200.0000 |
| Mean | 63.31579 | 4439.946 | 78.63636 | 245.5443 | 221.8192 | 1181.227 | 2048.581 | 541.4062 |
| 3rd Qu. | 97.00000 | 333.500 | 90.00000 | 205.0000 | 200.0000 | 500.000 | 1090.500 | 616.5000 |
| Max. | 250.00000 | 506517.000 | 940.00000 | 2970.0000 | 10000.0000 | 43998.000 | 60000.000 | 5200.0000 |
Trial Group Type
| group_type | Group_Count |
|---|---|
| Experimental | 1646 |
| Active Comparator | 467 |
| Placebo Comparator | 452 |
| No Intervention | 280 |
| Other | 146 |
| Sham Comparator | 16 |
| NA | 11 |
Intervention Model
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 952 |
| Single Group Assignment | 262 |
| Sequential Assignment | 59 |
| Factorial Assignment | 25 |
| Crossover Assignment | 22 |
Has Results
| nct_id | brief_title | link |
|---|---|---|
| NCT04280705 | Adaptive COVID-19 Treatment Trial (ACTT) | https://ClinicalTrials.gov/show/NCT04280705 |
| NCT04343261 | Convalescent Plasma in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343261 |
| NCT04410159 | Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410159 |
| NCT04422561 | Prophylactic Ivermectin in COVID-19 Contacts | https://ClinicalTrials.gov/show/NCT04422561 |
| NCT04491994 | Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression | https://ClinicalTrials.gov/show/NCT04491994 |
| NCT04523831 | Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04523831 |
Vaccines
| nct_id | brief_title | link |
|---|---|---|
| NCT04276896 | Immunity and Safety of Covid-19 Synthetic Minigene Vaccine | https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04283461 | Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04299724 | Safety and Immunity of Covid-19 aAPC Vaccine | https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04313127 | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults | https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04324606 | A Study of a Candidate COVID-19 Vaccine (COV001) | https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04341389 | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04352608 | Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04357028 | Measles Vaccine in HCW | https://ClinicalTrials.gov/show/NCT04357028 |
| NCT04368988 | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant | https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04369794 | COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement | https://ClinicalTrials.gov/show/NCT04369794 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | https://ClinicalTrials.gov/show/NCT04368728 |
| NCT04380532 | Tableted COVID-19 Therapeutic Vaccine | https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04380701 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04383574 | Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) | https://ClinicalTrials.gov/show/NCT04383574 |
| NCT04400838 | Investigating a Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400838 |
| NCT04405076 | Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older | https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04412538 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04405908 | SCB-2019 as COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04405908 |
| NCT04453852 | Monovalent Recombinant COVID19 Vaccine | https://ClinicalTrials.gov/show/NCT04453852 |
| NCT04444674 | COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection | https://ClinicalTrials.gov/show/NCT04444674 |
| NCT04447781 | Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 | https://ClinicalTrials.gov/show/NCT04447781 |
| NCT04445194 | Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04445194 |
| NCT04450004 | Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. | https://ClinicalTrials.gov/show/NCT04450004 |
| NCT04449276 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults | https://ClinicalTrials.gov/show/NCT04449276 |
| NCT04445389 | Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04445389 |
| NCT04445428 | OPV as Potential Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04445428 |
| NCT04456595 | Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04456595 |
| NCT04461379 | Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04461379 |
| NCT04460703 | COVID-19 Vaccine Messaging, Part 1 | https://ClinicalTrials.gov/show/NCT04460703 |
| NCT04466085 | Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04466085 |
| NCT04470427 | A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04470427 |
| NCT04495933 | A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04495933 |
| NCT04470609 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years | https://ClinicalTrials.gov/show/NCT04470609 |
| NCT04475302 | BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots | https://ClinicalTrials.gov/show/NCT04475302 |
| NCT04497298 | Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04497298 |
| NCT04510207 | A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above | https://ClinicalTrials.gov/show/NCT04510207 |
| NCT04498247 | A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) | https://ClinicalTrials.gov/show/NCT04498247 |
| NCT04508075 | Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine | https://ClinicalTrials.gov/show/NCT04508075 |
| NCT04527575 | Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04527575 |
| NCT04522089 | A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine | https://ClinicalTrials.gov/show/NCT04522089 |
| NCT04515147 | A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults | https://ClinicalTrials.gov/show/NCT04515147 |
| NCT04550351 | Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) | https://ClinicalTrials.gov/show/NCT04550351 |
| NCT04540419 | Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 | https://ClinicalTrials.gov/show/NCT04540419 |
| NCT04523571 | Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects | https://ClinicalTrials.gov/show/NCT04523571 |
| NCT04528641 | GRAd-COV2 Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04528641 |
| NCT04568031 | Study of AZD1222 for the Prevention of COVID-19 in Japan | https://ClinicalTrials.gov/show/NCT04568031 |
| NCT04530396 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04530396 |
| NCT04530357 | Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04530357 |
| NCT04533399 | A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults | https://ClinicalTrials.gov/show/NCT04533399 |
| NCT04537949 | A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04537949 |
| NCT04537208 | Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04537208 |
| NCT04540185 | A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 | https://ClinicalTrials.gov/show/NCT04540185 |
| NCT04552366 | A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults | https://ClinicalTrials.gov/show/NCT04552366 |
| NCT04560881 | Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) | https://ClinicalTrials.gov/show/NCT04560881 |
| NCT04563702 | Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04563702 |
| NCT04564716 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus | https://ClinicalTrials.gov/show/NCT04564716 |
| NCT04568811 | The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04568811 |
| NCT04582344 | Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) | https://ClinicalTrials.gov/show/NCT04582344 |
| NCT04583995 | A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom | https://ClinicalTrials.gov/show/NCT04583995 |
Phase
| phase | Study_Count |
|---|---|
| N/A | 1 |
| Phase 1 | 17 |
| Phase 1/Phase 2 | 19 |
| Phase 2 | 5 |
| Phase 2/Phase 3 | 2 |
| Phase 3 | 14 |
| Phase 4 | 2 |
Country
| country | Study_Count |
|---|---|
| Argentina | 2 |
| Australia | 4 |
| Austria | 1 |
| Bahrain | 1 |
| Belarus | 1 |
| Belgium | 3 |
| Brazil | 3 |
| Canada | 2 |
| China | 14 |
| Egypt | 2 |
| France | 1 |
| Germany | 3 |
| Guinea-Bissau | 1 |
| India | 1 |
| Indonesia | 1 |
| Italy | 1 |
| Japan | 1 |
| Jordan | 1 |
| Kazakhstan | 1 |
| Korea, Republic of | 2 |
| Mexico | 1 |
| Mongolia | 1 |
| New Zealand | 1 |
| Peru | 1 |
| Russian Federation | 3 |
| South Africa | 3 |
| Taiwan | 1 |
| Turkey | 2 |
| United Arab Emirates | 1 |
| United Kingdom | 3 |
| United States | 11 |
Site Count
| Site_count | Study_Count |
|---|---|
| 1 | 29 |
| 2 | 7 |
| 3 | 4 |
| 4 | 2 |
| 5 | 1 |
| 6 | 2 |
| 7 | 2 |
| 8 | 1 |
| 9 | 2 |
| 10 | 2 |
| 12 | 1 |
| 18 | 2 |
| 20 | 1 |
| 23 | 1 |
| 24 | 1 |
| 100 | 1 |
| 166 | 1 |
Arms
| number_of_arms | Study_Count |
|---|---|
| 1 | 4 |
| 2 | 17 |
| 3 | 8 |
| 4 | 10 |
| 6 | 8 |
| 7 | 1 |
| 8 | 2 |
| 9 | 1 |
| 10 | 2 |
| 11 | 1 |
| 12 | 1 |
| 13 | 1 |
| 14 | 1 |
| 15 | 1 |
| 21 | 1 |
| 24 | 1 |
Enrollment
| Measure | Vaccine |
|---|---|
| Min | 12.000 |
| 1st Qu | 117.000 |
| Median | 431.000 |
| Mean | 3991.517 |
| 3rd Qu | 1715.000 |
| Max | 45000.000 |
Model
| intervention_model | Study_Count |
|---|---|
| Crossover Assignment | 1 |
| Parallel Assignment | 34 |
| Sequential Assignment | 20 |
| Single Group Assignment | 5 |
Group Types
| group_type | Group_Count |
|---|---|
| Experimental | 222 |
| Placebo Comparator | 54 |
| Active Comparator | 33 |
| No Intervention | 1 |
| Other | 1 |
| Sham Comparator | 1 |
Update Count
| Count of Versions | Count of Studies |
|---|---|
| 1 | 10 |
| 2 | 19 |
| 3 | 12 |
| 4 | 4 |
| 5 | 6 |
| 6 | 2 |
| 7 | 3 |
| 11 | 2 |
| 13 | 1 |
| 15 | 1 |
Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 153 | 50 | 3.060000 |
| Contacts/Locations | 95 | 42 | 2.261905 |
| None (earliest Version on record) | 60 | 60 | 1.000000 |
| Recruitment Status | 44 | 35 | 1.257143 |
| Study Design | 32 | 17 | 1.882353 |
| Arms | 29 | 18 | 1.611111 |
| Interventions | 29 | 18 | 1.611111 |
| Eligibility | 28 | 14 | 2.000000 |
| Study Identification | 28 | 18 | 1.555556 |
| Study Description | 24 | 15 | 1.600000 |
| Outcome Measures | 22 | 15 | 1.466667 |
| Oversight | 14 | 13 | 1.076923 |
| Sponsor/Collaborators | 8 | 8 | 1.000000 |
| Conditions | 6 | 3 | 2.000000 |
| References | 6 | 3 | 2.000000 |
| IPDSharing | 4 | 4 | 1.000000 |
Observational Studies
Studies by Country
| Country | Study_Count |
|---|---|
| France | 236 |
| United States | 158 |
| Italy | 72 |
| Egypt | 69 |
| United Kingdom | 66 |
| Turkey | 52 |
| China | 41 |
| Spain | 39 |
| Germany | 27 |
| Switzerland | 25 |
| Canada | 21 |
| Belgium | 17 |
| Denmark | 15 |
| Norway | 13 |
| India | 11 |
| Russian Federation | 11 |
| Sweden | 11 |
| Austria | 10 |
| Mexico | 10 |
| Brazil | 9 |
| Hong Kong | 9 |
| Argentina | 8 |
| Saudi Arabia | 7 |
| Israel | 6 |
| Pakistan | 6 |
| Netherlands | 5 |
| Greece | 4 |
| Hungary | 4 |
| Malaysia | 4 |
| Singapore | 4 |
| Chile | 3 |
| Monaco | 3 |
| Poland | 3 |
| Portugal | 3 |
| Qatar | 3 |
| Australia | 2 |
| Chile|Colombia|Ecuador|Spain | 2 |
| Czechia | 2 |
| France|French Guiana | 2 |
| Korea, Republic of | 2 |
| Luxembourg | 2 |
| United Arab Emirates | 2 |
| Algeria | 1 |
| Argentina|Bosnia and Herzegovina|Ghana|India|Iran, Islamic Republic of|Sudan | 1 |
| Australia|Canada|China|France|Gambia|Germany|Israel|Italy|Malaysia|Poland|Portugal|Romania|Singapore|Switzerland | 1 |
| Austria|Belgium|Czechia|Germany|Greece|Italy|Netherlands|United Kingdom | 1 |
| Belgium|Italy|United Kingdom | 1 |
| Bolivia | 1 |
| Brazil|Chile|Uruguay | 1 |
| Burkina Faso | 1 |
| Colombia | 1 |
| Denmark|France|Germany|Norway | 1 |
| Ecuador | 1 |
| Ethiopia | 1 |
| Finland|France|Germany|Italy|Sweden|United Kingdom | 1 |
| France|Germany|Spain | 1 |
| France|Guadeloupe|Martinique | 1 |
| France|Martinique | 1 |
| Germany|Romania | 1 |
| Iran, Islamic Republic of | 1 |
| Ireland | 1 |
| Italy|Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|United Kingdom | 1 |
| Italy|Romania|United Kingdom | 1 |
| Italy|San Marino | 1 |
| Japan | 1 |
| Jordan | 1 |
| Nepal | 1 |
| Nigeria | 1 |
| Peru | 1 |
| Philippines | 1 |
| Romania | 1 |
| Slovenia | 1 |
| Taiwan | 1 |
| Tunisia | 1 |
| United States|Albania|Australia|Czechia|France|Germany|Hong Kong|Israel|Italy|Lebanon|Norway|Poland|Spain|Sweden|Taiwan | 1 |
| United States|Argentina|Armenia|Australia|Bolivia|Chile|Costa Rica|Czechia|Germany|Guatemala|Italy|Lebanon|Mexico|Netherlands|Nigeria|Puerto Rico|Saudi Arabia|Spain|Tunisia|Turkey|Venezuela | 1 |
| United States|Argentina|Botswana|Brazil|Kenya|Malawi|Mexico|Mozambique|Peru|South Africa|Tanzania|Zambia|Zimbabwe | 1 |
| United States|Argentina|Denmark|United Kingdom | 1 |
| United States|Bolivia|Canada|Chile|India|United Kingdom | 1 |
| United States|Egypt|Germany|Peru|Singapore | 1 |
| United States|Egypt|Iran, Islamic Republic of | 1 |
| United States|France|Germany|Italy|Poland|Spain|United Kingdom | 1 |
| United States|India | 1 |
| United States|Malawi|Mozambique|Peru|South Africa|Tanzania|Zambia|Zimbabwe | 1 |
| United States|Puerto Rico | 1 |
| United States|Spain | 1 |
| United States|United Kingdom | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 859 |
| 2 | 59 |
| 3 | 32 |
| 4 | 15 |
| 5 | 11 |
| 6 | 9 |
| 7 | 7 |
| 8 | 6 |
| 9 | 6 |
| 11 | 3 |
| 12 | 5 |
| 13 | 1 |
| 14 | 5 |
| 15 | 2 |
| 16 | 1 |
| 17 | 3 |
| 18 | 1 |
| 19 | 1 |
| 20 | 2 |
| 22 | 3 |
| 23 | 2 |
| 32 | 1 |
| 34 | 1 |
| 40 | 1 |
| 44 | 1 |
| 58 | 2 |
| 68 | 1 |
| 81 | 1 |
| 97 | 1 |
| 128 | 1 |
| 793 | 1 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 419 |
| 2 | 347 |
| 3 | 157 |
| 4 | 59 |
| 5 | 23 |
| 6 | 6 |
| 7 | 5 |
| 8 | 4 |
| 9 | 3 |
| 10 | 1 |
| 11 | 2 |
| 13 | 7 |
| 17 | 1 |
| 28 | 1 |
| 32 | 1 |
| 40 | 1 |
| 71 | 1 |
| 80 | 1 |
| 89 | 1 |
| 92 | 1 |
| 97 | 1 |
| 102 | 1 |
| 114 | 1 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 1904 | 625 | 3.046400 |
| None (earliest Version on record) | 1044 | 1044 | 1.000000 |
| Contacts/Locations | 580 | 373 | 1.554960 |
| Recruitment Status | 378 | 327 | 1.155963 |
| Study Description | 236 | 197 | 1.197969 |
| Outcome Measures | 218 | 191 | 1.141361 |
| Study Identification | 200 | 181 | 1.104972 |
| Study Design | 185 | 163 | 1.134969 |
| Eligibility | 145 | 121 | 1.198347 |
| Oversight | 121 | 117 | 1.034188 |
| Groups | 86 | 74 | 1.162162 |
| Interventions | 86 | 74 | 1.162162 |
| Sponsor/Collaborators | 79 | 73 | 1.082192 |
| Conditions | 55 | 52 | 1.057692 |
| References | 26 | 24 | 1.083333 |
| IPDSharing | 10 | 10 | 1.000000 |
| Documents | 6 | 5 | 1.200000 |
| Results Submission Events | 2 | 2 | 1.000000 |
Enrollment Metrics
| Measure | Observational |
|---|---|
| Min | 5.0 |
| 1st Qu | 100.0 |
| Median | 300.0 |
| Mean | 29864.4 |
| 3rd Qu | 1000.0 |
| Max | 10000000.0 |
Observation Model
| observational_model | Study_Count |
|---|---|
| Cohort | 658 |
| Case-Only | 122 |
| Other | 113 |
| Case-Control | 92 |
| Ecologic or Community | 40 |
| Case-Crossover | 12 |
| Family-Based | 6 |
| NA | 1 |
Time Perspective
| time_perspective | Study_Count |
|---|---|
| Prospective | 604 |
| Retrospective | 235 |
| Cross-Sectional | 136 |
| Other | 68 |
| NA | 1 |
Registries
Studies by Country
| Country | Study_Count |
|---|---|
| United States | 28 |
| France | 27 |
| Spain | 21 |
| Italy | 12 |
| Turkey | 10 |
| Germany | 7 |
| Egypt | 6 |
| Sweden | 6 |
| Belgium | 5 |
| Brazil | 4 |
| Mexico | 4 |
| Switzerland | 4 |
| United Kingdom | 4 |
| China | 3 |
| Denmark | 3 |
| Netherlands | 3 |
| Argentina | 2 |
| Austria | 2 |
| Bangladesh | 2 |
| Canada | 2 |
| Norway | 2 |
| Poland | 2 |
| Russian Federation | 2 |
| Australia | 1 |
| Belgium|France | 1 |
| China|Hong Kong|Spain | 1 |
| China|India|Indonesia|Japan|Malaysia|Pakistan|Singapore | 1 |
| France|Martinique | 1 |
| France|United States|Brazil|Colombia|Egypt|Mexico|Spain | 1 |
| Hungary | 1 |
| Iceland | 1 |
| India | 1 |
| Kuwait | 1 |
| Qatar | 1 |
| Singapore | 1 |
| South Africa | 1 |
| Tunisia | 1 |
| Ukraine | 1 |
| United States|Canada|Israel|Japan|Serbia|Spain|United Kingdom | 1 |
| United States|Poland | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 136 |
| 2 | 14 |
| 3 | 2 |
| 4 | 3 |
| 5 | 1 |
| 6 | 1 |
| 7 | 2 |
| 9 | 2 |
| 10 | 1 |
| 11 | 3 |
| 14 | 1 |
| 15 | 1 |
| 17 | 2 |
| 18 | 1 |
| 22 | 1 |
| 27 | 1 |
| 31 | 1 |
| 40 | 1 |
| 42 | 1 |
| 47 | 1 |
| 75 | 1 |
| 76 | 1 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 69 |
| 2 | 59 |
| 3 | 31 |
| 4 | 11 |
| 5 | 2 |
| 6 | 2 |
| 7 | 2 |
| 8 | 1 |
| 13 | 1 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 202 | 109 | 1.853211 |
| None (earliest Version on record) | 178 | 178 | 1.000000 |
| Contacts/Locations | 101 | 64 | 1.578125 |
| Recruitment Status | 61 | 57 | 1.070175 |
| Study Description | 35 | 32 | 1.093750 |
| Study Design | 35 | 32 | 1.093750 |
| Outcome Measures | 32 | 29 | 1.103448 |
| Study Identification | 32 | 30 | 1.066667 |
| Oversight | 22 | 22 | 1.000000 |
| Eligibility | 19 | 19 | 1.000000 |
| Groups | 12 | 12 | 1.000000 |
| Interventions | 12 | 12 | 1.000000 |
| Sponsor/Collaborators | 10 | 10 | 1.000000 |
| Conditions | 7 | 7 | 1.000000 |
| References | 6 | 6 | 1.000000 |
| Documents | 5 | 3 | 1.666667 |
| IPDSharing | 3 | 3 | 1.000000 |
| Results | 1 | 1 | 1.000000 |
| Results Submission Events | 1 | 1 | 1.000000 |
Enrollment Metrics
| Measure | Registries |
|---|---|
| Min | 1.00 |
| 1st Qu | 100.00 |
| Median | 350.00 |
| Mean | 21495.83 |
| 3rd Qu | 1500.00 |
| Max | 3000000.00 |
Registry Model
| observational_model | Study_Count |
|---|---|
| Cohort | 132 |
| Case-Control | 20 |
| Case-Only | 12 |
| Other | 11 |
| Ecologic or Community | 3 |
Time Perspective
| time_perspective | Study_Count |
|---|---|
| Prospective | 131 |
| Other | 29 |
| Cross-Sectional | 18 |
Follow-up
| target_duration | Study_Count |
|---|---|
| 1 Year | 24 |
| 12 Months | 21 |
| 6 Months | 18 |
| 1 Month | 15 |
| 3 Months | 12 |
| 2 Months | 10 |
| 1 Day | 9 |
| 30 Days | 9 |
| 2 Years | 8 |
| 4 Weeks | 5 |
| 14 Days | 3 |
| 2 Weeks | 3 |
| 20 Years | 3 |
| 28 Days | 3 |
| 60 Days | 3 |
| 10 Days | 2 |
| 18 Months | 2 |
| 21 Days | 2 |
| 3 Weeks | 2 |
| 3 Years | 2 |
| 5 Years | 2 |
| 6 Weeks | 2 |
| 1 Week | 1 |
| 10 Months | 1 |
| 12 Years | 1 |
| 14 Weeks | 1 |
| 16 Months | 1 |
| 20 Days | 1 |
| 20 Months | 1 |
| 24 Months | 1 |
| 3 Days | 1 |
| 36 Months | 1 |
| 5 Days | 1 |
| 5 Months | 1 |
| 7 Days | 1 |
| 7 Months | 1 |
| 8 Weeks | 1 |
| 9 Months | 1 |
| 9 Weeks | 1 |
| 90 Days | 1 |
Has Results
| nct_id | brief_title | link |
|---|---|---|
| NCT04323592 | Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome | https://ClinicalTrials.gov/show/NCT04323592 |
Overview of trials
Interventional Trials
| nct_id | brief_title | link |
|---|---|---|
| NCT04244591 | Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04244591 |
| NCT04252118 | Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04252118 |
| NCT04251871 | Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04251871 |
| NCT04252274 | Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04252274 |
| NCT04252885 | The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04252885 |
| NCT04257656 | A Trial of Remdesivir in Adults With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04257656 |
| NCT04263402 | The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04263402 |
| NCT04255017 | A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04255017 |
| NCT04254874 | A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04254874 |
| NCT04261270 | A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04261270 |
| NCT04264533 | Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia | https://ClinicalTrials.gov/show/NCT04264533 |
| NCT04331613 | Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS | https://ClinicalTrials.gov/show/NCT04331613 |
| NCT04275245 | Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04275245 |
| NCT04261517 | Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04261517 |
| NCT04269525 | Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia | https://ClinicalTrials.gov/show/NCT04269525 |
| NCT04282902 | A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04282902 |
| NCT04276688 | Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment | https://ClinicalTrials.gov/show/NCT04276688 |
| NCT04280224 | NK Cells Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04280224 |
| NCT04304313 | A Pilot Study of Sildenafil in COVID-19 | https://ClinicalTrials.gov/show/NCT04304313 |
| NCT04275414 | Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04275414 |
| NCT04273763 | Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04273763 |
| NCT04279197 | Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu | https://ClinicalTrials.gov/show/NCT04279197 |
| NCT04273321 | Efficacy and Safety of Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04273321 |
| NCT04276987 | A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04276987 |
| NCT04276896 | Immunity and Safety of Covid-19 Synthetic Minigene Vaccine | https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04343794 | Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 | https://ClinicalTrials.gov/show/NCT04343794 |
| NCT04280705 | Adaptive COVID-19 Treatment Trial (ACTT) | https://ClinicalTrials.gov/show/NCT04280705 |
| NCT04280588 | Fingolimod in COVID-19 | https://ClinicalTrials.gov/show/NCT04280588 |
| NCT04283461 | Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04303299 | Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04303299 |
| NCT04288102 | Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04288102 |
| NCT04291729 | Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04291729 |
| NCT04292899 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04292899 |
| NCT04292730 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | https://ClinicalTrials.gov/show/NCT04292730 |
| NCT04308317 | Tetrandrine Tablets Used in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04308317 |
| NCT04304053 | Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention | https://ClinicalTrials.gov/show/NCT04304053 |
| NCT04299724 | Safety and Immunity of Covid-19 aAPC Vaccine | https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04303507 | Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting | https://ClinicalTrials.gov/show/NCT04303507 |
| NCT04306055 | Blood Donor Recruitment During Epidemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04306055 |
| NCT04310228 | Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 | https://ClinicalTrials.gov/show/NCT04310228 |
| NCT04305457 | Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04305457 |
| NCT04305106 | Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT | https://ClinicalTrials.gov/show/NCT04305106 |
| NCT04304690 | COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic | https://ClinicalTrials.gov/show/NCT04304690 |
| NCT04307693 | Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04307693 |
| NCT04306393 | Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 | https://ClinicalTrials.gov/show/NCT04306393 |
| NCT04308668 | Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04308668 |
| NCT04316377 | Norwegian Coronavirus Disease 2019 Study | https://ClinicalTrials.gov/show/NCT04316377 |
| NCT04315948 | Trial of Treatments for COVID-19 in Hospitalized Adults | https://ClinicalTrials.gov/show/NCT04315948 |
| NCT04312009 | Losartan for Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04312009 |
| NCT04311177 | Losartan for Patients With COVID-19 Not Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04311177 |
| NCT04315480 | Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis | https://ClinicalTrials.gov/show/NCT04315480 |
| NCT04311697 | Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04311697 |
| NCT04313322 | Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells | https://ClinicalTrials.gov/show/NCT04313322 |
| NCT04313127 | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults | https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04312243 | NO Prevention of COVID-19 for Healthcare Providers | https://ClinicalTrials.gov/show/NCT04312243 |
| NCT04315298 | Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04315298 |
| NCT04312997 | The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04312997 |
| NCT04313023 | The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04313023 |
| NCT04323514 | Use of Ascorbic Acid in Patients With COVID 19 | https://ClinicalTrials.gov/show/NCT04323514 |
| NCT04321174 | COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir | https://ClinicalTrials.gov/show/NCT04321174 |
| NCT04315896 | Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) | https://ClinicalTrials.gov/show/NCT04315896 |
| NCT04323527 | Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 | https://ClinicalTrials.gov/show/NCT04323527 |
| NCT04320056 | Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04320056 |
| NCT04318015 | Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) | https://ClinicalTrials.gov/show/NCT04318015 |
| NCT04317092 | Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) | https://ClinicalTrials.gov/show/NCT04317092 |
| NCT04317040 | CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04317040 |
| NCT04321928 | Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary | https://ClinicalTrials.gov/show/NCT04321928 |
| NCT04319900 | Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04319900 |
| NCT04319445 | Mindfulness During COVID-19 | https://ClinicalTrials.gov/show/NCT04319445 |
| NCT04318444 | Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04318444 |
| NCT04318431 | Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children | https://ClinicalTrials.gov/show/NCT04318431 |
| NCT04324606 | A Study of a Candidate COVID-19 Vaccine (COV001) | https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04325867 | Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04325867 |
| NCT04320953 | Non-contact Endoscopy at Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04320953 |
| NCT04320238 | Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff | https://ClinicalTrials.gov/show/NCT04320238 |
| NCT04319731 | A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure | https://ClinicalTrials.gov/show/NCT04319731 |
| NCT04328961 | Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) | https://ClinicalTrials.gov/show/NCT04328961 |
| NCT04328129 | Household Transmission Investigation Study for COVID-19 in Tropical Regions | https://ClinicalTrials.gov/show/NCT04328129 |
| NCT04323345 | Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus | https://ClinicalTrials.gov/show/NCT04323345 |
| NCT04323228 | Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19 | https://ClinicalTrials.gov/show/NCT04323228 |
| NCT04322682 | Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) | https://ClinicalTrials.gov/show/NCT04322682 |
| NCT04322396 | Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04322396 |
| NCT04322344 | Escin in Patients With Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04322344 |
| NCT04321616 | The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients | https://ClinicalTrials.gov/show/NCT04321616 |
| NCT04321421 | Hyperimmune Plasma for Critical Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04321421 |
| NCT04321278 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) | https://ClinicalTrials.gov/show/NCT04321278 |
| NCT04321096 | The Impact of Camostat Mesilate on COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04321096 |
| NCT04320615 | A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04320615 |
| NCT04330690 | Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial | https://ClinicalTrials.gov/show/NCT04330690 |
| NCT04327349 | Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial | https://ClinicalTrials.gov/show/NCT04327349 |
| NCT04326920 | Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) | https://ClinicalTrials.gov/show/NCT04326920 |
| NCT04322565 | Colchicine Counteracting Inflammation in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04322565 |
| NCT04322123 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) | https://ClinicalTrials.gov/show/NCT04322123 |
| NCT04321993 | Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04321993 |
| NCT04323800 | Convalescent Plasma to Stem Coronavirus (CSSC-001) | https://ClinicalTrials.gov/show/NCT04323800 |
| NCT04322773 | Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure | https://ClinicalTrials.gov/show/NCT04322773 |
| NCT04371601 | Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04371601 |
| NCT04353271 | Trial of Hydroxychloroquine In Covid-19 Kinetics | https://ClinicalTrials.gov/show/NCT04353271 |
| NCT04336462 | Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04336462 |
| NCT04328285 | Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers | https://ClinicalTrials.gov/show/NCT04328285 |
| NCT04327505 | Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04327505 |
| NCT04327206 | BCG Vaccination to Protect Healthcare Workers Against COVID-19 | https://ClinicalTrials.gov/show/NCT04327206 |
| NCT04324996 | A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 | https://ClinicalTrials.gov/show/NCT04324996 |
| NCT04324528 | Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation | https://ClinicalTrials.gov/show/NCT04324528 |
| NCT04324489 | DAS181 for Severe COVID-19: Compassionate Use | https://ClinicalTrials.gov/show/NCT04324489 |
| NCT04324073 | Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI | https://ClinicalTrials.gov/show/NCT04324073 |
| NCT04324021 | Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04324021 |
| NCT04326452 | Treating COVID-19 With a Bidirectional Oxygenation Valve | https://ClinicalTrials.gov/show/NCT04326452 |
| NCT04325893 | Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease | https://ClinicalTrials.gov/show/NCT04325893 |
| NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | https://ClinicalTrials.gov/show/NCT04324463 |
| NCT04355962 | Sevoflurane in COVID-19 ARDS (SevCov) | https://ClinicalTrials.gov/show/NCT04355962 |
| NCT04329533 | Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04329533 |
| NCT04327401 | COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III | https://ClinicalTrials.gov/show/NCT04327401 |
| NCT04326790 | The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention | https://ClinicalTrials.gov/show/NCT04326790 |
| NCT04326426 | ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04326426 |
| NCT04324190 | DIgital Online SuPport for COVID-19 StrEss | https://ClinicalTrials.gov/show/NCT04324190 |
| NCT04327388 | Sarilumab COVID-19 | https://ClinicalTrials.gov/show/NCT04327388 |
| NCT04325906 | Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS | https://ClinicalTrials.gov/show/NCT04325906 |
| NCT04326036 | Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04326036 |
| NCT04328493 | The Vietnam Chloroquine Treatment on COVID-19 | https://ClinicalTrials.gov/show/NCT04328493 |
| NCT04328467 | Pre-exposure Prophylaxis for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04328467 |
| NCT04328441 | Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine | https://ClinicalTrials.gov/show/NCT04328441 |
| NCT04328012 | COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04328012 |
| NCT04331899 | Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04331899 |
| NCT04336254 | Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04336254 |
| NCT04329195 | ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic | https://ClinicalTrials.gov/show/NCT04329195 |
| NCT04333368 | Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS | https://ClinicalTrials.gov/show/NCT04333368 |
| NCT04331054 | Protective Role of Inhaled Steroids for Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04331054 |
| NCT04329611 | ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease | https://ClinicalTrials.gov/show/NCT04329611 |
| NCT04348370 | BCG Vaccine for Health Care Workers as Defense Against COVID 19 | https://ClinicalTrials.gov/show/NCT04348370 |
| NCT04332380 | Convalescent Plasma for Patients With COVID-19: A Pilot Study | https://ClinicalTrials.gov/show/NCT04332380 |
| NCT04332107 | Azithromycin for COVID-19 Treatment in Outpatients Nationwide | https://ClinicalTrials.gov/show/NCT04332107 |
| NCT04332081 | Hyperbaric Oxygen for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04332081 |
| NCT04331600 | Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 | https://ClinicalTrials.gov/show/NCT04331600 |
| NCT04331470 | Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04331470 |
| NCT04329923 | The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) | https://ClinicalTrials.gov/show/NCT04329923 |
| NCT04329832 | Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04329832 |
| NCT04328480 | The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04328480 |
| NCT04376515 | Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19) | https://ClinicalTrials.gov/show/NCT04376515 |
| NCT04352348 | Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being | https://ClinicalTrials.gov/show/NCT04352348 |
| NCT04347174 | A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04347174 |
| NCT04343651 | Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04343651 |
| NCT04342182 | Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) | https://ClinicalTrials.gov/show/NCT04342182 |
| NCT04336332 | Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04336332 |
| NCT04335123 | Study of Open Label Losartan in COVID-19 | https://ClinicalTrials.gov/show/NCT04335123 |
| NCT04333732 | CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION | https://ClinicalTrials.gov/show/NCT04333732 |
| NCT04333355 | Safety in Convalescent Plasma Transfusion to COVID-19 | https://ClinicalTrials.gov/show/NCT04333355 |
| NCT04332991 | Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease | https://ClinicalTrials.gov/show/NCT04332991 |
| NCT04332835 | Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study | https://ClinicalTrials.gov/show/NCT04332835 |
| NCT04332094 | Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04332094 |
| NCT04331808 | CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) | https://ClinicalTrials.gov/show/NCT04331808 |
| NCT04331366 | Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04331366 |
| NCT04330638 | Treatment of COVID-19 Patients With Anti-interleukin Drugs | https://ClinicalTrials.gov/show/NCT04330638 |
| NCT04330586 | A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04330586 |
| NCT04329650 | Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04329650 |
| NCT04335305 | Checkpoint Blockade in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04335305 |
| NCT04339712 | Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction | https://ClinicalTrials.gov/show/NCT04339712 |
| NCT04338009 | Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04338009 |
| NCT04337996 | Dynamic Evaluation of COVID-19 Diagnostic Tests | https://ClinicalTrials.gov/show/NCT04337996 |
| NCT04335279 | Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program | https://ClinicalTrials.gov/show/NCT04335279 |
| NCT04335097 | Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation | https://ClinicalTrials.gov/show/NCT04335097 |
| NCT04334265 | Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 | https://ClinicalTrials.gov/show/NCT04334265 |
| NCT04334044 | Treatment of SARS Caused by COVID-19 With Ruxolitinib | https://ClinicalTrials.gov/show/NCT04334044 |
| NCT04333654 | Hydroxychloroquine in Outpatient Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04333654 |
| NCT04333589 | Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive | https://ClinicalTrials.gov/show/NCT04333589 |
| NCT04333550 | Application of Desferal to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04333550 |
| NCT04333420 | Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04333420 |
| NCT04333407 | Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. | https://ClinicalTrials.gov/show/NCT04333407 |
| NCT04333225 | Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04333225 |
| NCT04331795 | Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04331795 |
| NCT04335136 | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04335136 |
| NCT04345523 | Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04345523 |
| NCT04340349 | Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04340349 |
| NCT04339660 | Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04339660 |
| NCT04337541 | Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System | https://ClinicalTrials.gov/show/NCT04337541 |
| NCT04335851 | Video-Based Exercises and Well-Being During Social Isolation | https://ClinicalTrials.gov/show/NCT04335851 |
| NCT04335786 | Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease | https://ClinicalTrials.gov/show/NCT04335786 |
| NCT04335084 | A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04335084 |
| NCT04335071 | Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04335071 |
| NCT04334928 | Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel | https://ClinicalTrials.gov/show/NCT04334928 |
| NCT04334850 | Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04334850 |
| NCT04334629 | LIBERATE Trial in COVID-19 | https://ClinicalTrials.gov/show/NCT04334629 |
| NCT04334512 | A Study of Quintuple Therapy to Treat COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04334512 |
| NCT04334460 | Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects | https://ClinicalTrials.gov/show/NCT04334460 |
| NCT04334382 | Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 | https://ClinicalTrials.gov/show/NCT04334382 |
| NCT04347226 | Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04347226 |
| NCT04348409 | Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04348409 |
| NCT04343053 | Pro-thrombotic Status in Patients With SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04343053 |
| NCT04340544 | Hydroxychloroquine for the Treatment of Mild COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04340544 |
| NCT04337008 | Renin Angiotensin System - CoronaVirus | https://ClinicalTrials.gov/show/NCT04337008 |
| NCT04336904 | Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 | https://ClinicalTrials.gov/show/NCT04336904 |
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04335552 | Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04335552 |
| NCT04342650 | Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04342650 |
| NCT04341116 | Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04341116 |
| NCT04338698 | Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT | https://ClinicalTrials.gov/show/NCT04338698 |
| NCT04338568 | Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study | https://ClinicalTrials.gov/show/NCT04338568 |
| NCT04345861 | Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) | https://ClinicalTrials.gov/show/NCT04345861 |
| NCT04343092 | Efficacy of Ivermectin as Add on Therapy in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04343092 |
| NCT04341675 | Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04341675 |
| NCT04338841 | HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04338841 |
| NCT04338828 | Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED | https://ClinicalTrials.gov/show/NCT04338828 |
| NCT04349631 | A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04349631 |
| NCT04346797 | CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort | https://ClinicalTrials.gov/show/NCT04346797 |
| NCT04344951 | Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04344951 |
| NCT04340557 | Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04340557 |
| NCT04339816 | Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial | https://ClinicalTrials.gov/show/NCT04339816 |
| NCT04338074 | TXA and Corona Virus 2019 (COVID19) in Outpatients | https://ClinicalTrials.gov/show/NCT04338074 |
| NCT04337918 | Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04337918 |
| NCT04384380 | Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384380 |
| NCT04364893 | Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04364893 |
| NCT04353674 | Modulation of Hyperinflammation in COVID-19 | https://ClinicalTrials.gov/show/NCT04353674 |
| NCT04352933 | PROLIFIC ChemoprophylaxisTrial (COVID-19) | https://ClinicalTrials.gov/show/NCT04352933 |
| NCT04347031 | A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04347031 |
| NCT04346147 | Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 | https://ClinicalTrials.gov/show/NCT04346147 |
| NCT04345848 | Preventing COVID-19 Complications With Low- and High-dose Anticoagulation | https://ClinicalTrials.gov/show/NCT04345848 |
| NCT04344210 | Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus | https://ClinicalTrials.gov/show/NCT04344210 |
| NCT04342169 | University of Utah COVID-19 Hydrochloroquine Trial | https://ClinicalTrials.gov/show/NCT04342169 |
| NCT04341922 | A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04341922 |
| NCT04341493 | Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04341493 |
| NCT04341441 | Will Hydroxychloroquine Impede or Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04341441 |
| NCT04341415 | Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome | https://ClinicalTrials.gov/show/NCT04341415 |
| NCT04341389 | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04341038 | Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury | https://ClinicalTrials.gov/show/NCT04341038 |
| NCT04340050 | COVID-19 Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04340050 |
| NCT04339426 | Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04339426 |
| NCT04338958 | Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation | https://ClinicalTrials.gov/show/NCT04338958 |
| NCT04345614 | A Study of Auxora in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04345614 |
| NCT04350580 | Polyvalent Immunoglobulin in COVID-19 Related ARds | https://ClinicalTrials.gov/show/NCT04350580 |
| NCT04348383 | Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. | https://ClinicalTrials.gov/show/NCT04348383 |
| NCT04347941 | Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE | https://ClinicalTrials.gov/show/NCT04347941 |
| NCT04347681 | Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04347681 |
| NCT04346693 | An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19 | https://ClinicalTrials.gov/show/NCT04346693 |
| NCT04346420 | Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 | https://ClinicalTrials.gov/show/NCT04346420 |
| NCT04345653 | Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers | https://ClinicalTrials.gov/show/NCT04345653 |
| NCT04344587 | Awake Prone Position for Early Hypoxemia in COVID-19 | https://ClinicalTrials.gov/show/NCT04344587 |
| NCT04344457 | Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04344457 |
| NCT04344236 | Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04344236 |
| NCT04344106 | Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study | https://ClinicalTrials.gov/show/NCT04344106 |
| NCT04343768 | An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04343768 |
| NCT04343755 | Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04343755 |
| NCT04343261 | Convalescent Plasma in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343261 |
| NCT04343248 | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) | https://ClinicalTrials.gov/show/NCT04343248 |
| NCT04342728 | Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation | https://ClinicalTrials.gov/show/NCT04342728 |
| NCT04342689 | The Role of Resistant Starch in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04342689 |
| NCT04342663 | A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04342663 |
| NCT04342221 | Hydroxychloroquine for COVID-19 | https://ClinicalTrials.gov/show/NCT04342221 |
| NCT04341207 | Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients | https://ClinicalTrials.gov/show/NCT04341207 |
| NCT04341142 | Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER | https://ClinicalTrials.gov/show/NCT04341142 |
| NCT04358081 | Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04358081 |
| NCT04353037 | PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04353037 |
| NCT04348513 | Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04348513 |
| NCT04347980 | Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 | https://ClinicalTrials.gov/show/NCT04347980 |
| NCT04346615 | Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen | https://ClinicalTrials.gov/show/NCT04346615 |
| NCT04346589 | Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04346589 |
| NCT04346199 | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | https://ClinicalTrials.gov/show/NCT04346199 |
| NCT04345692 | A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04345692 |
| NCT04344730 | Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04344730 |
| NCT04344431 | Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04344431 |
| NCT04344080 | Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04344080 |
| NCT04344015 | COVID-19 Plasma Collection | https://ClinicalTrials.gov/show/NCT04344015 |
| NCT04343989 | A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04343989 |
| NCT04343976 | Pegylated Interferon Lambda Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04343976 |
| NCT04343963 | Pyridostigmine in Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04343963 |
| NCT04343729 | Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 | https://ClinicalTrials.gov/show/NCT04343729 |
| NCT04351906 | Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04351906 |
| NCT04344041 | COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) | https://ClinicalTrials.gov/show/NCT04344041 |
| NCT04438850 | COVidIVERmectin: Ivermectin for Treatment of Covid-19 | https://ClinicalTrials.gov/show/NCT04438850 |
| NCT04390178 | Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04390178 |
| NCT04351724 | Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) | https://ClinicalTrials.gov/show/NCT04351724 |
| NCT04345991 | Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort | https://ClinicalTrials.gov/show/NCT04345991 |
| NCT04345549 | Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04345549 |
| NCT04345289 | Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04345289 |
| NCT04345276 | Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04345276 |
| NCT04344600 | Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04344600 |
| NCT04344561 | Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation | https://ClinicalTrials.gov/show/NCT04344561 |
| NCT04344535 | Convalescent Plasma vs. Standard Plasma for COVID-19 | https://ClinicalTrials.gov/show/NCT04344535 |
| NCT04344444 | Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease | https://ClinicalTrials.gov/show/NCT04344444 |
| NCT04344288 | Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04344288 |
| NCT04346628 | Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04346628 |
| NCT04348929 | Birth Experience During COVID-19 Confinement | https://ClinicalTrials.gov/show/NCT04348929 |
| NCT04342897 | A Study of LY3127804 in Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04342897 |
| NCT04351789 | Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark | https://ClinicalTrials.gov/show/NCT04351789 |
| NCT04348305 | Hydrocortisone for COVID-19 and Severe Hypoxia | https://ClinicalTrials.gov/show/NCT04348305 |
| NCT04347538 | Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04347538 |
| NCT04345419 | Remdesivir vs Chloroquine in Covid 19 | https://ClinicalTrials.gov/show/NCT04345419 |
| NCT04356495 | Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04356495 |
| NCT04349410 | The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol | https://ClinicalTrials.gov/show/NCT04349410 |
| NCT04347382 | Honey & Nigella Sativa Trial Against COVID-19 | https://ClinicalTrials.gov/show/NCT04347382 |
| NCT04349371 | Saved From COVID-19 | https://ClinicalTrials.gov/show/NCT04349371 |
| NCT04463433 | Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China | https://ClinicalTrials.gov/show/NCT04463433 |
| NCT04349592 | Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19 | https://ClinicalTrials.gov/show/NCT04349592 |
| NCT04346355 | Efficacy of Early Administration of Tocilizumab in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04346355 |
| NCT04360824 | Covid-19 Associated Coagulopathy | https://ClinicalTrials.gov/show/NCT04360824 |
| NCT04359251 | Different PEEP Settings of COVID-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04359251 |
| NCT04357340 | The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04357340 |
| NCT04355728 | Use of UC-MSCs for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355728 |
| NCT04354155 | COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial | https://ClinicalTrials.gov/show/NCT04354155 |
| NCT04350281 | Double Therapy With IFN-beta 1b and Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04350281 |
| NCT04348864 | COVID-19 Diagnostic Self-testing Using Virtual Point-of-care | https://ClinicalTrials.gov/show/NCT04348864 |
| NCT04349241 | Efficacy and Safety of Favipiravir in Management of COVID-19 | https://ClinicalTrials.gov/show/NCT04349241 |
| NCT04348695 | Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. | https://ClinicalTrials.gov/show/NCT04348695 |
| NCT04348656 | CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) | https://ClinicalTrials.gov/show/NCT04348656 |
| NCT04347954 | PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) | https://ClinicalTrials.gov/show/NCT04347954 |
| NCT04347239 | Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04347239 |
| NCT04346667 | Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds | https://ClinicalTrials.gov/show/NCT04346667 |
| NCT04346017 | Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome | https://ClinicalTrials.gov/show/NCT04346017 |
| NCT04348500 | Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease | https://ClinicalTrials.gov/show/NCT04348500 |
| NCT04498936 | Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04498936 |
| NCT04382391 | Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04382391 |
| NCT04361916 | Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) | https://ClinicalTrials.gov/show/NCT04361916 |
| NCT04357808 | Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) | https://ClinicalTrials.gov/show/NCT04357808 |
| NCT04357106 | COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma | https://ClinicalTrials.gov/show/NCT04357106 |
| NCT04355143 | Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) | https://ClinicalTrials.gov/show/NCT04355143 |
| NCT04354831 | A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04354831 |
| NCT04354610 | Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04354610 |
| NCT04353596 | Stopping ACE-inhibitors in COVID-19 | https://ClinicalTrials.gov/show/NCT04353596 |
| NCT04352608 | Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04351763 | Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms | https://ClinicalTrials.gov/show/NCT04351763 |
| NCT04351620 | High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04351620 |
| NCT04351581 | Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04351581 |
| NCT04351542 | Ayurveda for Flu Like Illness During Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351542 |
| NCT04351191 | PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds | https://ClinicalTrials.gov/show/NCT04351191 |
| NCT04350736 | First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04350736 |
| NCT04350684 | Umifenovir in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04350684 |
| NCT04350671 | Interferon Beta 1a in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04350671 |
| NCT04350593 | Dapagliflozin in Respiratory Failure in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04350593 |
| NCT04350320 | Trial to Study the Benefit of Colchicine in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04350320 |
| NCT04349098 | Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04349098 |
| NCT04348435 | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04348435 |
| NCT04347915 | The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04347915 |
| NCT04346446 | Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04346446 |
| NCT04359290 | Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS | https://ClinicalTrials.gov/show/NCT04359290 |
| NCT04357327 | Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04357327 |
| NCT04356534 | Convalescent Plasma Trial in COVID -19 Patients | https://ClinicalTrials.gov/show/NCT04356534 |
| NCT04355897 | CoVID-19 Plasma in Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355897 |
| NCT04355637 | Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia | https://ClinicalTrials.gov/show/NCT04355637 |
| NCT04355364 | Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE) | https://ClinicalTrials.gov/show/NCT04355364 |
| NCT04355026 | Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04355026 |
| NCT04353336 | Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04353336 |
| NCT04352959 | COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses | https://ClinicalTrials.gov/show/NCT04352959 |
| NCT04351516 | Test and Treat COVID 65plus+ | https://ClinicalTrials.gov/show/NCT04351516 |
| NCT04351347 | The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04351347 |
| NCT04351243 | A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) | https://ClinicalTrials.gov/show/NCT04351243 |
| NCT04351152 | Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04351152 |
| NCT04351295 | Efficacy of Faviprevir in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04351295 |
| NCT04359095 | Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia | https://ClinicalTrials.gov/show/NCT04359095 |
| NCT04367662 | Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 | https://ClinicalTrials.gov/show/NCT04367662 |
| NCT04361838 | The COVID-19 ICU PRAYER Study | https://ClinicalTrials.gov/show/NCT04361838 |
| NCT04361344 | Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04361344 |
| NCT04359264 | Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04359264 |
| NCT04358939 | Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) | https://ClinicalTrials.gov/show/NCT04358939 |
| NCT04358549 | Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04358549 |
| NCT04358406 | Rhu-pGSN for Severe Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04358406 |
| NCT04354259 | Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 | https://ClinicalTrials.gov/show/NCT04354259 |
| NCT04353284 | Camostat Mesylate in COVID-19 Outpatients | https://ClinicalTrials.gov/show/NCT04353284 |
| NCT04353206 | Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure | https://ClinicalTrials.gov/show/NCT04353206 |
| NCT04353128 | Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. | https://ClinicalTrials.gov/show/NCT04353128 |
| NCT04352751 | Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 | https://ClinicalTrials.gov/show/NCT04352751 |
| NCT04354870 | COVID-19 PrEP HCW HCQ Study | https://ClinicalTrials.gov/show/NCT04354870 |
| NCT04354428 | Treatment for COVID-19 in High-Risk Adult Outpatients | https://ClinicalTrials.gov/show/NCT04354428 |
| NCT04373044 | Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04373044 |
| NCT04364009 | Anakinra for COVID-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04364009 |
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04363853 |
| NCT04361942 | Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) | https://ClinicalTrials.gov/show/NCT04361942 |
| NCT04359953 | Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04359953 |
| NCT04357782 | Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation | https://ClinicalTrials.gov/show/NCT04357782 |
| NCT04356690 | Etoposide in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04356690 |
| NCT04356482 | CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 | https://ClinicalTrials.gov/show/NCT04356482 |
| NCT04355936 | Telmisartan for Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355936 |
| NCT04355533 | Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 | https://ClinicalTrials.gov/show/NCT04355533 |
| NCT04355351 | Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) | https://ClinicalTrials.gov/show/NCT04355351 |
| NCT04355247 | Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm | https://ClinicalTrials.gov/show/NCT04355247 |
| NCT04355234 | Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns | https://ClinicalTrials.gov/show/NCT04355234 |
| NCT04355767 | Convalescent Plasma in Outpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04355767 |
| NCT04377308 | Fluoxetine to Reduce Intubation and Death After COVID19 Infection | https://ClinicalTrials.gov/show/NCT04377308 |
| NCT04357730 | Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04357730 |
| NCT04376034 | Convalescent Plasma Collection and Treatment in Pediatrics and Adults | https://ClinicalTrials.gov/show/NCT04376034 |
| NCT04363814 | Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04363814 |
| NCT04358614 | Baricitinib Therapy in COVID-19 | https://ClinicalTrials.gov/show/NCT04358614 |
| NCT04357028 | Measles Vaccine in HCW | https://ClinicalTrials.gov/show/NCT04357028 |
| NCT04356937 | Efficacy of Tocilizumab on Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04356937 |
| NCT04534673 | Pegylated Interferon Lambda for Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04534673 |
| NCT04374149 | Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS | https://ClinicalTrials.gov/show/NCT04374149 |
| NCT04374084 | Moxibustion Plus Cupping in Convalescent Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374084 |
| NCT04368845 | Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study | https://ClinicalTrials.gov/show/NCT04368845 |
| NCT04368156 | Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04368156 |
| NCT04366063 | Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04366063 |
| NCT04362332 | Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04362332 |
| NCT04362085 | Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care | https://ClinicalTrials.gov/show/NCT04362085 |
| NCT04362059 | A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04362059 |
| NCT04359901 | Sarilumab for Patients With Moderate COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04359901 |
| NCT04359680 | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04359680 |
| NCT04359537 | Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 | https://ClinicalTrials.gov/show/NCT04359537 |
| NCT04358068 | Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04358068 |
| NCT04358003 | Plasma Adsorption in Patients With Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04358003 |
| NCT04357990 | Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04357990 |
| NCT04357457 | Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia | https://ClinicalTrials.gov/show/NCT04357457 |
| NCT04364763 | A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) | https://ClinicalTrials.gov/show/NCT04364763 |
| NCT04357366 | suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) | https://ClinicalTrials.gov/show/NCT04357366 |
| NCT04359277 | A Randomized Trial of Anticoagulation Strategies in COVID-19 | https://ClinicalTrials.gov/show/NCT04359277 |
| NCT04359797 | COVID-19 Patient Positioning Pragmatic Trial | https://ClinicalTrials.gov/show/NCT04359797 |
| NCT04413864 | Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 | https://ClinicalTrials.gov/show/NCT04413864 |
| NCT04363736 | A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04363736 |
| NCT04363385 | Collection of Biological Samples With Clinical Characterization of Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04363385 |
| NCT04362189 | Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04362189 |
| NCT04362176 | Passive Immunity Trial Of the Nation for COVID-19 | https://ClinicalTrials.gov/show/NCT04362176 |
| NCT04362111 | Early Treatment of Cytokine Storm Syndrome in Covid-19 | https://ClinicalTrials.gov/show/NCT04362111 |
| NCT04361526 | Pilot Study on Cytokine Filtration in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04361526 |
| NCT04360551 | Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04360551 |
| NCT04359862 | Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection | https://ClinicalTrials.gov/show/NCT04359862 |
| NCT04359810 | Plasma Therapy of COVID-19 in Critically Ill Patients | https://ClinicalTrials.gov/show/NCT04359810 |
| NCT04359329 | Estrogen Patch for COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04359329 |
| NCT04358926 | Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) | https://ClinicalTrials.gov/show/NCT04358926 |
| NCT04358783 | Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia | https://ClinicalTrials.gov/show/NCT04358783 |
| NCT04373200 | Human Ab Response & immunoMONItoring of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04373200 |
| NCT04366882 | Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04366882 |
| NCT04366323 | Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04366323 |
| NCT04366245 | Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04366245 |
| NCT04366089 | Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora | https://ClinicalTrials.gov/show/NCT04366089 |
| NCT04365101 | Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) | https://ClinicalTrials.gov/show/NCT04365101 |
| NCT04364737 | CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04364737 |
| NCT04364594 | COVID-19 Search in Conjunctival Cells | https://ClinicalTrials.gov/show/NCT04364594 |
| NCT04361396 | Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361396 |
| NCT04361474 | Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity | https://ClinicalTrials.gov/show/NCT04361474 |
| NCT04361214 | Leflunomide in Mild COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361214 |
| NCT04360980 | The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04360980 |
| NCT04360837 | PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04360837 |
| NCT04360811 | Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04360811 |
| NCT04362137 | Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) | https://ClinicalTrials.gov/show/NCT04362137 |
| NCT04377750 | The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation | https://ClinicalTrials.gov/show/NCT04377750 |
| NCT04368377 | Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04368377 |
| NCT04366947 | Intravascular Access in Suspected/Confirmed COVID-19 Patient | https://ClinicalTrials.gov/show/NCT04366947 |
| NCT04366297 | Intravascular Access of COVID-19 Patient Under Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04366297 |
| NCT04366271 | Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04366271 |
| NCT04364022 | Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland | https://ClinicalTrials.gov/show/NCT04364022 |
| NCT04363528 | Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU | https://ClinicalTrials.gov/show/NCT04363528 |
| NCT04363502 | Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04363502 |
| NCT04363450 | Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) | https://ClinicalTrials.gov/show/NCT04363450 |
| NCT04363437 | COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04363437 |
| NCT04363346 | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia | https://ClinicalTrials.gov/show/NCT04363346 |
| NCT04361253 | Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy | https://ClinicalTrials.gov/show/NCT04361253 |
| NCT04393961 | At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study | https://ClinicalTrials.gov/show/NCT04393961 |
| NCT04385095 | Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04385095 |
| NCT04372589 | Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ) | https://ClinicalTrials.gov/show/NCT04372589 |
| NCT04368923 | Management of Covid-19 Patients During Home Isolation | https://ClinicalTrials.gov/show/NCT04368923 |
| NCT04368260 | Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04368260 |
| NCT04368000 | Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04368000 |
| NCT04367168 | Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04367168 |
| NCT04366960 | Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04366960 |
| NCT04366791 | Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04366791 |
| NCT04366050 | Ramipril for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04366050 |
| NCT04365972 | Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04365972 |
| NCT04365608 | Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04365608 |
| NCT04365309 | Protective Effect of Aspirin on COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04365309 |
| NCT04365257 | Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) | https://ClinicalTrials.gov/show/NCT04365257 |
| NCT04365153 | Canakinumab in Covid-19 Cardiac Injury (The Three C Study) | https://ClinicalTrials.gov/show/NCT04365153 |
| NCT04365127 | Progesterone for the Treatment of COVID-19 in Hospitalized Men | https://ClinicalTrials.gov/show/NCT04365127 |
| NCT04363827 | Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04363827 |
| NCT04363593 | Serology COVID-19 From the Cornwall Hospital Union | https://ClinicalTrials.gov/show/NCT04363593 |
| NCT04363372 | A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04363372 |
| NCT04368988 | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant | https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04363606 | Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability | https://ClinicalTrials.gov/show/NCT04363606 |
| NCT04362813 | Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia | https://ClinicalTrials.gov/show/NCT04362813 |
| NCT04518969 | Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19 | https://ClinicalTrials.gov/show/NCT04518969 |
| NCT04392778 | Clinical Use of Stem Cells for the Treatment of Covid-19 | https://ClinicalTrials.gov/show/NCT04392778 |
| NCT04372017 | Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04372017 |
| NCT04368299 | Telemedicine for Follow-up of Systemic Lupus Erythematosus | https://ClinicalTrials.gov/show/NCT04368299 |
| NCT04365699 | Cardiovascular Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04365699 |
| NCT04364802 | COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients | https://ClinicalTrials.gov/show/NCT04364802 |
| NCT04428268 | Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04428268 |
| NCT04373824 | Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study | https://ClinicalTrials.gov/show/NCT04373824 |
| NCT04370782 | Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting | https://ClinicalTrials.gov/show/NCT04370782 |
| NCT04368676 | Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness | https://ClinicalTrials.gov/show/NCT04368676 |
| NCT04366856 | PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study) | https://ClinicalTrials.gov/show/NCT04366856 |
| NCT04365985 | Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 | https://ClinicalTrials.gov/show/NCT04365985 |
| NCT04365738 | Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04365738 |
| NCT04400032 | Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard | https://ClinicalTrials.gov/show/NCT04400032 |
| NCT04389710 | Convalescent Plasma for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04389710 |
| NCT04379453 | Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses | https://ClinicalTrials.gov/show/NCT04379453 |
| NCT04374565 | Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia | https://ClinicalTrials.gov/show/NCT04374565 |
| NCT04372693 | Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement | https://ClinicalTrials.gov/show/NCT04372693 |
| NCT04370262 | Multi-site Adaptive Trials for COVID-19 | https://ClinicalTrials.gov/show/NCT04370262 |
| NCT04369794 | COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement | https://ClinicalTrials.gov/show/NCT04369794 |
| NCT04369456 | Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients | https://ClinicalTrials.gov/show/NCT04369456 |
| NCT04369365 | A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04369365 |
| NCT04369066 | COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur | https://ClinicalTrials.gov/show/NCT04369066 |
| NCT04367831 | Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04367831 |
| NCT04367545 | Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04367545 |
| NCT04366180 | Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04366180 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | https://ClinicalTrials.gov/show/NCT04368728 |
| NCT04367077 | MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) | https://ClinicalTrials.gov/show/NCT04367077 |
| NCT04406181 | Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04406181 |
| NCT04379154 | Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04379154 |
| NCT04376476 | Host-pathogen Interactions During SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04376476 |
| NCT04371640 | Sirolimus in COVID-19 Phase 1 | https://ClinicalTrials.gov/show/NCT04371640 |
| NCT04371510 | Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients | https://ClinicalTrials.gov/show/NCT04371510 |
| NCT04371419 | COVID-19 Health Messaging to Underserved Communities | https://ClinicalTrials.gov/show/NCT04371419 |
| NCT04371029 | Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS | https://ClinicalTrials.gov/show/NCT04371029 |
| NCT04370886 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04370886 |
| NCT04371393 | MSCs in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04371393 |
| NCT04410354 | Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19 | https://ClinicalTrials.gov/show/NCT04410354 |
| NCT04369469 | Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04369469 |
| NCT04385810 | Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 | https://ClinicalTrials.gov/show/NCT04385810 |
| NCT04384588 | COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) | https://ClinicalTrials.gov/show/NCT04384588 |
| NCT04380532 | Tableted COVID-19 Therapeutic Vaccine | https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04378712 | Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04378712 |
| NCT04375202 | Colchicine in COVID-19: a Pilot Study | https://ClinicalTrials.gov/show/NCT04375202 |
| NCT04374487 | Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications | https://ClinicalTrials.gov/show/NCT04374487 |
| NCT04372186 | A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04372186 |
| NCT04372004 | Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) | https://ClinicalTrials.gov/show/NCT04372004 |
| NCT04371965 | Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04371965 |
| NCT04371367 | Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) | https://ClinicalTrials.gov/show/NCT04371367 |
| NCT04370938 | Provider Burnout During COVID-19 | https://ClinicalTrials.gov/show/NCT04370938 |
| NCT04370288 | Clinical Application of Methylene Blue for Treatment of Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04370288 |
| NCT04369820 | C5a Receptor Expression - COVID-19 (C5-COV) | https://ClinicalTrials.gov/show/NCT04369820 |
| NCT04408066 | COVID-19: A POC Test Under Research & Evaluation | https://ClinicalTrials.gov/show/NCT04408066 |
| NCT04379531 | LDCT in COVID-19 Pneumonia: a Prospective Moscow Study | https://ClinicalTrials.gov/show/NCT04379531 |
| NCT04374942 | Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? | https://ClinicalTrials.gov/show/NCT04374942 |
| NCT04373382 | Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04373382 |
| NCT04373135 | Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 | https://ClinicalTrials.gov/show/NCT04373135 |
| NCT04373161 | Home Pulse Oximeter Use in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04373161 |
| NCT04372680 | WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound | https://ClinicalTrials.gov/show/NCT04372680 |
| NCT04372628 | Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 | https://ClinicalTrials.gov/show/NCT04372628 |
| NCT04374032 | Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04374032 |
| NCT04371978 | Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 | https://ClinicalTrials.gov/show/NCT04371978 |
| NCT04377568 | Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children | https://ClinicalTrials.gov/show/NCT04377568 |
| NCT04373460 | Convalescent Plasma to Limit SARS-CoV-2 Associated Complications | https://ClinicalTrials.gov/show/NCT04373460 |
| NCT04383002 | High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients) | https://ClinicalTrials.gov/show/NCT04383002 |
| NCT04379271 | A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) | https://ClinicalTrials.gov/show/NCT04379271 |
| NCT04378738 | Social Media and Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04378738 |
| NCT04377789 | Effect of Quercetin on Prophylaxis and Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04377789 |
| NCT04376788 | Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04376788 |
| NCT04375124 | Treatment of Angiotensin Peptide (1-7) for COVID-19 | https://ClinicalTrials.gov/show/NCT04375124 |
| NCT04374786 | Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04374786 |
| NCT04374019 | Novel Agents for Treatment of High-risk COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04374019 |
| NCT04373733 | Early Intervention in COVID-19: Favipiravir Verses Standard Care | https://ClinicalTrials.gov/show/NCT04373733 |
| NCT04373707 | Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 | https://ClinicalTrials.gov/show/NCT04373707 |
| NCT04374461 | A Study of N-acetylcysteine in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04374461 |
| NCT04374539 | Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04374539 |
| NCT04374591 | The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04374591 |
| NCT04374526 | Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. | https://ClinicalTrials.gov/show/NCT04374526 |
| NCT04394455 | Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms | https://ClinicalTrials.gov/show/NCT04394455 |
| NCT04392531 | Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04392531 |
| NCT04376814 | Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 | https://ClinicalTrials.gov/show/NCT04376814 |
| NCT04376593 | PET/CT Imaging in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04376593 |
| NCT04375098 | Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04375098 |
| NCT04391712 | Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease | https://ClinicalTrials.gov/show/NCT04391712 |
| NCT04388527 | COVID-19 Convalescent Plasma for Mechanically Ventilated Population | https://ClinicalTrials.gov/show/NCT04388527 |
| NCT04385043 | Hyperimmune Plasma in Patients With COVID-19 Severe Infection | https://ClinicalTrials.gov/show/NCT04385043 |
| NCT04380935 | Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04380935 |
| NCT04380818 | Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 | https://ClinicalTrials.gov/show/NCT04380818 |
| NCT04379336 | BCG Vaccination for Healthcare Workers in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04379336 |
| NCT04378803 | Mindfulness Training for Seniors | https://ClinicalTrials.gov/show/NCT04378803 |
| NCT04377672 | Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04377672 |
| NCT04377659 | Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04377659 |
| NCT04377620 | Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) | https://ClinicalTrials.gov/show/NCT04377620 |
| NCT04377477 | COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) | https://ClinicalTrials.gov/show/NCT04377477 |
| NCT04377165 | Innovative Tool to Limit Spread of SARS-CoV-2 in Residential Aged Care Facilities | https://ClinicalTrials.gov/show/NCT04377165 |
| NCT04375397 | Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury | https://ClinicalTrials.gov/show/NCT04375397 |
| NCT04379375 | Nudges to Improve Health Behaviors That Limit COVID-19 Spread | https://ClinicalTrials.gov/show/NCT04379375 |
| NCT04376684 | Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease | https://ClinicalTrials.gov/show/NCT04376684 |
| NCT04581031 | COntinuous Signs Monitoring In Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04581031 |
| NCT04392713 | Efficacy of Ivermectin in COVID-19 | https://ClinicalTrials.gov/show/NCT04392713 |
| NCT04389372 | Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse | https://ClinicalTrials.gov/show/NCT04389372 |
| NCT04385108 | Predictive Immune Biomarkers for COVID-19 Pathogenesis | https://ClinicalTrials.gov/show/NCT04385108 |
| NCT04383613 | Prone Positioning for Patients on General Medical Wards With COVID19 | https://ClinicalTrials.gov/show/NCT04383613 |
| NCT04379037 | Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04379037 |
| NCT04379661 | SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 | https://ClinicalTrials.gov/show/NCT04379661 |
| NCT04379076 | InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort | https://ClinicalTrials.gov/show/NCT04379076 |
| NCT04378920 | A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715) | https://ClinicalTrials.gov/show/NCT04378920 |
| NCT04377711 | A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04377711 |
| NCT04381884 | Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04381884 |
| NCT04377100 | Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses | https://ClinicalTrials.gov/show/NCT04377100 |
| NCT04433910 | A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04433910 |
| NCT04385901 | Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth | https://ClinicalTrials.gov/show/NCT04385901 |
| NCT04384549 | Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers | https://ClinicalTrials.gov/show/NCT04384549 |
| NCT04382768 | Inhaled Ibuprofen to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04382768 |
| NCT04382092 | Co-infection Management in COVID-19 Critically Ill | https://ClinicalTrials.gov/show/NCT04382092 |
| NCT04381858 | Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04381858 |
| NCT04380701 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04380376 | Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia | https://ClinicalTrials.gov/show/NCT04380376 |
| NCT04379518 | Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients | https://ClinicalTrials.gov/show/NCT04379518 |
| NCT04380519 | Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04380519 |
| NCT04383535 | Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04383535 |
| NCT04521309 | SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04521309 |
| NCT04390477 | Study to Evaluate the Effect of a Probiotic in COVID-19 | https://ClinicalTrials.gov/show/NCT04390477 |
| NCT04390139 | Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04390139 |
| NCT04390022 | Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial | https://ClinicalTrials.gov/show/NCT04390022 |
| NCT04384497 | Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study | https://ClinicalTrials.gov/show/NCT04384497 |
| NCT04384731 | Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04384731 |
| NCT04382755 | Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04382755 |
| NCT04382066 | Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04382066 |
| NCT04381962 | A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) | https://ClinicalTrials.gov/show/NCT04381962 |
| NCT04381377 | Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 | https://ClinicalTrials.gov/show/NCT04381377 |
| NCT04381364 | Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) | https://ClinicalTrials.gov/show/NCT04381364 |
| NCT04381000 | Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04381000 |
| NCT04380961 | A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 | https://ClinicalTrials.gov/show/NCT04380961 |
| NCT04380909 | ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation | https://ClinicalTrials.gov/show/NCT04380909 |
| NCT04380688 | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | https://ClinicalTrials.gov/show/NCT04380688 |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | https://ClinicalTrials.gov/show/NCT04381936 |
| NCT04382040 | A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04382040 |
| NCT04382586 | Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants | https://ClinicalTrials.gov/show/NCT04382586 |
| NCT04405986 | Exploring Brain Damages After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04405986 |
| NCT04400929 | Using GM-CSF as a Host Directed Therapeutic Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400929 |
| NCT04394416 | Trial of Imatinib for Hospitalized Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04394416 |
| NCT04390464 | mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) | https://ClinicalTrials.gov/show/NCT04390464 |
| NCT04389294 | HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists | https://ClinicalTrials.gov/show/NCT04389294 |
| NCT04386694 | Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04386694 |
| NCT04384965 | Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04384965 |
| NCT04382924 | Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04382924 |
| NCT04382729 | Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia | https://ClinicalTrials.gov/show/NCT04382729 |
| NCT04382651 | Study of Efficacy and Safety of MAS825 in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04382651 |
| NCT04382547 | Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells | https://ClinicalTrials.gov/show/NCT04382547 |
| NCT04382131 | Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) | https://ClinicalTrials.gov/show/NCT04382131 |
| NCT04381988 | A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy | https://ClinicalTrials.gov/show/NCT04381988 |
| NCT04394377 | Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial | https://ClinicalTrials.gov/show/NCT04394377 |
| NCT04382053 | Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04382053 |
| NCT04384458 | Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis | https://ClinicalTrials.gov/show/NCT04384458 |
| NCT04389333 | Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04389333 |
| NCT04387760 | Favipiravir vs Hydroxychloroquine in COVID -19 | https://ClinicalTrials.gov/show/NCT04387760 |
| NCT04385199 | Convalescent Plasma for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04385199 |
| NCT04383574 | Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) | https://ClinicalTrials.gov/show/NCT04383574 |
| NCT04384445 | Zofin (Organicell Flow) for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384445 |
| NCT04392973 | FAvipiravir and HydroxyChloroquine Combination Therapy | https://ClinicalTrials.gov/show/NCT04392973 |
| NCT04391140 | Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04391140 |
| NCT04385836 | Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04385836 |
| NCT04385017 | Role of Inflammasomes in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04385017 |
| NCT04446104 | A Preventive Treatment for Migrant Workers at High-risk of COVID-19 | https://ClinicalTrials.gov/show/NCT04446104 |
| NCT04442191 | Convalescent Plasma as a Possible Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04442191 |
| NCT04393636 | Digital Cardiac Counseling Trial: DCC Trial | https://ClinicalTrials.gov/show/NCT04393636 |
| NCT04388514 | Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04388514 |
| NCT04386850 | Oral 25-hydroxyvitamin D3 and COVID-19 | https://ClinicalTrials.gov/show/NCT04386850 |
| NCT04386291 | Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04386291 |
| NCT04384900 | Accelerated Prone Position Ventilation of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384900 |
| NCT04387409 | Study to Assess VPM1002 in Reducing Healthcare Professionals’ Absenteeism in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04387409 |
| NCT04386616 | A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04386616 |
| NCT04522128 | Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life? | https://ClinicalTrials.gov/show/NCT04522128 |
| NCT04412330 | Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 | https://ClinicalTrials.gov/show/NCT04412330 |
| NCT04400838 | Investigating a Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400838 |
| NCT04391127 | Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04391127 |
| NCT04390191 | Early CPAP in COVID-19 Confirmed or Suspected Patients | https://ClinicalTrials.gov/show/NCT04390191 |
| NCT04389944 | Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04389944 |
| NCT04389385 | COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) | https://ClinicalTrials.gov/show/NCT04389385 |
| NCT04388410 | Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04388410 |
| NCT04387292 | Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic | https://ClinicalTrials.gov/show/NCT04387292 |
| NCT04387253 | Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID | https://ClinicalTrials.gov/show/NCT04387253 |
| NCT04386668 | Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04386668 |
| NCT04479202 | The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04479202 |
| NCT04416919 | Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04416919 |
| NCT04405076 | Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older | https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04394169 | Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04394169 |
| NCT04392414 | Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04392414 |
| NCT04390412 | Low Dose Radiotherapy in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04390412 |
| NCT04388683 | Inhaled Nitric Oxide for Preventing Progression in COVID-19 | https://ClinicalTrials.gov/show/NCT04388683 |
| NCT04389840 | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure | https://ClinicalTrials.gov/show/NCT04389840 |
| NCT04388826 | COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 | https://ClinicalTrials.gov/show/NCT04388826 |
| NCT04420390 | Low Dose Radiotherapy for COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04420390 |
| NCT04390594 | Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal | https://ClinicalTrials.gov/show/NCT04390594 |
| NCT04390516 | Respiratory Decompensation and Model for the Triage of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04390516 |
| NCT04390503 | Convalescent Plasma for COVID-19 Close Contacts | https://ClinicalTrials.gov/show/NCT04390503 |
| NCT04389450 | Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04389450 |
| NCT04397718 | Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04397718 |
| NCT04408040 | Use of Convalescent Plasma for COVID-19 | https://ClinicalTrials.gov/show/NCT04408040 |
| NCT04400799 | Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04400799 |
| NCT04395144 | COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss | https://ClinicalTrials.gov/show/NCT04395144 |
| NCT04394208 | Silymarin in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04394208 |
| NCT04394182 | Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 | https://ClinicalTrials.gov/show/NCT04394182 |
| NCT04393948 | Lung Irradiation for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04393948 |
| NCT04393415 | Using PRP and Cord Blood in Treatment of Covid -19 | https://ClinicalTrials.gov/show/NCT04393415 |
| NCT04392232 | A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection | https://ClinicalTrials.gov/show/NCT04392232 |
| NCT04392323 | Incidence of COVID-19 Test Conversion in Post-surgical Patients | https://ClinicalTrials.gov/show/NCT04392323 |
| NCT04392141 | Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04392141 |
| NCT04391179 | Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 | https://ClinicalTrials.gov/show/NCT04391179 |
| NCT04407208 | Convalescent Plasma Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04407208 |
| NCT04396106 | Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04396106 |
| NCT04395105 | Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04395105 |
| NCT04393727 | Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04393727 |
| NCT04393246 | mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms | https://ClinicalTrials.gov/show/NCT04393246 |
| NCT04407130 | Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04407130 |
| NCT04398004 | Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early | https://ClinicalTrials.gov/show/NCT04398004 |
| NCT04395911 | Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections | https://ClinicalTrials.gov/show/NCT04395911 |
| NCT04394793 | Low Dose Radiation Therapy for Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04394793 |
| NCT04394442 | Hydroxychloroquine in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04394442 |
| NCT04421625 | Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04421625 |
| NCT04405999 | Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04405999 |
| NCT04403269 | NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE | https://ClinicalTrials.gov/show/NCT04403269 |
| NCT04402918 | Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy | https://ClinicalTrials.gov/show/NCT04402918 |
| NCT04399317 | Flow Controlled Ventilation in ARDS Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04399317 |
| NCT04397796 | Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04397796 |
| NCT04395807 | Helmet CPAP Versus HFNC in COVID-19 | https://ClinicalTrials.gov/show/NCT04395807 |
| NCT04395768 | International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 | https://ClinicalTrials.gov/show/NCT04395768 |
| NCT04394117 | Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease | https://ClinicalTrials.gov/show/NCT04394117 |
| NCT04394013 | A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period | https://ClinicalTrials.gov/show/NCT04394013 |
| NCT04393818 | Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19 | https://ClinicalTrials.gov/show/NCT04393818 |
| NCT04393792 | SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 | https://ClinicalTrials.gov/show/NCT04393792 |
| NCT04393038 | ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04393038 |
| NCT04416360 | Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04416360 |
| NCT04414631 | Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04414631 |
| NCT04407286 | Vitamin D Testing and Treatment for COVID 19 | https://ClinicalTrials.gov/show/NCT04407286 |
| NCT04402203 | Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh | https://ClinicalTrials.gov/show/NCT04402203 |
| NCT04399746 | Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04399746 |
| NCT04399252 | Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 | https://ClinicalTrials.gov/show/NCT04399252 |
| NCT04399005 | The Efficacy Comparing Daily and After-each-case Room Disinfection. | https://ClinicalTrials.gov/show/NCT04399005 |
| NCT04397757 | COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. | https://ClinicalTrials.gov/show/NCT04397757 |
| NCT04397692 | Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) | https://ClinicalTrials.gov/show/NCT04397692 |
| NCT04397562 | A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04397562 |
| NCT04397510 | Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury | https://ClinicalTrials.gov/show/NCT04397510 |
| NCT04399967 | COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via “Quit to Win” Contest 2020 | https://ClinicalTrials.gov/show/NCT04399967 |
| NCT04441684 | Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19) | https://ClinicalTrials.gov/show/NCT04441684 |
| NCT04403477 | Convalescent Plasma Therapy in Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04403477 |
| NCT04402970 | Dornase Alfa for ARDS in Patients With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04402970 |
| NCT04401293 | Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04401293 |
| NCT04398277 | A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04398277 |
| NCT04397666 | RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04397666 |
| NCT04397523 | Efficacy and Safety of COVID-19 Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04397523 |
| NCT04552951 | Effect of Vitamin D on Morbidity and Mortality of the COVID-19 | https://ClinicalTrials.gov/show/NCT04552951 |
| NCT04413006 | Self-compassion for Chronic Pain Virtual Group Treatment Program | https://ClinicalTrials.gov/show/NCT04413006 |
| NCT04412538 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04410549 | Pulmonary Optical Coherence Tomography in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410549 |
| NCT04401423 | TXA127 for the Treatment of Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04401423 |
| NCT04401202 | Nigella Sativa in COVID-19 | https://ClinicalTrials.gov/show/NCT04401202 |
| NCT04401150 | Lessening Organ Dysfunction With VITamin C - COVID-19 | https://ClinicalTrials.gov/show/NCT04401150 |
| NCT04400305 | “Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” | https://ClinicalTrials.gov/show/NCT04400305 |
| NCT04400279 | The COVID-19 Pandemic and Exercise Study | https://ClinicalTrials.gov/show/NCT04400279 |
| NCT04399889 | hCT-MSCs for COVID19 ARDS | https://ClinicalTrials.gov/show/NCT04399889 |
| NCT04399681 | The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 | https://ClinicalTrials.gov/show/NCT04399681 |
| NCT04399109 | Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) | https://ClinicalTrials.gov/show/NCT04399109 |
| NCT04399980 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04399980 |
| NCT04400058 | Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression | https://ClinicalTrials.gov/show/NCT04400058 |
| NCT04411602 | Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD | https://ClinicalTrials.gov/show/NCT04411602 |
| NCT04410016 | Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study | https://ClinicalTrials.gov/show/NCT04410016 |
| NCT04408183 | GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel | https://ClinicalTrials.gov/show/NCT04408183 |
| NCT04407390 | Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly | https://ClinicalTrials.gov/show/NCT04407390 |
| NCT04404361 | PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer | https://ClinicalTrials.gov/show/NCT04404361 |
| NCT04402983 | The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04402983 |
| NCT04402879 | CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals | https://ClinicalTrials.gov/show/NCT04402879 |
| NCT04402866 | TD-0903 for ALI Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04402866 |
| NCT04402840 | Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04402840 |
| NCT04402060 | A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04402060 |
| NCT04401579 | Adaptive COVID-19 Treatment Trial 2 (ACTT-2) | https://ClinicalTrials.gov/show/NCT04401579 |
| NCT04401046 | COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder | https://ClinicalTrials.gov/show/NCT04401046 |
| NCT04400890 | Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of a Plant Polyphenol for COVID-19 | https://ClinicalTrials.gov/show/NCT04400890 |
| NCT04411433 | Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04411433 |
| NCT04406493 | Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique | https://ClinicalTrials.gov/show/NCT04406493 |
| NCT04405843 | Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 | https://ClinicalTrials.gov/show/NCT04405843 |
| NCT04403555 | Ivermectin and Doxycycine in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04403555 |
| NCT04403100 | Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” | https://ClinicalTrials.gov/show/NCT04403100 |
| NCT04429711 | Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04429711 |
| NCT04412356 | Timing of Tracheotomy in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04412356 |
| NCT04408456 | Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04408456 |
| NCT04406246 | Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide | https://ClinicalTrials.gov/show/NCT04406246 |
| NCT04404218 | The Açaà Berry COVID-19 Anti-Inflammation Trial | https://ClinicalTrials.gov/show/NCT04404218 |
| NCT04403685 | Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers | https://ClinicalTrials.gov/show/NCT04403685 |
| NCT04417335 | Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination | https://ClinicalTrials.gov/show/NCT04417335 |
| NCT04407182 | Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 | https://ClinicalTrials.gov/show/NCT04407182 |
| NCT04405908 | SCB-2019 as COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04405908 |
| NCT04408209 | Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04408209 |
| NCT04410536 | Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency | https://ClinicalTrials.gov/show/NCT04410536 |
| NCT04430608 | Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04430608 |
| NCT04411446 | Cholecalciferol to Improve the Outcomes of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04411446 |
| NCT04410562 | Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy | https://ClinicalTrials.gov/show/NCT04410562 |
| NCT04409496 | Chat-based Support for Preveting Smoking Relapse | https://ClinicalTrials.gov/show/NCT04409496 |
| NCT04408157 | A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04408157 |
| NCT04405544 | Determination of Acute Encephalopathy Predictors in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04405544 |
| NCT04406389 | Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial) | https://ClinicalTrials.gov/show/NCT04406389 |
| NCT04405310 | Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial | https://ClinicalTrials.gov/show/NCT04405310 |
| NCT04405102 | COVID-19 Ozanimod Intervention Study | https://ClinicalTrials.gov/show/NCT04405102 |
| NCT04405739 | The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) | https://ClinicalTrials.gov/show/NCT04405739 |
| NCT04414618 | A Study of Opaganib in Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04414618 |
| NCT04405570 | A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04405570 |
| NCT04457609 | Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04457609 |
| NCT04444271 | Mesenchymal Stem Cell Infusion for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04444271 |
| NCT04425317 | Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04425317 |
| NCT04416308 | COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) | https://ClinicalTrials.gov/show/NCT04416308 |
| NCT04410692 | Can the Prediction Market Improve Predictions of COVID-19? | https://ClinicalTrials.gov/show/NCT04410692 |
| NCT04410159 | Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410159 |
| NCT04407689 | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort | https://ClinicalTrials.gov/show/NCT04407689 |
| NCT04410510 | P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04410510 |
| NCT04417257 | Study of LAU-7b for the Treatment of COVID-19 Disease in Adults | https://ClinicalTrials.gov/show/NCT04417257 |
| NCT04412486 | COVID-19 Convalescent Plasma (CCP) Transfusion | https://ClinicalTrials.gov/show/NCT04412486 |
| NCT04409834 | Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial | https://ClinicalTrials.gov/show/NCT04409834 |
| NCT04409743 | Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04409743 |
| NCT04409522 | Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04409522 |
| NCT04409327 | Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes | https://ClinicalTrials.gov/show/NCT04409327 |
| NCT04409262 | A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04409262 |
| NCT04408131 | Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study | https://ClinicalTrials.gov/show/NCT04408131 |
| NCT04409509 | Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04409509 |
| NCT04433546 | Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). | https://ClinicalTrials.gov/show/NCT04433546 |
| NCT04427098 | Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04427098 |
| NCT04424901 | Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04424901 |
| NCT04418947 | Project Resurgence Communication Trial | https://ClinicalTrials.gov/show/NCT04418947 |
| NCT04412018 | An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT04412018 |
| NCT04411667 | Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04411667 |
| NCT04411628 | A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04411628 |
| NCT04410458 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） | https://ClinicalTrials.gov/show/NCT04410458 |
| NCT04420182 | COVID-19 Virtual Care at Home | https://ClinicalTrials.gov/show/NCT04420182 |
| NCT04412057 | Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury | https://ClinicalTrials.gov/show/NCT04412057 |
| NCT04412343 | The Seniors COvid-19 Pandemic and Exercise Study | https://ClinicalTrials.gov/show/NCT04412343 |
| NCT04411680 | Study of Sargramostim in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04411680 |
| NCT04416139 | Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 | https://ClinicalTrials.gov/show/NCT04416139 |
| NCT04412239 | To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04412239 |
| NCT04414371 | Tools for Wellbeing COVID-19 National Study of Undergraduate Students | https://ClinicalTrials.gov/show/NCT04414371 |
| NCT04424953 | To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn | https://ClinicalTrials.gov/show/NCT04424953 |
| NCT04417270 | Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge | https://ClinicalTrials.gov/show/NCT04417270 |
| NCT04415086 | Treatment of Patients With COVID-19 With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04415086 |
| NCT04414267 | Bacillus Calmette-guérin Vaccination to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04414267 |
| NCT04414124 | A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04414124 |
| NCT04412785 | Cyclosporine in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04412785 |
| NCT04412772 | A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS | https://ClinicalTrials.gov/show/NCT04412772 |
| NCT04412291 | A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study | https://ClinicalTrials.gov/show/NCT04412291 |
| NCT04412668 | Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04412668 |
| NCT04420247 | Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 | https://ClinicalTrials.gov/show/NCT04420247 |
| NCT04415060 | SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival | https://ClinicalTrials.gov/show/NCT04415060 |
| NCT04413968 | COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants | https://ClinicalTrials.gov/show/NCT04413968 |
| NCT04415151 | Tofacitinib for Treatment of Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04415151 |
| NCT04453852 | Monovalent Recombinant COVID19 Vaccine | https://ClinicalTrials.gov/show/NCT04453852 |
| NCT04439045 | Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity | https://ClinicalTrials.gov/show/NCT04439045 |
| NCT04426305 | Community Health Workers Against COVID19 | https://ClinicalTrials.gov/show/NCT04426305 |
| NCT04425616 | SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer | https://ClinicalTrials.gov/show/NCT04425616 |
| NCT04422509 | Lanadelumab for Treatment of COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04422509 |
| NCT04421404 | Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04421404 |
| NCT04419623 | A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer | https://ClinicalTrials.gov/show/NCT04419623 |
| NCT04419025 | Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease | https://ClinicalTrials.gov/show/NCT04419025 |
| NCT04418518 | A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness | https://ClinicalTrials.gov/show/NCT04418518 |
| NCT04418505 | Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04418505 |
| NCT04416399 | STerOids in COVID-19 Study | https://ClinicalTrials.gov/show/NCT04416399 |
| NCT04416334 | PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 70 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS | https://ClinicalTrials.gov/show/NCT04416334 |
| NCT04435808 | Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 | https://ClinicalTrials.gov/show/NCT04435808 |
| NCT04424212 | ICBT for Mental Health Problems Related to the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04424212 |
| NCT04421391 | QuadraMune(TM) for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04421391 |
| NCT04420741 | Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04420741 |
| NCT04541979 | Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04541979 |
| NCT04513990 | Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04513990 |
| NCT04427566 | Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise | https://ClinicalTrials.gov/show/NCT04427566 |
| NCT04425031 | Handling Oxygenation Targets in COVID-19 | https://ClinicalTrials.gov/show/NCT04425031 |
| NCT04424797 | Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol | https://ClinicalTrials.gov/show/NCT04424797 |
| NCT04422613 | Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04422613 |
| NCT04421664 | Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) | https://ClinicalTrials.gov/show/NCT04421664 |
| NCT04421508 | A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04421508 |
| NCT04420806 | Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women | https://ClinicalTrials.gov/show/NCT04420806 |
| NCT04420338 | SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study | https://ClinicalTrials.gov/show/NCT04420338 |
| NCT04420299 | Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 | https://ClinicalTrials.gov/show/NCT04420299 |
| NCT04421027 | A Study of Baricitinib (LY3009104) in Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04421027 |
| NCT04441918 | Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects | https://ClinicalTrials.gov/show/NCT04441918 |
| NCT04423289 | Telematic Monitoring Through a Mobile Application of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423289 |
| NCT04422561 | Prophylactic Ivermectin in COVID-19 Contacts | https://ClinicalTrials.gov/show/NCT04422561 |
| NCT04425915 | Efficacy of Convalescent Plasma Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425915 |
| NCT04424082 | External Dead Space in Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424082 |
| NCT04422353 | Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson’s Disease | https://ClinicalTrials.gov/show/NCT04422353 |
| NCT04475601 | Enzalutamide Treatment in COVID-19 | https://ClinicalTrials.gov/show/NCT04475601 |
| NCT04426292 | SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04426292 |
| NCT04425707 | Ivermectin In Treatment of COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04425707 |
| NCT04425538 | A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). | https://ClinicalTrials.gov/show/NCT04425538 |
| NCT04425005 | Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric | https://ClinicalTrials.gov/show/NCT04425005 |
| NCT04423991 | Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning | https://ClinicalTrials.gov/show/NCT04423991 |
| NCT04442087 | Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP | https://ClinicalTrials.gov/show/NCT04442087 |
| NCT04431453 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04431453 |
| NCT04426695 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04426695 |
| NCT04425629 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425629 |
| NCT04458948 | Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04458948 |
| NCT04445246 | Inhaled Iloprost for Suspected COVID-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445246 |
| NCT04434131 | Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04434131 |
| NCT04429854 | Donated Antibodies Working Against nCoV | https://ClinicalTrials.gov/show/NCT04429854 |
| NCT04428099 | Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression | https://ClinicalTrials.gov/show/NCT04428099 |
| NCT04427501 | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness | https://ClinicalTrials.gov/show/NCT04427501 |
| NCT04426318 | COVID-19 and the Healthy Minds Program for Educators | https://ClinicalTrials.gov/show/NCT04426318 |
| NCT04425252 | Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425252 |
| NCT04431466 | A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19 | https://ClinicalTrials.gov/show/NCT04431466 |
| NCT04429867 | Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease | https://ClinicalTrials.gov/show/NCT04429867 |
| NCT04429724 | Health Professional Exposure Assessment to Covid-19 | https://ClinicalTrials.gov/show/NCT04429724 |
| NCT04427137 | Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04427137 |
| NCT04555005 | Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04555005 |
| NCT04435717 | Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) | https://ClinicalTrials.gov/show/NCT04435717 |
| NCT04432051 | The Use of Lung Ultrasonography in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04432051 |
| NCT04462757 | SCIL-1Ra in COVID-19 Feasibility & PK/PD | https://ClinicalTrials.gov/show/NCT04462757 |
| NCT04441424 | Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04441424 |
| NCT04433949 | Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04433949 |
| NCT04432298 | Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04432298 |
| NCT04432272 | ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) | https://ClinicalTrials.gov/show/NCT04432272 |
| NCT04431856 | CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment | https://ClinicalTrials.gov/show/NCT04431856 |
| NCT04431180 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# | https://ClinicalTrials.gov/show/NCT04431180 |
| NCT04432324 | Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04432324 |
| NCT04445272 | Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04445272 |
| NCT04434248 | An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04434248 |
| NCT04435353 | Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19 | https://ClinicalTrials.gov/show/NCT04435353 |
| NCT04444674 | COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection | https://ClinicalTrials.gov/show/NCT04444674 |
| NCT04435522 | Maraviroc in Patients With Moderate and Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04435522 |
| NCT04432987 | Dornase Alpha for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04432987 |
| NCT04432805 | Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04432805 |
| NCT04449718 | Vitamin D Supplementation in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04449718 |
| NCT04447781 | Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 | https://ClinicalTrials.gov/show/NCT04447781 |
| NCT04445194 | Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04445194 |
| NCT04437875 | An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04437875 |
| NCT04436471 | An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04436471 |
| NCT04435379 | Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04435379 |
| NCT04435184 | Crizanlizumab for Treating COVID-19 Vasculopathy | https://ClinicalTrials.gov/show/NCT04435184 |
| NCT04438694 | Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection | https://ClinicalTrials.gov/show/NCT04438694 |
| NCT04499677 | FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals | https://ClinicalTrials.gov/show/NCT04499677 |
| NCT04442958 | Effectiveness of Convalescent Immune Plasma Therapy | https://ClinicalTrials.gov/show/NCT04442958 |
| NCT04439071 | A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19) | https://ClinicalTrials.gov/show/NCT04439071 |
| NCT04439006 | Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04439006 |
| NCT04438070 | COVID Screening Strategies in Homeless Shelters | https://ClinicalTrials.gov/show/NCT04438070 |
| NCT04438057 | Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04438057 |
| NCT04437823 | Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04437823 |
| NCT04437719 | Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04437719 |
| NCT04442230 | NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04442230 |
| NCT04450004 | Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. | https://ClinicalTrials.gov/show/NCT04450004 |
| NCT04449276 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults | https://ClinicalTrials.gov/show/NCT04449276 |
| NCT04444596 | Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04444596 |
| NCT04443881 | Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) | https://ClinicalTrials.gov/show/NCT04443881 |
| NCT04443673 | Glycine Supplement for Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04443673 |
| NCT04441632 | Effect of Positive Attitudes on Behavior and Wellness | https://ClinicalTrials.gov/show/NCT04441632 |
| NCT04441385 | Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). | https://ClinicalTrials.gov/show/NCT04441385 |
| NCT04438980 | Glucocorticoids in COVID-19 (CORTIVID) | https://ClinicalTrials.gov/show/NCT04438980 |
| NCT04445454 | Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04445454 |
| NCT04445389 | Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04445389 |
| NCT04445311 | Ivermectin in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04445311 |
| NCT04442152 | Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants | https://ClinicalTrials.gov/show/NCT04442152 |
| NCT04442048 | Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure | https://ClinicalTrials.gov/show/NCT04442048 |
| NCT04441996 | Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity | https://ClinicalTrials.gov/show/NCT04441996 |
| NCT04442178 | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) | https://ClinicalTrials.gov/show/NCT04442178 |
| NCT04466683 | Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia | https://ClinicalTrials.gov/show/NCT04466683 |
| NCT04473274 | GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study | https://ClinicalTrials.gov/show/NCT04473274 |
| NCT04453384 | Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia | https://ClinicalTrials.gov/show/NCT04453384 |
| NCT04447235 | Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04447235 |
| NCT04446429 | Anti-Androgen Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04446429 |
| NCT04445597 | Unraveling the Mechanisms of Olfactory Dysfunction in COVID-19 | https://ClinicalTrials.gov/show/NCT04445597 |
| NCT04445467 | An Adaptive Clinical Trial of Antivirals for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04445467 |
| NCT04445428 | OPV as Potential Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04445428 |
| NCT04445285 | Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445285 |
| NCT04444700 | A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04444700 |
| NCT04445324 | Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 | https://ClinicalTrials.gov/show/NCT04445324 |
| NCT04445376 | Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery. | https://ClinicalTrials.gov/show/NCT04445376 |
| NCT04456361 | Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04456361 |
| NCT04448769 | Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) | https://ClinicalTrials.gov/show/NCT04448769 |
| NCT04447534 | Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04447534 |
| NCT04446377 | A Study of LAM-002A for the Prevention of Progression of COVID-19 | https://ClinicalTrials.gov/show/NCT04446377 |
| NCT04445935 | Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial | https://ClinicalTrials.gov/show/NCT04445935 |
| NCT04447404 | DUR-928 in Subjects With SARS-CoV-2 With Acute Liver or Kidney Injury | https://ClinicalTrials.gov/show/NCT04447404 |
| NCT04447469 | Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04447469 |
| NCT04448119 | Control of COVID-19 Outbreaks in Long Term Care | https://ClinicalTrials.gov/show/NCT04448119 |
| NCT04458363 | Convalescent Plasma in Pediatric COVID-19 | https://ClinicalTrials.gov/show/NCT04458363 |
| NCT04452773 | Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04452773 |
| NCT04455815 | A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home | https://ClinicalTrials.gov/show/NCT04455815 |
| NCT04448756 | M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia | https://ClinicalTrials.gov/show/NCT04448756 |
| NCT04464486 | Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic | https://ClinicalTrials.gov/show/NCT04464486 |
| NCT04454606 | The New Silicone N99 Half-Piece Respirator | https://ClinicalTrials.gov/show/NCT04454606 |
| NCT04452565 | NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04452565 |
| NCT04451174 | Early Use of Corticosteroids in Hospitalized Patients With Moderate COVID19 Pneumonia | https://ClinicalTrials.gov/show/NCT04451174 |
| NCT04449588 | Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS | https://ClinicalTrials.gov/show/NCT04449588 |
| NCT04463264 | Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04463264 |
| NCT04452318 | Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay | https://ClinicalTrials.gov/show/NCT04452318 |
| NCT04525742 | COVID-19 Pandemic and Parents of Disabled Children | https://ClinicalTrials.gov/show/NCT04525742 |
| NCT04464408 | Favipiravir Therapy in Adults With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04464408 |
| NCT04469621 | A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04469621 |
| NCT04479163 | Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2 | https://ClinicalTrials.gov/show/NCT04479163 |
| NCT04459455 | Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04459455 |
| NCT04458298 | A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04458298 |
| NCT04453475 | Feasibility and Benefits of Digital Services During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04453475 |
| NCT04452435 | Safety and Efficacy of C21 in Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04452435 |
| NCT04451889 | Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04451889 |
| NCT04457388 | Tele-Yoga Therapy for Chronic Pain | https://ClinicalTrials.gov/show/NCT04457388 |
| NCT04457349 | Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19 | https://ClinicalTrials.gov/show/NCT04457349 |
| NCT04456595 | Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04456595 |
| NCT04456153 | Atovaquone for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04456153 |
| NCT04456062 | Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04456062 |
| NCT04455308 | COVID-19 and Chilblains | https://ClinicalTrials.gov/show/NCT04455308 |
| NCT04453514 | Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04453514 |
| NCT04456452 | Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation | https://ClinicalTrials.gov/show/NCT04456452 |
| NCT04454398 | Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04454398 |
| NCT04482673 | Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04482673 |
| NCT04461925 | Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs | https://ClinicalTrials.gov/show/NCT04461925 |
| NCT04460027 | W-SUDs for COVID-19 | https://ClinicalTrials.gov/show/NCT04460027 |
| NCT04458246 | Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04458246 |
| NCT04458519 | Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection | https://ClinicalTrials.gov/show/NCT04458519 |
| NCT04465604 | Hypertonic Saline for COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04465604 |
| NCT04463849 | Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients | https://ClinicalTrials.gov/show/NCT04463849 |
| NCT04461379 | Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04461379 |
| NCT04460703 | COVID-19 Vaccine Messaging, Part 1 | https://ClinicalTrials.gov/show/NCT04460703 |
| NCT04460534 | Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) | https://ClinicalTrials.gov/show/NCT04460534 |
| NCT04457726 | Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04457726 |
| NCT04505761 | The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19 | https://ClinicalTrials.gov/show/NCT04505761 |
| NCT04470869 | Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement. | https://ClinicalTrials.gov/show/NCT04470869 |
| NCT04466540 | Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04466540 |
| NCT04459962 | Covid-19 Breath Test | https://ClinicalTrials.gov/show/NCT04459962 |
| NCT04459676 | Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04459676 |
| NCT04459325 | Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04459325 |
| NCT04459247 | Short Term, High Dose Vitamin D Supplementation for COVID-19 | https://ClinicalTrials.gov/show/NCT04459247 |
| NCT04467918 | CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms | https://ClinicalTrials.gov/show/NCT04467918 |
| NCT04460183 | A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04460183 |
| NCT04463420 | Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04463420 |
| NCT04461340 | Efficacy and Safety of Sirolimus in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04461340 |
| NCT04460443 | Sofosbuvir With and Without Ribavirin in Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04460443 |
| NCT04468139 | The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04468139 |
| NCT04459520 | Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance | https://ClinicalTrials.gov/show/NCT04459520 |
| NCT04479540 | Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease | https://ClinicalTrials.gov/show/NCT04479540 |
| NCT04472728 | Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04472728 |
| NCT04460677 | ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04460677 |
| NCT04460690 | Rapid, Onsite COVID-19 Detection | https://ClinicalTrials.gov/show/NCT04460690 |
| NCT04460014 | Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT | https://ClinicalTrials.gov/show/NCT04460014 |
| NCT04468646 | To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04468646 |
| NCT04464395 | Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04464395 |
| NCT04463602 | Desidustat in the Management of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04463602 |
| NCT04463004 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04463004 |
| NCT04462627 | Reduction of COVID 19 Transmission to Health Care Professionals | https://ClinicalTrials.gov/show/NCT04462627 |
| NCT04514627 | Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04514627 |
| NCT04469179 | Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04469179 |
| NCT04466670 | Hemostasis in COVID-19: an Adaptive Clinical Trial | https://ClinicalTrials.gov/show/NCT04466670 |
| NCT04466098 | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) | https://ClinicalTrials.gov/show/NCT04466098 |
| NCT04466085 | Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04466085 |
| NCT04463472 | Study of COVID-19 DNA Vaccine (AG0301-COVID19) | https://ClinicalTrials.gov/show/NCT04463472 |
| NCT04473053 | Rapid Experimental Medicine for COVID-19 | https://ClinicalTrials.gov/show/NCT04473053 |
| NCT04471636 | Telemedicine in Outpatient Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04471636 |
| NCT04470999 | Changes in Cellular Immune Profile During COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04470999 |
| NCT04470544 | Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04470544 |
| NCT04468009 | Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04468009 |
| NCT04466800 | Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19) | https://ClinicalTrials.gov/show/NCT04466800 |
| NCT04466605 | Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown | https://ClinicalTrials.gov/show/NCT04466605 |
| NCT04466280 | Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04466280 |
| NCT04465695 | Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 | https://ClinicalTrials.gov/show/NCT04465695 |
| NCT04467840 | Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04467840 |
| NCT04469114 | Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04469114 |
| NCT04468893 | Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04468893 |
| NCT04468971 | REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia | https://ClinicalTrials.gov/show/NCT04468971 |
| NCT04560231 | Remdesivir in COVID-19 Lahore General Hospital | https://ClinicalTrials.gov/show/NCT04560231 |
| NCT04560205 | Tocilizumab in COVID-19 Lahore General Hospital | https://ClinicalTrials.gov/show/NCT04560205 |
| NCT04470531 | Role of Co-trimoxazole in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04470531 |
| NCT04470427 | A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04470427 |
| NCT04470739 | Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities? | https://ClinicalTrials.gov/show/NCT04470739 |
| NCT04480593 | The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19. | https://ClinicalTrials.gov/show/NCT04480593 |
| NCT04495933 | A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04495933 |
| NCT04479358 | Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04479358 |
| NCT04477993 | Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04477993 |
| NCT04476667 | Online Delivery of Psychotherapy, Tailored to Patients’ Suffering From Mental Health Problems Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04476667 |
| NCT04470622 | Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) | https://ClinicalTrials.gov/show/NCT04470622 |
| NCT04470609 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years | https://ClinicalTrials.gov/show/NCT04470609 |
| NCT04560257 | High Flow Nasal Cannula HFNC In Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04560257 |
| NCT04537962 | Evaluationof the Load of SARS-CoV-2 Virus in Oral Cavity, Oropharinge and Saliva of Patients With Covid-19 After Disinfection With Oral Antimicrobial Solutions: a Pilot Study | https://ClinicalTrials.gov/show/NCT04537962 |
| NCT04478539 | Extracorporeal Blood Purification as a Treatment Modality for COVID-19 | https://ClinicalTrials.gov/show/NCT04478539 |
| NCT04477083 | Development and Validation of “Ready-to-Use” Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04477083 |
| NCT04475913 | Digital vs Analog Impression in Cases of All-on-4 - Prosthesis | https://ClinicalTrials.gov/show/NCT04475913 |
| NCT04475107 | The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04475107 |
| NCT04473898 | Telerehabilitation After Coronavirus | https://ClinicalTrials.gov/show/NCT04473898 |
| NCT04473261 | Efficacy of Iodine Complex Against COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04473261 |
| NCT04473248 | Spartan COVID-19 System: Evaluation of Clinical Sample Collection | https://ClinicalTrials.gov/show/NCT04473248 |
| NCT04473170 | Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 | https://ClinicalTrials.gov/show/NCT04473170 |
| NCT04472585 | Efficacy of Subcutaneous Ivermectin With or Without Zinc and Nigella Sativa in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04472585 |
| NCT04471766 | Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention | https://ClinicalTrials.gov/show/NCT04471766 |
| NCT04488081 | I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients | https://ClinicalTrials.gov/show/NCT04488081 |
| NCT04472494 | Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise | https://ClinicalTrials.gov/show/NCT04472494 |
| NCT04475575 | Can the Electronic Nose Smell COVID-19 Antibodies? | https://ClinicalTrials.gov/show/NCT04475575 |
| NCT04475562 | Can the Electronic Nose Smell COVID-19? | https://ClinicalTrials.gov/show/NCT04475562 |
| NCT04500067 | Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment | https://ClinicalTrials.gov/show/NCT04500067 |
| NCT04481685 | A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04481685 |
| NCT04478071 | Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04478071 |
| NCT04478019 | SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding | https://ClinicalTrials.gov/show/NCT04478019 |
| NCT04477655 | Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04477655 |
| NCT04476953 | COVID-FISETIN: Pilot in Covid-19 of Fisetin to Alleviate Dysfunction and Inflammation | https://ClinicalTrials.gov/show/NCT04476953 |
| NCT04475185 | Safety and Effectiveness Assessment of the MakAir Artificial Ventilator | https://ClinicalTrials.gov/show/NCT04475185 |
| NCT04474340 | COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients | https://ClinicalTrials.gov/show/NCT04474340 |
| NCT04477954 | Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia | https://ClinicalTrials.gov/show/NCT04477954 |
| NCT04476992 | Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement | https://ClinicalTrials.gov/show/NCT04476992 |
| NCT04476979 | Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04476979 |
| NCT04476888 | Convalescent Plasma Treatment in COVID-19 | https://ClinicalTrials.gov/show/NCT04476888 |
| NCT04475588 | Efficacy and Safety of Itolizumab in COVID-19 Complications | https://ClinicalTrials.gov/show/NCT04475588 |
| NCT04475302 | BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots | https://ClinicalTrials.gov/show/NCT04475302 |
| NCT04475120 | Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients | https://ClinicalTrials.gov/show/NCT04475120 |
| NCT04485429 | Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04485429 |
| NCT04480424 | Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04480424 |
| NCT04480138 | Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04480138 |
| NCT04514900 | Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program | https://ClinicalTrials.gov/show/NCT04514900 |
| NCT04494724 | Clazakizumab vs. Placebo - COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04494724 |
| NCT04487639 | Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ? | https://ClinicalTrials.gov/show/NCT04487639 |
| NCT04483752 | Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images | https://ClinicalTrials.gov/show/NCT04483752 |
| NCT04482647 | Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04482647 |
| NCT04482621 | Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial | https://ClinicalTrials.gov/show/NCT04482621 |
| NCT04485169 | Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; | https://ClinicalTrials.gov/show/NCT04485169 |
| NCT04570462 | Mild Hypothermia for COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04570462 |
| NCT04484207 | Addressing COVID-19 Mental Health Problems Among US Veterans | https://ClinicalTrials.gov/show/NCT04484207 |
| NCT04488796 | STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers | https://ClinicalTrials.gov/show/NCT04488796 |
| NCT04487574 | A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04487574 |
| NCT04487444 | Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04487444 |
| NCT04486508 | Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04486508 |
| NCT04484493 | Corticosteroid Nasal Spray in COVID-19 Anosmia | https://ClinicalTrials.gov/show/NCT04484493 |
| NCT04483960 | Australasian COVID-19 Trial (ASCOT) | https://ClinicalTrials.gov/show/NCT04483960 |
| NCT04483830 | Suloexide in the Treatment of Early Stages of COVID-19 | https://ClinicalTrials.gov/show/NCT04483830 |
| NCT04488575 | Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04488575 |
| NCT04487990 | CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04487990 |
| NCT04486482 | A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function | https://ClinicalTrials.gov/show/NCT04486482 |
| NCT04486313 | Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04486313 |
| NCT04490278 | CoV-PICS: A Virtual Post-ICU Clinic | https://ClinicalTrials.gov/show/NCT04490278 |
| NCT04519437 | Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04519437 |
| NCT04494386 | Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04494386 |
| NCT04487964 | Complementary Intervention for COVID-19 | https://ClinicalTrials.gov/show/NCT04487964 |
| NCT04487171 | Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic | https://ClinicalTrials.gov/show/NCT04487171 |
| NCT04490473 | Turkish of the SARS-CoV-2 Anxiety Scale | https://ClinicalTrials.gov/show/NCT04490473 |
| NCT04489446 | Sildenafil in COVID-19 | https://ClinicalTrials.gov/show/NCT04489446 |
| NCT04492228 | Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome | https://ClinicalTrials.gov/show/NCT04492228 |
| NCT04496245 | Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 | https://ClinicalTrials.gov/show/NCT04496245 |
| NCT04501796 | A Trial of NT-I7 in COVID-19 (SPESELPIS) | https://ClinicalTrials.gov/show/NCT04501796 |
| NCT04499313 | Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04499313 |
| NCT04497623 | Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons. | https://ClinicalTrials.gov/show/NCT04497623 |
| NCT04491240 | Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. | https://ClinicalTrials.gov/show/NCT04491240 |
| NCT04490824 | Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals | https://ClinicalTrials.gov/show/NCT04490824 |
| NCT04518514 | Telemedical Risk Assessment and Preoperative Evaluation (TAPE) | https://ClinicalTrials.gov/show/NCT04518514 |
| NCT04494399 | IFN Beta-1b and Ribavirin for Covid-19 | https://ClinicalTrials.gov/show/NCT04494399 |
| NCT04494204 | Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04494204 |
| NCT04492527 | Student-delivered Telehealth Program for COVID-19 Education and Health Promotion | https://ClinicalTrials.gov/show/NCT04492527 |
| NCT04492514 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation | https://ClinicalTrials.gov/show/NCT04492514 |
| NCT04492501 | Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan | https://ClinicalTrials.gov/show/NCT04492501 |
| NCT04492410 | COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID) | https://ClinicalTrials.gov/show/NCT04492410 |
| NCT04491994 | Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression | https://ClinicalTrials.gov/show/NCT04491994 |
| NCT04490850 | COVID-19 Seroprevalence Study in French Guiana | https://ClinicalTrials.gov/show/NCT04490850 |
| NCT04495101 | Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04495101 |
| NCT04492475 | Adaptive COVID-19 Treatment Trial 3 (ACTT-3) | https://ClinicalTrials.gov/show/NCT04492475 |
| NCT04494984 | A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. | https://ClinicalTrials.gov/show/NCT04494984 |
| NCT04494867 | Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04494867 |
| NCT04493359 | Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04493359 |
| NCT04494646 | BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04494646 |
| NCT04535791 | Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04535791 |
| NCT04495816 | COVID-19 Anosmia Study | https://ClinicalTrials.gov/show/NCT04495816 |
| NCT04525378 | MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04525378 |
| NCT04498377 | Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04498377 |
| NCT04497454 | Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04497454 |
| NCT04497298 | Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04497298 |
| NCT04497987 | A Study of LY3819253 (LY-CoV555) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff | https://ClinicalTrials.gov/show/NCT04497987 |
| NCT04505722 | A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants | https://ClinicalTrials.gov/show/NCT04505722 |
| NCT04497649 | Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04497649 |
| NCT04501965 | Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04501965 |
| NCT04526054 | Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04526054 |
| NCT04510207 | A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above | https://ClinicalTrials.gov/show/NCT04510207 |
| NCT04501978 | ACTIV-3: Therapeutics for Inpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04501978 |
| NCT04498442 | A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls | https://ClinicalTrials.gov/show/NCT04498442 |
| NCT04498247 | A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) | https://ClinicalTrials.gov/show/NCT04498247 |
| NCT04504877 | Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19 | https://ClinicalTrials.gov/show/NCT04504877 |
| NCT04502667 | Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19 | https://ClinicalTrials.gov/show/NCT04502667 |
| NCT04502472 | Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04502472 |
| NCT04502342 | Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04502342 |
| NCT04500418 | Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04500418 |
| NCT04500132 | To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia | https://ClinicalTrials.gov/show/NCT04500132 |
| NCT04504734 | Bucillamine in Treatment of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04504734 |
| NCT04501445 | Psychological Symptoms and Families of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04501445 |
| NCT04534790 | Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04534790 |
| NCT04508439 | Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04508439 |
| NCT04501783 | Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04501783 |
| NCT04501458 | Western Kenya Integrated COVID-19 Response | https://ClinicalTrials.gov/show/NCT04501458 |
| NCT04501952 | Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting | https://ClinicalTrials.gov/show/NCT04501952 |
| NCT04504032 | A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) | https://ClinicalTrials.gov/show/NCT04504032 |
| NCT04527471 | Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04527471 |
| NCT04513158 | Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04513158 |
| NCT04504240 | Role of Famotidine in the Symptomatic Improvement of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04504240 |
| NCT04505592 | Tenecteplase in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04505592 |
| NCT04505774 | Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4) | https://ClinicalTrials.gov/show/NCT04505774 |
| NCT04522492 | Impact of COVID-19 on Mental Health of Patients With Skin Picking | https://ClinicalTrials.gov/show/NCT04522492 |
| NCT04508075 | Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine | https://ClinicalTrials.gov/show/NCT04508075 |
| NCT04506268 | COVID-19 SAFE Enrollment | https://ClinicalTrials.gov/show/NCT04506268 |
| NCT04511650 | A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04511650 |
| NCT04511819 | Losmapimod Safety and Efficacy in COVID-19 | https://ClinicalTrials.gov/show/NCT04511819 |
| NCT04516915 | IMU-838 and Oseltamivir in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04516915 |
| NCT04513470 | Allocetra-OTS in COVID-19 | https://ClinicalTrials.gov/show/NCT04513470 |
| NCT04508868 | Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19 | https://ClinicalTrials.gov/show/NCT04508868 |
| NCT04508023 | A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04508023 |
| NCT04527575 | Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04527575 |
| NCT04514705 | Characteristics in Post Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04514705 |
| NCT04512027 | Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. | https://ClinicalTrials.gov/show/NCT04512027 |
| NCT04510662 | Telmisartan in Respiratory Failure Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04510662 |
| NCT04509973 | Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia | https://ClinicalTrials.gov/show/NCT04509973 |
| NCT04509947 | A Study of Ad26.COV2.S in Adults (COVID-19) | https://ClinicalTrials.gov/show/NCT04509947 |
| NCT04581018 | An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04581018 |
| NCT04510493 | Canakinumab in Patients With COVID-19 and Type 2 Diabetes | https://ClinicalTrials.gov/show/NCT04510493 |
| NCT04522089 | A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine | https://ClinicalTrials.gov/show/NCT04522089 |
| NCT04519216 | Breastfeeding Education in the Time of COVID-19 | https://ClinicalTrials.gov/show/NCT04519216 |
| NCT04516811 | Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04516811 |
| NCT04513184 | Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04513184 |
| NCT04511949 | COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04511949 |
| NCT04540120 | Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome | https://ClinicalTrials.gov/show/NCT04540120 |
| NCT04515147 | A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults | https://ClinicalTrials.gov/show/NCT04515147 |
| NCT04517162 | Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04517162 |
| NCT04517123 | Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The “PRONE” Study | https://ClinicalTrials.gov/show/NCT04517123 |
| NCT04516759 | AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04516759 |
| NCT04550351 | Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) | https://ClinicalTrials.gov/show/NCT04550351 |
| NCT04517422 | Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19 | https://ClinicalTrials.gov/show/NCT04517422 |
| NCT04516837 | Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) | https://ClinicalTrials.gov/show/NCT04516837 |
| NCT04547634 | Telerehabilitation in Oncology Patients | https://ClinicalTrials.gov/show/NCT04547634 |
| NCT04540419 | Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 | https://ClinicalTrials.gov/show/NCT04540419 |
| NCT04530578 | Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 | https://ClinicalTrials.gov/show/NCT04530578 |
| NCT04519385 | Toclizumam Versus Dexamethasone in Severe Covid-19 Cases | https://ClinicalTrials.gov/show/NCT04519385 |
| NCT04517396 | FEnofibRate as a Metabolic INtervention for COVID-19 | https://ClinicalTrials.gov/show/NCT04517396 |
| NCT04516954 | Convalescent Plasma for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04516954 |
| NCT04518410 | ACTIV-2: A Study for Outpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04518410 |
| NCT04523571 | Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects | https://ClinicalTrials.gov/show/NCT04523571 |
| NCT04522830 | A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04522830 |
| NCT04519411 | Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04519411 |
| NCT04519320 | Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae | https://ClinicalTrials.gov/show/NCT04519320 |
| NCT04531618 | Mother-infant Bonding During COVID-19 | https://ClinicalTrials.gov/show/NCT04531618 |
| NCT04529499 | Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04529499 |
| NCT04528641 | GRAd-COV2 Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04528641 |
| NCT04528368 | Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support | https://ClinicalTrials.gov/show/NCT04528368 |
| NCT04524715 | LLLT Treatment of Lung Inflammation in COVID-19 | https://ClinicalTrials.gov/show/NCT04524715 |
| NCT04522466 | Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients | https://ClinicalTrials.gov/show/NCT04522466 |
| NCT04521322 | Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04521322 |
| NCT04581161 | Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04581161 |
| NCT04523831 | Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04523831 |
| NCT04524598 | A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19 | https://ClinicalTrials.gov/show/NCT04524598 |
| NCT04523090 | Catalysing the Containment of COVID-19 | https://ClinicalTrials.gov/show/NCT04523090 |
| NCT04522817 | CLBS119 for Repair of COVID-19 Induced Pulmonary Damage | https://ClinicalTrials.gov/show/NCT04522817 |
| NCT04529525 | Ivermectin to Prevent Hospitalizations in COVID-19 | https://ClinicalTrials.gov/show/NCT04529525 |
| NCT04526912 | Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04526912 |
| NCT04525417 | Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04525417 |
| NCT04568031 | Study of AZD1222 for the Prevention of COVID-19 in Japan | https://ClinicalTrials.gov/show/NCT04568031 |
| NCT04524507 | COVID-19 Antibody Plasma Research Study in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04524507 |
| NCT04535167 | First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending Dose And Extended Infusion of PF 07304814 In Hospitalized Participants With COVID-19. | https://ClinicalTrials.gov/show/NCT04535167 |
| NCT04530409 | Timing of Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04530409 |
| NCT04527133 | An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04527133 |
| NCT04527081 | Study of COVID-19 DNA Vaccine (AG0302-COVID19) | https://ClinicalTrials.gov/show/NCT04527081 |
| NCT04527354 | Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04527354 |
| NCT04537351 | The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04537351 |
| NCT04530396 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04530396 |
| NCT04527562 | Colchicine in Moderate Symptomatic COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04527562 |
| NCT04530435 | PEP Flute-selfcare in COVID-19 | https://ClinicalTrials.gov/show/NCT04530435 |
| NCT04554992 | Convalescent Plasma for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04554992 |
| NCT04536441 | Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order | https://ClinicalTrials.gov/show/NCT04536441 |
| NCT04531774 | RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04531774 |
| NCT04530422 | Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment | https://ClinicalTrials.gov/show/NCT04530422 |
| NCT04530370 | Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients | https://ClinicalTrials.gov/show/NCT04530370 |
| NCT04530357 | Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04530357 |
| NCT04539262 | Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation | https://ClinicalTrials.gov/show/NCT04539262 |
| NCT04532931 | COVID-19 Treatment in South Africa | https://ClinicalTrials.gov/show/NCT04532931 |
| NCT04535453 | A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults | https://ClinicalTrials.gov/show/NCT04535453 |
| NCT04532294 | Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants | https://ClinicalTrials.gov/show/NCT04532294 |
| NCT04537663 | Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults | https://ClinicalTrials.gov/show/NCT04537663 |
| NCT04533399 | A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults | https://ClinicalTrials.gov/show/NCT04533399 |
| NCT04537858 | Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19 | https://ClinicalTrials.gov/show/NCT04537858 |
| NCT04535063 | Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04535063 |
| NCT04542941 | Assessment of Safety and Efficacy of CCP | https://ClinicalTrials.gov/show/NCT04542941 |
| NCT04554264 | Complicated Grief in ICU in the Aftermath of COVID-19 | https://ClinicalTrials.gov/show/NCT04554264 |
| NCT04537949 | A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04537949 |
| NCT04537208 | Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older | https://ClinicalTrials.gov/show/NCT04537208 |
| NCT04558463 | The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04558463 |
| NCT04542213 | Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04542213 |
| NCT04577534 | COVID-19: Salvage TOcilizumab as a Rescue Measure | https://ClinicalTrials.gov/show/NCT04577534 |
| NCT04545060 | VIR-7831 for the Early Treatment of COVID-19 in Outpatients | https://ClinicalTrials.gov/show/NCT04545060 |
| NCT04542967 | Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04542967 |
| NCT04542694 | Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04542694 |
| NCT04540185 | A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 | https://ClinicalTrials.gov/show/NCT04540185 |
| NCT04542421 | Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04542421 |
| NCT04569188 | Convalescent Plasma in COVID-19 Elderly Patients | https://ClinicalTrials.gov/show/NCT04569188 |
| NCT04542447 | To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04542447 |
| NCT04542876 | Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04542876 |
| NCT04543760 | Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04543760 |
| NCT04561154 | Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV | https://ClinicalTrials.gov/show/NCT04561154 |
| NCT04557605 | Effects of a Face Mask on Oxygenation During Exercise | https://ClinicalTrials.gov/show/NCT04557605 |
| NCT04552483 | Effects of Early Use of Nitazoxanide in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04552483 |
| NCT04547660 | Convalescent Plasma for Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04547660 |
| NCT04547283 | Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04547283 |
| NCT04551339 | Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 | https://ClinicalTrials.gov/show/NCT04551339 |
| NCT04548531 | Engaging Patients in Colon Cancer Screening Decisions During COVID-19 | https://ClinicalTrials.gov/show/NCT04548531 |
| NCT04550325 | Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 | https://ClinicalTrials.gov/show/NCT04550325 |
| NCT04547127 | A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04547127 |
| NCT04546737 | Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04546737 |
| NCT04569266 | Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU | https://ClinicalTrials.gov/show/NCT04569266 |
| NCT04549376 | Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo | https://ClinicalTrials.gov/show/NCT04549376 |
| NCT04548544 | A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19 | https://ClinicalTrials.gov/show/NCT04548544 |
| NCT04551781 | Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis | https://ClinicalTrials.gov/show/NCT04551781 |
| NCT04558476 | Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04558476 |
| NCT04559113 | Methylprednisolone in COVID-19 Patients (Methyl19LGH) | https://ClinicalTrials.gov/show/NCT04559113 |
| NCT04553705 | Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) | https://ClinicalTrials.gov/show/NCT04553705 |
| NCT04552366 | A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults | https://ClinicalTrials.gov/show/NCT04552366 |
| NCT04555148 | COVIDIG (COVID-19 Hyper-ImmunoGlobulin) | https://ClinicalTrials.gov/show/NCT04555148 |
| NCT04555096 | A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04555096 |
| NCT04560881 | Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) | https://ClinicalTrials.gov/show/NCT04560881 |
| NCT04581915 | PHRU CoV01 A Phase II and III Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04581915 |
| NCT04557046 | Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test | https://ClinicalTrials.gov/show/NCT04557046 |
| NCT04563650 | COVID-19 Serology and Immunosenescence | https://ClinicalTrials.gov/show/NCT04563650 |
| NCT04567810 | Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19) | https://ClinicalTrials.gov/show/NCT04567810 |
| NCT04568564 | Telerehabilitation in Lung Surgery Patients | https://ClinicalTrials.gov/show/NCT04568564 |
| NCT04558021 | A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19 | https://ClinicalTrials.gov/show/NCT04558021 |
| NCT04558125 | Low-Dose Tenecteplase in Covid-19 | https://ClinicalTrials.gov/show/NCT04558125 |
| NCT04563065 | Active Pregnancy Against COVID-19 | https://ClinicalTrials.gov/show/NCT04563065 |
| NCT04558411 | Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students | https://ClinicalTrials.gov/show/NCT04558411 |
| NCT04558372 | Genosvid Diagnostic Test for Early Detection of COVID-19 | https://ClinicalTrials.gov/show/NCT04558372 |
| NCT04559035 | Nasal Irrigation to Reduce COVID-19 Morbidity | https://ClinicalTrials.gov/show/NCT04559035 |
| NCT04563702 | Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04563702 |
| NCT04565665 | Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04565665 |
| NCT04563689 | Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04563689 |
| NCT04561219 | Nitazoxanide Therapy for Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04561219 |
| NCT04563676 | Physiopathology and Sequelae of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04563676 |
| NCT04568525 | Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs | https://ClinicalTrials.gov/show/NCT04568525 |
| NCT04565379 | Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients | https://ClinicalTrials.gov/show/NCT04565379 |
| NCT04573270 | Mesenchymal Stem Cells for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04573270 |
| NCT04565197 | Convalescent Plasma Therapy for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04565197 |
| NCT04567173 | Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04567173 |
| NCT04564716 | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus | https://ClinicalTrials.gov/show/NCT04564716 |
| NCT04576728 | Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04576728 |
| NCT04567953 | COVID-19 Tests With Saliva Specimens | https://ClinicalTrials.gov/show/NCT04567953 |
| NCT04570488 | Predicting Favorable Outcomes in Hospitalized Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04570488 |
| NCT04569877 | GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04569877 |
| NCT04570254 | Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04570254 |
| NCT04568356 | A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests | https://ClinicalTrials.gov/show/NCT04568356 |
| NCT04568863 | Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 | https://ClinicalTrials.gov/show/NCT04568863 |
| NCT04568811 | The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04568811 |
| NCT04576312 | Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04576312 |
| NCT04572399 | UVA Light Device to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04572399 |
| NCT04569825 | Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04569825 |
| NCT04573361 | Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain | https://ClinicalTrials.gov/show/NCT04573361 |
| NCT04573322 | Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects | https://ClinicalTrials.gov/show/NCT04573322 |
| NCT04577235 | Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores. | https://ClinicalTrials.gov/show/NCT04577235 |
| NCT04575064 | An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY | https://ClinicalTrials.gov/show/NCT04575064 |
| NCT04573153 | Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04573153 |
| NCT04578210 | Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia (WHO) | https://ClinicalTrials.gov/show/NCT04578210 |
| NCT04582344 | Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) | https://ClinicalTrials.gov/show/NCT04582344 |
| NCT04583449 | Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04583449 |
| NCT04581291 | The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial | https://ClinicalTrials.gov/show/NCT04581291 |
| NCT04581954 | Inflammatory Signal Inhibitors for COVID-19 (MATIS) | https://ClinicalTrials.gov/show/NCT04581954 |
| NCT04582214 | Oscillation and Lung Expansion Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04582214 |
| NCT04582201 | An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing. | https://ClinicalTrials.gov/show/NCT04582201 |
| NCT04579549 | Repeat Testing for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04579549 |
| NCT04579393 | Fostamatinib for Hospitalized Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04579393 |
| NCT04583995 | A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom | https://ClinicalTrials.gov/show/NCT04583995 |
Observational Studies
| nct_id | brief_title | link |
|---|---|---|
| NCT04245631 | Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV | https://ClinicalTrials.gov/show/NCT04245631 |
| NCT04256395 | Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19 | https://ClinicalTrials.gov/show/NCT04256395 |
| NCT04260308 | A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04260308 |
| NCT04255940 | 2019-nCoV Outbreak and Cardiovascular Diseases | https://ClinicalTrials.gov/show/NCT04255940 |
| NCT04259892 | Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. | https://ClinicalTrials.gov/show/NCT04259892 |
| NCT04283396 | Study for Novel Coronavirus Pneumonia (NCP) | https://ClinicalTrials.gov/show/NCT04283396 |
| NCT04279782 | Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04279782 |
| NCT04274322 | Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool | https://ClinicalTrials.gov/show/NCT04274322 |
| NCT04275947 | The COVID-19 Mobile Health Study (CMHS) | https://ClinicalTrials.gov/show/NCT04275947 |
| NCT04279899 | The Investigation of the Neonates With or With Risk of COVID-19 | https://ClinicalTrials.gov/show/NCT04279899 |
| NCT04279795 | Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations | https://ClinicalTrials.gov/show/NCT04279795 |
| NCT04282135 | Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling | https://ClinicalTrials.gov/show/NCT04282135 |
| NCT04284046 | CT Scores Predict Mortality in 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04284046 |
| NCT04292327 | Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus | https://ClinicalTrials.gov/show/NCT04292327 |
| NCT04285801 | Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study | https://ClinicalTrials.gov/show/NCT04285801 |
| NCT04292340 | Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04292340 |
| NCT04290780 | COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus | https://ClinicalTrials.gov/show/NCT04290780 |
| NCT04306497 | TCM Differentiation and Treatment Protocol of COVID-19 | https://ClinicalTrials.gov/show/NCT04306497 |
| NCT04292964 | Prognostic Factors of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04292964 |
| NCT04312464 | Myocardial Damage in COVID-19 | https://ClinicalTrials.gov/show/NCT04312464 |
| NCT04302688 | Accurate Classification System for Patients With COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04302688 |
| NCT04306705 | Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 | https://ClinicalTrials.gov/show/NCT04306705 |
| NCT04307459 | Acute Respiratory Failure and COVID-19 in Real Life | https://ClinicalTrials.gov/show/NCT04307459 |
| NCT04316884 | Mechanisms for Organ Dysfunction in Covid-19 | https://ClinicalTrials.gov/show/NCT04316884 |
| NCT04312100 | Sequential Oxygen Therapy Strategy for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04312100 |
| NCT04319315 | Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak | https://ClinicalTrials.gov/show/NCT04319315 |
| NCT04316299 | Acute Kidney Injury in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04316299 |
| NCT04314817 | Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04314817 |
| NCT04314232 | Mechanisms for Covid-19 Disease Complications | https://ClinicalTrials.gov/show/NCT04314232 |
| NCT04313946 | Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays | https://ClinicalTrials.gov/show/NCT04313946 |
| NCT04347369 | A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04347369 |
| NCT04321265 | Outcomes and Prognostic Factors in COVID-19 | https://ClinicalTrials.gov/show/NCT04321265 |
| NCT04318418 | ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19 | https://ClinicalTrials.gov/show/NCT04318418 |
| NCT04318366 | COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor | https://ClinicalTrials.gov/show/NCT04318366 |
| NCT04316949 | Predictors of Respiratory Failure in SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04316949 |
| NCT04320017 | Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04320017 |
| NCT04319172 | Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients | https://ClinicalTrials.gov/show/NCT04319172 |
| NCT04318301 | Hypertension in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04318301 |
| NCT04322513 | Biomarkers for Identification of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04322513 |
| NCT04322487 | Simple, Safe, Same: Lung Ultrasound for COVID-19 | https://ClinicalTrials.gov/show/NCT04322487 |
| NCT04321369 | Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals | https://ClinicalTrials.gov/show/NCT04321369 |
| NCT04320732 | Risk Factors for Community- and Workplace Transmission of COVID-19 | https://ClinicalTrials.gov/show/NCT04320732 |
| NCT04320511 | Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 | https://ClinicalTrials.gov/show/NCT04320511 |
| NCT04325919 | Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong | https://ClinicalTrials.gov/show/NCT04325919 |
| NCT04323787 | Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04323787 |
| NCT04322279 | Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19. | https://ClinicalTrials.gov/show/NCT04322279 |
| NCT04322188 | An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications | https://ClinicalTrials.gov/show/NCT04322188 |
| NCT04327180 | PREdiction of DIagnosed Covid-19 infecTion in IUC Patients | https://ClinicalTrials.gov/show/NCT04327180 |
| NCT04324736 | “COVID-19 and Diabetes Outcomes” | https://ClinicalTrials.gov/show/NCT04324736 |
| NCT04324684 | Prognostic Factors Keeping Track for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04324684 |
| NCT04324047 | Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04324047 |
| NCT04323878 | Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. | https://ClinicalTrials.gov/show/NCT04323878 |
| NCT04323644 | Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) | https://ClinicalTrials.gov/show/NCT04323644 |
| NCT04332913 | Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia | https://ClinicalTrials.gov/show/NCT04332913 |
| NCT04329507 | Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS) | https://ClinicalTrials.gov/show/NCT04329507 |
| NCT04327804 | A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research | https://ClinicalTrials.gov/show/NCT04327804 |
| NCT04326725 | Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04326725 |
| NCT04326387 | Evaluation of Novel Diagnostic Tests for COVID-19 | https://ClinicalTrials.gov/show/NCT04326387 |
| NCT04325646 | Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France | https://ClinicalTrials.gov/show/NCT04325646 |
| NCT04331106 | Survey of the Anxiety Associated With the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04331106 |
| NCT04328454 | Clinical Characteristics and Prognostic Factors of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04328454 |
| NCT04327531 | Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study | https://ClinicalTrials.gov/show/NCT04327531 |
| NCT04329546 | Understanding COVID-19 | https://ClinicalTrials.gov/show/NCT04329546 |
| NCT04337983 | Hemodynamic Characteristics of Patients With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04337983 |
| NCT04336384 | Impact of Covid-19 in Congenital Heart Disease | https://ClinicalTrials.gov/show/NCT04336384 |
| NCT04332016 | COVID-19 Biological Samples Collection | https://ClinicalTrials.gov/show/NCT04332016 |
| NCT04330521 | Impact of the Coronavirus (COVID-19) on Patients With Cancer | https://ClinicalTrials.gov/show/NCT04330521 |
| NCT04330261 | Clinical Characteristics and Outcomes of Pediatric COVID-19 | https://ClinicalTrials.gov/show/NCT04330261 |
| NCT04340219 | Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04340219 |
| NCT04335188 | COVID-19 Registry Rhineland-Palatinate (Germany) | https://ClinicalTrials.gov/show/NCT04335188 |
| NCT04331886 | An Observational Study of Patients With Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04331886 |
| NCT04331509 | COVID-19 Symptom Tracker | https://ClinicalTrials.gov/show/NCT04331509 |
| NCT04333849 | Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 | https://ClinicalTrials.gov/show/NCT04333849 |
| NCT04333862 | Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy | https://ClinicalTrials.gov/show/NCT04333862 |
| NCT04336215 | Rutgers COVID-19 Cohort Study | https://ClinicalTrials.gov/show/NCT04336215 |
| NCT04335630 | Cardiovascular Manifestations of COVID-19 | https://ClinicalTrials.gov/show/NCT04335630 |
| NCT04334252 | Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04334252 |
| NCT04344925 | Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19 | https://ClinicalTrials.gov/show/NCT04344925 |
| NCT04340921 | The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury | https://ClinicalTrials.gov/show/NCT04340921 |
| NCT04337190 | Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2) | https://ClinicalTrials.gov/show/NCT04337190 |
| NCT04337151 | Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment | https://ClinicalTrials.gov/show/NCT04337151 |
| NCT04337047 | Distress in Crisis Situations During COVID-19 | https://ClinicalTrials.gov/show/NCT04337047 |
| NCT04336761 | Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France | https://ClinicalTrials.gov/show/NCT04336761 |
| NCT04336657 | Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease? | https://ClinicalTrials.gov/show/NCT04336657 |
| NCT04335747 | COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases | https://ClinicalTrials.gov/show/NCT04335747 |
| NCT04335162 | Cardiovascular Complications and COVID-19 (CovCardioVasc) | https://ClinicalTrials.gov/show/NCT04335162 |
| NCT04334954 | SARS-COV2 Pandemic Serosurvey and Blood Sampling | https://ClinicalTrials.gov/show/NCT04334954 |
| NCT04342702 | A Study on the Prospective Cohort Library of COVID-19 in Southeran | https://ClinicalTrials.gov/show/NCT04342702 |
| NCT04338672 | The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients | https://ClinicalTrials.gov/show/NCT04338672 |
| NCT04337320 | Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study | https://ClinicalTrials.gov/show/NCT04337320 |
| NCT04337424 | Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04337424 |
| NCT04337502 | Clinical and Radiomic Model of COVID-19 | https://ClinicalTrials.gov/show/NCT04337502 |
| NCT04366765 | COVID-19 Survival - The COVIVA Study | https://ClinicalTrials.gov/show/NCT04366765 |
| NCT04354558 | French Single Centre Experience of Critically Ill Patients With Covid 19 | https://ClinicalTrials.gov/show/NCT04354558 |
| NCT04346602 | A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019 | https://ClinicalTrials.gov/show/NCT04346602 |
| NCT04339998 | Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) | https://ClinicalTrials.gov/show/NCT04339998 |
| NCT04339387 | COVID-19 Risk Stratification | https://ClinicalTrials.gov/show/NCT04339387 |
| NCT04337762 | Beat COVID-19 - Observational Trial | https://ClinicalTrials.gov/show/NCT04337762 |
| NCT04347408 | Seroprevalence of SARS-Cov-2 Antibodies in Children | https://ClinicalTrials.gov/show/NCT04347408 |
| NCT04343742 | Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343742 |
| NCT04342637 | COVID-19 Endoscopy Survey | https://ClinicalTrials.gov/show/NCT04342637 |
| NCT04341792 | Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient | https://ClinicalTrials.gov/show/NCT04341792 |
| NCT04341506 | Non-contact ECG Sensor System for COVID19 | https://ClinicalTrials.gov/show/NCT04341506 |
| NCT04338932 | COVID-19 and Deep Venous Thrombosis | https://ClinicalTrials.gov/show/NCT04338932 |
| NCT04339634 | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy | https://ClinicalTrials.gov/show/NCT04339634 |
| NCT04339608 | Max COVID19- Study | https://ClinicalTrials.gov/show/NCT04339608 |
| NCT04338945 | Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy | https://ClinicalTrials.gov/show/NCT04338945 |
| NCT04341519 | Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers | https://ClinicalTrials.gov/show/NCT04341519 |
| NCT04341480 | The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19 | https://ClinicalTrials.gov/show/NCT04341480 |
| NCT04352634 | The Covid-19 HEalth caRe wOrkErS (HEROES) Study | https://ClinicalTrials.gov/show/NCT04352634 |
| NCT04347928 | Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19 | https://ClinicalTrials.gov/show/NCT04347928 |
| NCT04347460 | Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH | https://ClinicalTrials.gov/show/NCT04347460 |
| NCT04343404 | Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 | https://ClinicalTrials.gov/show/NCT04343404 |
| NCT04342884 | COVID-19 Community Research Partnership | https://ClinicalTrials.gov/show/NCT04342884 |
| NCT04342195 | Acquiring Convalescent Specimens for COVID-19 Antibodies | https://ClinicalTrials.gov/show/NCT04342195 |
| NCT04342104 | NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure | https://ClinicalTrials.gov/show/NCT04342104 |
| NCT04341714 | Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04341714 |
| NCT04339686 | Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. | https://ClinicalTrials.gov/show/NCT04339686 |
| NCT04343339 | Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment | https://ClinicalTrials.gov/show/NCT04343339 |
| NCT04339790 | Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers | https://ClinicalTrials.gov/show/NCT04339790 |
| NCT04358952 | Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients | https://ClinicalTrials.gov/show/NCT04358952 |
| NCT04357847 | Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04357847 |
| NCT04352556 | COVID19-hematological Malignancies: the Italian Hematology Alliance | https://ClinicalTrials.gov/show/NCT04352556 |
| NCT04350710 | Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS | https://ClinicalTrials.gov/show/NCT04350710 |
| NCT04347850 | A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04347850 |
| NCT04347824 | Predict Adverse Events by Covid-19 Nephritis | https://ClinicalTrials.gov/show/NCT04347824 |
| NCT04346342 | PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) | https://ClinicalTrials.gov/show/NCT04346342 |
| NCT04344327 | Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF | https://ClinicalTrials.gov/show/NCT04344327 |
| NCT04344197 | Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey | https://ClinicalTrials.gov/show/NCT04344197 |
| NCT04344145 | Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population | https://ClinicalTrials.gov/show/NCT04344145 |
| NCT04344119 | Assessment of Chilbains Occuring During Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04344119 |
| NCT04343898 | Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04343898 |
| NCT04343781 | National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04343781 |
| NCT04381312 | Direct and Indirect Impact of COVID-19 In Older Populations | https://ClinicalTrials.gov/show/NCT04381312 |
| NCT04352517 | Influence Physical Activity Psychological Responses COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04352517 |
| NCT04351711 | Immunological Profiling of Patients With COVID-19 in Respiratory Distress | https://ClinicalTrials.gov/show/NCT04351711 |
| NCT04348396 | Clinical and Biological Predictors of COVID-19 Disease in Older Patients | https://ClinicalTrials.gov/show/NCT04348396 |
| NCT04347070 | Implementation of Physiotherapy on COVID-19 Patients in ICU | https://ClinicalTrials.gov/show/NCT04347070 |
| NCT04346212 | Oropharyngeal Dysphagia in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04346212 |
| NCT04346121 | Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis | https://ClinicalTrials.gov/show/NCT04346121 |
| NCT04345640 | The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. | https://ClinicalTrials.gov/show/NCT04345640 |
| NCT04345315 | Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. | https://ClinicalTrials.gov/show/NCT04345315 |
| NCT04344964 | Endoscopy-related Phone Consultation During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04344964 |
| NCT04344171 | CovidDB: The Covid-19 Inpatient Database | https://ClinicalTrials.gov/show/NCT04344171 |
| NCT04345159 | Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease | https://ClinicalTrials.gov/show/NCT04345159 |
| NCT04346186 | COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff | https://ClinicalTrials.gov/show/NCT04346186 |
| NCT04569851 | Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019) | https://ClinicalTrials.gov/show/NCT04569851 |
| NCT04353934 | The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04353934 |
| NCT04347694 | Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04347694 |
| NCT04373889 | COVID-19 Among Healthcare Workers in Belgian Hospitals | https://ClinicalTrials.gov/show/NCT04373889 |
| NCT04356560 | COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department | https://ClinicalTrials.gov/show/NCT04356560 |
| NCT04354584 | Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04354584 |
| NCT04352582 | COVID-19 and Vaccination Attitudes | https://ClinicalTrials.gov/show/NCT04352582 |
| NCT04349202 | Beaumont Health Large-scale Automated Serologic Testing for COVID-19 | https://ClinicalTrials.gov/show/NCT04349202 |
| NCT04349163 | Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort. | https://ClinicalTrials.gov/show/NCT04349163 |
| NCT04348552 | Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study | https://ClinicalTrials.gov/show/NCT04348552 |
| NCT04348214 | Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals | https://ClinicalTrials.gov/show/NCT04348214 |
| NCT04346264 | CoVid-19 - Infection and Antibody Formation in the Viennese Population | https://ClinicalTrials.gov/show/NCT04346264 |
| NCT04346056 | Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19 | https://ClinicalTrials.gov/show/NCT04346056 |
| NCT04344977 | Collection of Anti-SARS-CoV-2 Immune Plasma | https://ClinicalTrials.gov/show/NCT04344977 |
| NCT04386369 | Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04386369 |
| NCT04352699 | Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All? | https://ClinicalTrials.gov/show/NCT04352699 |
| NCT04352491 | An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease | https://ClinicalTrials.gov/show/NCT04352491 |
| NCT04351568 | Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics; | https://ClinicalTrials.gov/show/NCT04351568 |
| NCT04351399 | Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351399 |
| NCT04350073 | Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) | https://ClinicalTrials.gov/show/NCT04350073 |
| NCT04349540 | Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 | https://ClinicalTrials.gov/show/NCT04349540 |
| NCT04347876 | Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis? | https://ClinicalTrials.gov/show/NCT04347876 |
| NCT04386109 | Neonatal Complications of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04386109 |
| NCT04355741 | Gut Microbiota, “Spark and Flame” of COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04355741 |
| NCT04353609 | Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases | https://ClinicalTrials.gov/show/NCT04353609 |
| NCT04353401 | WGS ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS | https://ClinicalTrials.gov/show/NCT04353401 |
| NCT04353011 | Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04353011 |
| NCT04351633 | Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351633 |
| NCT04351503 | A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19 | https://ClinicalTrials.gov/show/NCT04351503 |
| NCT04351139 | Impact of the COVID-19 Pandemic in Gynecological Oncology | https://ClinicalTrials.gov/show/NCT04351139 |
| NCT04348240 | Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions | https://ClinicalTrials.gov/show/NCT04348240 |
| NCT04568148 | COVID-19 Biorepository | https://ClinicalTrials.gov/show/NCT04568148 |
| NCT04385121 | Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04385121 |
| NCT04376905 | Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04376905 |
| NCT04373109 | Stroke Rehabilitation Outcome During COVID-19 Lockdown | https://ClinicalTrials.gov/show/NCT04373109 |
| NCT04367129 | Electrocardiogram Analysis in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04367129 |
| NCT04366154 | Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers | https://ClinicalTrials.gov/show/NCT04366154 |
| NCT04360538 | Long Term Outcomes of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04360538 |
| NCT04357769 | COVID-19 Pandemic Burden in Severe Mental Disease Patients | https://ClinicalTrials.gov/show/NCT04357769 |
| NCT04357418 | Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives | https://ClinicalTrials.gov/show/NCT04357418 |
| NCT04356950 | Analysis of the Coagulopathy Developed by COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04356950 |
| NCT04356443 | Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04356443 |
| NCT04355442 | Evolution of Facial Trauma During COVID Containment Measures | https://ClinicalTrials.gov/show/NCT04355442 |
| NCT04354792 | Asymptomatic COVID-19 Infection Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04354792 |
| NCT04353141 | International Lung UltraSound Analysis (ILUSA) Study | https://ClinicalTrials.gov/show/NCT04353141 |
| NCT04352842 | Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19） | https://ClinicalTrials.gov/show/NCT04352842 |
| NCT04351659 | Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04351659 |
| NCT04366921 | European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO | https://ClinicalTrials.gov/show/NCT04366921 |
| NCT04367402 | COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) | https://ClinicalTrials.gov/show/NCT04367402 |
| NCT04367363 | Social Media and COVID-19 | https://ClinicalTrials.gov/show/NCT04367363 |
| NCT04361786 | Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04361786 |
| NCT04354753 | AiM COVID for Covid 19 Tracking and Prediction | https://ClinicalTrials.gov/show/NCT04354753 |
| NCT04357041 | COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being | https://ClinicalTrials.gov/show/NCT04357041 |
| NCT04356378 | Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation | https://ClinicalTrials.gov/show/NCT04356378 |
| NCT04355715 | Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia | https://ClinicalTrials.gov/show/NCT04355715 |
| NCT04355702 | Covid-19 in Lupus Patients | https://ClinicalTrials.gov/show/NCT04355702 |
| NCT04355624 | Kidney Involvement in COVID-19 Disease (COVKID) | https://ClinicalTrials.gov/show/NCT04355624 |
| NCT04355611 | Epidemiological Characteristics of COVID-19 in Patients With MS or NMO | https://ClinicalTrials.gov/show/NCT04355611 |
| NCT04355481 | Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04355481 |
| NCT04354857 | Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04354857 |
| NCT04354766 | COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2 | https://ClinicalTrials.gov/show/NCT04354766 |
| NCT04354779 | Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. | https://ClinicalTrials.gov/show/NCT04354779 |
| NCT04358380 | Liver Injury in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04358380 |
| NCT04365166 | Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04365166 |
| NCT04363333 | Obstructive Sleep Apnea & Covid-19 Outcomes | https://ClinicalTrials.gov/show/NCT04363333 |
| NCT04359914 | Neurocognitive Impairment in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04359914 |
| NCT04357535 | Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives | https://ClinicalTrials.gov/show/NCT04357535 |
| NCT04357314 | Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study | https://ClinicalTrials.gov/show/NCT04357314 |
| NCT04356885 | COVID-19 and Psychotic Symptoms in France | https://ClinicalTrials.gov/show/NCT04356885 |
| NCT04355871 | Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain | https://ClinicalTrials.gov/show/NCT04355871 |
| NCT04385069 | COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study | https://ClinicalTrials.gov/show/NCT04385069 |
| NCT04384029 | The Geneva Covid-19 CVD Study | https://ClinicalTrials.gov/show/NCT04384029 |
| NCT04376853 | CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch | https://ClinicalTrials.gov/show/NCT04376853 |
| NCT04374123 | COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit | https://ClinicalTrials.gov/show/NCT04374123 |
| NCT04362345 | Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04362345 |
| NCT04361877 | Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial) | https://ClinicalTrials.gov/show/NCT04361877 |
| NCT04360954 | Evaluation of Antibody Tests for COVID-19 | https://ClinicalTrials.gov/show/NCT04360954 |
| NCT04359849 | Sequencing and Tracking of Phylogeny in COVID-19 Study | https://ClinicalTrials.gov/show/NCT04359849 |
| NCT04359407 | Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04359407 |
| NCT04358536 | Classification of COVID-19 Infection in Posteroanterior Chest X-rays | https://ClinicalTrials.gov/show/NCT04358536 |
| NCT04358510 | COVID-19 Mortality Prediction Model | https://ClinicalTrials.gov/show/NCT04358510 |
| NCT04358029 | Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04358029 |
| NCT04357938 | Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections | https://ClinicalTrials.gov/show/NCT04357938 |
| NCT04357574 | Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 | https://ClinicalTrials.gov/show/NCT04357574 |
| NCT04359836 | A Study to Explore the Role of Gut Flora in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04359836 |
| NCT04403009 | The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04403009 |
| NCT04397835 | Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population | https://ClinicalTrials.gov/show/NCT04397835 |
| NCT04375748 | Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases | https://ClinicalTrials.gov/show/NCT04375748 |
| NCT04366024 | A Novel Nomogram to Predict Severity of COVID-19 | https://ClinicalTrials.gov/show/NCT04366024 |
| NCT04365959 | The Prone Position in Covid-19 Affected Patients | https://ClinicalTrials.gov/show/NCT04365959 |
| NCT04363008 | COVID 19 Biomarkers | https://ClinicalTrials.gov/show/NCT04363008 |
| NCT04362956 | Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04362956 |
| NCT04360850 | Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04360850 |
| NCT04359706 | Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19 | https://ClinicalTrials.gov/show/NCT04359706 |
| NCT04359693 | Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections | https://ClinicalTrials.gov/show/NCT04359693 |
| NCT04359212 | Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19 | https://ClinicalTrials.gov/show/NCT04359212 |
| NCT04359121 | COVID-19 and the Developement of Phobic Fears of Disease | https://ClinicalTrials.gov/show/NCT04359121 |
| NCT04358640 | Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey | https://ClinicalTrials.gov/show/NCT04358640 |
| NCT04357431 | COVID-19 Among Egyptian Health Care Providers | https://ClinicalTrials.gov/show/NCT04357431 |
| NCT04356365 | The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI’s) | https://ClinicalTrials.gov/show/NCT04356365 |
| NCT04393233 | Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation | https://ClinicalTrials.gov/show/NCT04393233 |
| NCT04371848 | Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study | https://ClinicalTrials.gov/show/NCT04371848 |
| NCT04371250 | Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures. | https://ClinicalTrials.gov/show/NCT04371250 |
| NCT04369807 | Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04369807 |
| NCT04366934 | Study of the Pathogenesis of Olfactory Disorders in COVID-19 | https://ClinicalTrials.gov/show/NCT04366934 |
| NCT04362943 | Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults | https://ClinicalTrials.gov/show/NCT04362943 |
| NCT04361565 | Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361565 |
| NCT04361123 | Atrium COVID-19 Syndromic and Serologic Surveillance | https://ClinicalTrials.gov/show/NCT04361123 |
| NCT04361019 | Physical Activity in University Students Around COVID-19 Confinement | https://ClinicalTrials.gov/show/NCT04361019 |
| NCT04360863 | The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong | https://ClinicalTrials.gov/show/NCT04360863 |
| NCT04360733 | Precision Immunology to Determine the Immune Response in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04360733 |
| NCT04360707 | Solid Organ Transplant Recipients With SARS-CoV-2 French Registry | https://ClinicalTrials.gov/show/NCT04360707 |
| NCT04360278 | Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04360278 |
| NCT04362995 | St. Jude Tracking of Viral and Host Factors Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04362995 |
| NCT04396600 | The Professional Peer Resilience Initiative | https://ClinicalTrials.gov/show/NCT04396600 |
| NCT04381286 | Transpulmonary Driving Pressure in ARDS COVID19 Patients | https://ClinicalTrials.gov/show/NCT04381286 |
| NCT04368793 | Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge | https://ClinicalTrials.gov/show/NCT04368793 |
| NCT04366778 | Thrombosis and Covid-19 | https://ClinicalTrials.gov/show/NCT04366778 |
| NCT04363788 | Needle Stick Injuries in Emergency Medical Service Practice | https://ClinicalTrials.gov/show/NCT04363788 |
| NCT04363268 | ACCESS A Master Digital Surveillance Protocol for COVID-19 | https://ClinicalTrials.gov/show/NCT04363268 |
| NCT04363099 | Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. | https://ClinicalTrials.gov/show/NCT04363099 |
| NCT04362319 | Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04362319 |
| NCT04362267 | Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital | https://ClinicalTrials.gov/show/NCT04362267 |
| NCT04362150 | Long-term Impact of Infection With Novel Coronavirus (COVID-19) | https://ClinicalTrials.gov/show/NCT04362150 |
| NCT04492943 | To Observe Whether Isoflurane Can Treat COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04492943 |
| NCT04377815 | Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste | https://ClinicalTrials.gov/show/NCT04377815 |
| NCT04371315 | Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children | https://ClinicalTrials.gov/show/NCT04371315 |
| NCT04370678 | Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures | https://ClinicalTrials.gov/show/NCT04370678 |
| NCT04368221 | Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU | https://ClinicalTrials.gov/show/NCT04368221 |
| NCT04366167 | Patient Recovery From Heart Surgery During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04366167 |
| NCT04365816 | NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30 | https://ClinicalTrials.gov/show/NCT04365816 |
| NCT04365595 | SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) | https://ClinicalTrials.gov/show/NCT04365595 |
| NCT04365335 | Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04365335 |
| NCT04364698 | Observational Cohort of COVID-19 Patients at Raymond-Poincare | https://ClinicalTrials.gov/show/NCT04364698 |
| NCT04362930 | Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) | https://ClinicalTrials.gov/show/NCT04362930 |
| NCT04362865 | Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04362865 |
| NCT04365764 | Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study | https://ClinicalTrials.gov/show/NCT04365764 |
| NCT04365725 | Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections | https://ClinicalTrials.gov/show/NCT04365725 |
| NCT04365634 | A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04365634 |
| NCT04365348 | The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families | https://ClinicalTrials.gov/show/NCT04365348 |
| NCT04365361 | The Psychological Impact of the COVID-19 on Students. | https://ClinicalTrials.gov/show/NCT04365361 |
| NCT04382534 | A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction | https://ClinicalTrials.gov/show/NCT04382534 |
| NCT04373811 | One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting | https://ClinicalTrials.gov/show/NCT04373811 |
| NCT04368637 | Acute Cardiovascular Events Triggered by COVID-19-Related Stress | https://ClinicalTrials.gov/show/NCT04368637 |
| NCT04367064 | To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study) | https://ClinicalTrials.gov/show/NCT04367064 |
| NCT04365881 | Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology | https://ClinicalTrials.gov/show/NCT04365881 |
| NCT04365530 | Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City | https://ClinicalTrials.gov/show/NCT04365530 |
| NCT04383470 | Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383470 |
| NCT04368897 | In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity | https://ClinicalTrials.gov/show/NCT04368897 |
| NCT04368351 | Bacteriotherapy in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04368351 |
| NCT04367896 | COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY | https://ClinicalTrials.gov/show/NCT04367896 |
| NCT04368026 | SARS-CoV-2 (COVID-19) and Surgery | https://ClinicalTrials.gov/show/NCT04368026 |
| NCT04367805 | COVID-19 Infection in Patients With Hepatocellular Carcinoma | https://ClinicalTrials.gov/show/NCT04367805 |
| NCT04367792 | Cardiac Injury in COVID-19: a Pathology Study | https://ClinicalTrials.gov/show/NCT04367792 |
| NCT04367740 | ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 | https://ClinicalTrials.gov/show/NCT04367740 |
| NCT04366752 | Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy | https://ClinicalTrials.gov/show/NCT04366752 |
| NCT04375670 | COVID19-FOIE National Observatory | https://ClinicalTrials.gov/show/NCT04375670 |
| NCT04371835 | COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings | https://ClinicalTrials.gov/show/NCT04371835 |
| NCT04371354 | Outcomes of Covid-19 Protective Measures in Endoscopy | https://ClinicalTrials.gov/show/NCT04371354 |
| NCT04370249 | Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 | https://ClinicalTrials.gov/show/NCT04370249 |
| NCT04369989 | Observational Study of COVID-19 Treatment Efficacy | https://ClinicalTrials.gov/show/NCT04369989 |
| NCT04368390 | Neuroradiolological Analysis of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04368390 |
| NCT04368338 | Lung Ultrasound to Diagnose COVID-19 | https://ClinicalTrials.gov/show/NCT04368338 |
| NCT04368208 | Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women’s Depression | https://ClinicalTrials.gov/show/NCT04368208 |
| NCT04367883 | Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection | https://ClinicalTrials.gov/show/NCT04367883 |
| NCT04367870 | COVID-19 Detection Test in Oncology | https://ClinicalTrials.gov/show/NCT04367870 |
| NCT04367337 | Health Behavior Change During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04367337 |
| NCT04372472 | SQuISH-COVID: A Pilot Study | https://ClinicalTrials.gov/show/NCT04372472 |
| NCT04385212 | Outcomes in Hospitalized Older Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04385212 |
| NCT04374422 | COVID-19 Pandemic and Female Sexual Behavior | https://ClinicalTrials.gov/show/NCT04374422 |
| NCT04372576 | Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04372576 |
| NCT04372056 | The COVID-ICU Healthcare Professional Study | https://ClinicalTrials.gov/show/NCT04372056 |
| NCT04370275 | Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia | https://ClinicalTrials.gov/show/NCT04370275 |
| NCT04370210 | Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry | https://ClinicalTrials.gov/show/NCT04370210 |
| NCT04370197 | Covid-19 Epidemic on Acute Stroke Management | https://ClinicalTrials.gov/show/NCT04370197 |
| NCT04370119 | Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04370119 |
| NCT04369859 | Obstetric and Perinatal Outcomes of Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04369859 |
| NCT04368884 | Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04368884 |
| NCT04368871 | Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study | https://ClinicalTrials.gov/show/NCT04368871 |
| NCT04371432 | Genetics of COVID-19 Susceptibility and Manifestations | https://ClinicalTrials.gov/show/NCT04371432 |
| NCT04380987 | Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis | https://ClinicalTrials.gov/show/NCT04380987 |
| NCT04379089 | Neurologic Manifestations of COVID 19 in Children | https://ClinicalTrials.gov/show/NCT04379089 |
| NCT04377581 | COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior | https://ClinicalTrials.gov/show/NCT04377581 |
| NCT04375761 | COVID-19: Human Epidemiology and Response to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04375761 |
| NCT04375410 | Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04375410 |
| NCT04374071 | Early Short Course Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04374071 |
| NCT04373486 | Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels | https://ClinicalTrials.gov/show/NCT04373486 |
| NCT04373148 | Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 | https://ClinicalTrials.gov/show/NCT04373148 |
| NCT04371679 | Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04371679 |
| NCT04371562 | Predicting Death and ICU Admission in COVID-19 Patients in ED | https://ClinicalTrials.gov/show/NCT04371562 |
| NCT04371471 | Covid-19 Pandemic Triage Score | https://ClinicalTrials.gov/show/NCT04371471 |
| NCT04376580 | Use of the Nasal Cannula During COVID-19 | https://ClinicalTrials.gov/show/NCT04376580 |
| NCT04384471 | Covid-19 Pandemic: Patients’ Experience in T1D | https://ClinicalTrials.gov/show/NCT04384471 |
| NCT04378777 | Immunophenotyping Assessment in a COVID-19 Cohort | https://ClinicalTrials.gov/show/NCT04378777 |
| NCT04377035 | The Role of Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04377035 |
| NCT04374838 | Effect of COVID-19 Pandemic on Pediatric Cancer Care | https://ClinicalTrials.gov/show/NCT04374838 |
| NCT04374656 | Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04374656 |
| NCT04374058 | Less Frequency Hemodialysis and COVID-19 | https://ClinicalTrials.gov/show/NCT04374058 |
| NCT04373798 | C-reactive Protein Levels Among Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT04373798 |
| NCT04377412 | Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04377412 |
| NCT04374617 | Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04374617 |
| NCT04374513 | Community Pharmacists Behaviour During Covid-19 | https://ClinicalTrials.gov/show/NCT04374513 |
| NCT04374097 | Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04374097 |
| NCT04378829 | Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19 | https://ClinicalTrials.gov/show/NCT04378829 |
| NCT04375176 | Monocytes and NK Cells Activity in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04375176 |
| NCT04375137 | Correlation Between Oxidative Stress Status and COVID-19 Severity | https://ClinicalTrials.gov/show/NCT04375137 |
| NCT04388813 | Predictors of Severe COVID-19 Outcomes | https://ClinicalTrials.gov/show/NCT04388813 |
| NCT04386083 | Neurologic Manifestations of COVID-19 | https://ClinicalTrials.gov/show/NCT04386083 |
| NCT04382417 | Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden | https://ClinicalTrials.gov/show/NCT04382417 |
| NCT04381819 | Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 | https://ClinicalTrials.gov/show/NCT04381819 |
| NCT04380896 | COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) | https://ClinicalTrials.gov/show/NCT04380896 |
| NCT04379466 | Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19 | https://ClinicalTrials.gov/show/NCT04379466 |
| NCT04379310 | Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) | https://ClinicalTrials.gov/show/NCT04379310 |
| NCT04379284 | Risks of COVID19 in the Pregnant Population | https://ClinicalTrials.gov/show/NCT04379284 |
| NCT04379245 | COVID-19 Infection in Patients Infected With HIV and/or on PrEP | https://ClinicalTrials.gov/show/NCT04379245 |
| NCT04379232 | Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center | https://ClinicalTrials.gov/show/NCT04379232 |
| NCT04377607 | Haemoglobin Concentration on COVID-19 | https://ClinicalTrials.gov/show/NCT04377607 |
| NCT04377074 | Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety | https://ClinicalTrials.gov/show/NCT04377074 |
| NCT04376996 | Slovenian National COVID-19 Prevalence Study | https://ClinicalTrials.gov/show/NCT04376996 |
| NCT04376944 | Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation | https://ClinicalTrials.gov/show/NCT04376944 |
| NCT04376879 | Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) | https://ClinicalTrials.gov/show/NCT04376879 |
| NCT04376775 | Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation | https://ClinicalTrials.gov/show/NCT04376775 |
| NCT04375709 | Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); | https://ClinicalTrials.gov/show/NCT04375709 |
| NCT04375501 | A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04375501 |
| NCT04410718 | Glycaemia and Cardiac Function in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04410718 |
| NCT04384419 | Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic) | https://ClinicalTrials.gov/show/NCT04384419 |
| NCT04382469 | Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT | https://ClinicalTrials.gov/show/NCT04382469 |
| NCT04382235 | Non-invasive Ventilatory Support of Patients Affected by COVID-19 | https://ClinicalTrials.gov/show/NCT04382235 |
| NCT04380870 | Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 | https://ClinicalTrials.gov/show/NCT04380870 |
| NCT04378881 | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations | https://ClinicalTrials.gov/show/NCT04378881 |
| NCT04378842 | COVID-19 and ICU-acquired MDR Bacteria | https://ClinicalTrials.gov/show/NCT04378842 |
| NCT04378686 | Serological Testing for COVID-19 (SARS-CoV-2) in ESKD | https://ClinicalTrials.gov/show/NCT04378686 |
| NCT04378595 | Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin | https://ClinicalTrials.gov/show/NCT04378595 |
| NCT04378582 | Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU | https://ClinicalTrials.gov/show/NCT04378582 |
| NCT04377776 | Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients | https://ClinicalTrials.gov/show/NCT04377776 |
| NCT04377763 | Developement and Evaluation of Serological Assays for COVID-19 | https://ClinicalTrials.gov/show/NCT04377763 |
| NCT04377724 | Spread and Course of COVID-19 Infections | https://ClinicalTrials.gov/show/NCT04377724 |
| NCT04377685 | Prediction of Clinical Course in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04377685 |
| NCT04377490 | Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy | https://ClinicalTrials.gov/show/NCT04377490 |
| NCT04379063 | COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress | https://ClinicalTrials.gov/show/NCT04379063 |
| NCT04416347 | COVID19 Clinical Predictors and Outcome | https://ClinicalTrials.gov/show/NCT04416347 |
| NCT04407156 | Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom | https://ClinicalTrials.gov/show/NCT04407156 |
| NCT04393155 | Longitudinal COVID-19 Cohort Study | https://ClinicalTrials.gov/show/NCT04393155 |
| NCT04386395 | Immune Changes in Severe COVID-19 Pulmonary Infections | https://ClinicalTrials.gov/show/NCT04386395 |
| NCT04384705 | HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital | https://ClinicalTrials.gov/show/NCT04384705 |
| NCT04382781 | Immunosupressive Treatment in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04382781 |
| NCT04382508 | Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. | https://ClinicalTrials.gov/show/NCT04382508 |
| NCT04381273 | Oral Health and Psychosocial Factors During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04381273 |
| NCT04379297 | COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE) | https://ClinicalTrials.gov/show/NCT04379297 |
| NCT04383899 | Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04383899 |
| NCT04383678 | Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04383678 |
| NCT04383652 | Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales | https://ClinicalTrials.gov/show/NCT04383652 |
| NCT04383483 | CoV-ICU Score, Intensive Care Unit, SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04383483 |
| NCT04381351 | Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction | https://ClinicalTrials.gov/show/NCT04381351 |
| NCT04380792 | Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital | https://ClinicalTrials.gov/show/NCT04380792 |
| NCT04380779 | Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses | https://ClinicalTrials.gov/show/NCT04380779 |
| NCT04380714 | Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19 | https://ClinicalTrials.gov/show/NCT04380714 |
| NCT04385251 | International SARS-CoV-2 (COVID-19) Infection Observational Study | https://ClinicalTrials.gov/show/NCT04385251 |
| NCT04385004 | Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU | https://ClinicalTrials.gov/show/NCT04385004 |
| NCT04384055 | Predicting Outcomes for Covid-19 Using Sonography | https://ClinicalTrials.gov/show/NCT04384055 |
| NCT04383886 | Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383886 |
| NCT04383730 | Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19) | https://ClinicalTrials.gov/show/NCT04383730 |
| NCT04382794 | Sitagliptin Treatment in Diabetic COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04382794 |
| NCT04382495 | The Impact of COVID-19 Pandemic on Cancer Care | https://ClinicalTrials.gov/show/NCT04382495 |
| NCT04382196 | Impact of COVID-19 on Mental Health of Health Care Workers | https://ClinicalTrials.gov/show/NCT04382196 |
| NCT04383444 | Surveillance of Individuals Following SARS-CoV-2 Exposure | https://ClinicalTrials.gov/show/NCT04383444 |
| NCT04385238 | Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04385238 |
| NCT04384250 | Genetic Basis of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04384250 |
| NCT04383626 | Fear Among Dentists During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383626 |
| NCT04431310 | Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04431310 |
| NCT04409535 | Effects of the COVID-19 Health Emergency on Biopsychosocial Health | https://ClinicalTrials.gov/show/NCT04409535 |
| NCT04389320 | Antimalarial and Covid 19 in Rheumatoid Arthritis | https://ClinicalTrials.gov/show/NCT04389320 |
| NCT04387786 | Dornase Alfa Administered to Patients With COVID-19 (DACOVID) | https://ClinicalTrials.gov/show/NCT04387786 |
| NCT04386720 | Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19. | https://ClinicalTrials.gov/show/NCT04386720 |
| NCT04386564 | Kidney Injury Severity and COVID-19 | https://ClinicalTrials.gov/show/NCT04386564 |
| NCT04386551 | Detection of COVID-19 in Saliva Collection | https://ClinicalTrials.gov/show/NCT04386551 |
| NCT04385823 | Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04385823 |
| NCT04385147 | Advanced Endoscopy During COVID-19 | https://ClinicalTrials.gov/show/NCT04385147 |
| NCT04385160 | Myeloproliferative Neoplasms (MPN) and COVID-19 | https://ClinicalTrials.gov/show/NCT04385160 |
| NCT04384926 | Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis | https://ClinicalTrials.gov/show/NCT04384926 |
| NCT04384887 | “Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women” | https://ClinicalTrials.gov/show/NCT04384887 |
| NCT04388670 | Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04388670 |
| NCT04388579 | Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19 | https://ClinicalTrials.gov/show/NCT04388579 |
| NCT04387968 | Epidemiological Study of the Covid-19 Presto Test - The “COVIDOR” Study | https://ClinicalTrials.gov/show/NCT04387968 |
| NCT04387279 | The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT04387279 |
| NCT04387214 | COVID-19 Pandemic and Academic Performance of Veterinary Students | https://ClinicalTrials.gov/show/NCT04387214 |
| NCT04386512 | Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1) | https://ClinicalTrials.gov/show/NCT04386512 |
| NCT04386460 | Covid-19 and Prevention of Malnutrition After Confinement by Dentists | https://ClinicalTrials.gov/show/NCT04386460 |
| NCT04406324 | COVID-19: Respiratory and Sleep Follow-up | https://ClinicalTrials.gov/show/NCT04406324 |
| NCT04392401 | COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study | https://ClinicalTrials.gov/show/NCT04392401 |
| NCT04389645 | Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04389645 |
| NCT04389567 | Famotidine Outpatient COVID-19 Treatment Study | https://ClinicalTrials.gov/show/NCT04389567 |
| NCT04388618 | Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia | https://ClinicalTrials.gov/show/NCT04388618 |
| NCT04388657 | COVID-19, bLOod Coagulation and Thrombosis | https://ClinicalTrials.gov/show/NCT04388657 |
| NCT04387838 | Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff | https://ClinicalTrials.gov/show/NCT04387838 |
| NCT04387799 | Determinants of COVID-19 Pneumonia (MC-19) | https://ClinicalTrials.gov/show/NCT04387799 |
| NCT04387643 | Protecting Health Care Workers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04387643 |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | https://ClinicalTrials.gov/show/NCT04387656 |
| NCT04410835 | Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders | https://ClinicalTrials.gov/show/NCT04410835 |
| NCT04393428 | Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04393428 |
| NCT04392089 | Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS | https://ClinicalTrials.gov/show/NCT04392089 |
| NCT04391881 | Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population | https://ClinicalTrials.gov/show/NCT04391881 |
| NCT04391738 | Association Between BMI and COVID-19 | https://ClinicalTrials.gov/show/NCT04391738 |
| NCT04390126 | COVID-19 Related Lockdown Effects On Chronic Diseases | https://ClinicalTrials.gov/show/NCT04390126 |
| NCT04390074 | COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality | https://ClinicalTrials.gov/show/NCT04390074 |
| NCT04389684 | Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors | https://ClinicalTrials.gov/show/NCT04389684 |
| NCT04389515 | Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04389515 |
| NCT04389489 | Postpartum Sexual Function in Pregnant Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04389489 |
| NCT04389463 | Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04389463 |
| NCT04389658 | Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION) | https://ClinicalTrials.gov/show/NCT04389658 |
| NCT04453670 | Neuropathology in Adults Intensive Care Unit Patients With COVID 19 | https://ClinicalTrials.gov/show/NCT04453670 |
| NCT04395833 | National Survey on the Lockdown of Children With Disabilities | https://ClinicalTrials.gov/show/NCT04395833 |
| NCT04394026 | Imaging Feature of SARS-CoV2 Infection | https://ClinicalTrials.gov/show/NCT04394026 |
| NCT04393402 | Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) | https://ClinicalTrials.gov/show/NCT04393402 |
| NCT04392245 | Proctologic Practice and Covid-19 | https://ClinicalTrials.gov/show/NCT04392245 |
| NCT04392388 | Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis | https://ClinicalTrials.gov/show/NCT04392388 |
| NCT04391166 | Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04391166 |
| NCT04391816 | COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study | https://ClinicalTrials.gov/show/NCT04391816 |
| NCT04394195 | sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? | https://ClinicalTrials.gov/show/NCT04394195 |
| NCT04393805 | Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto | https://ClinicalTrials.gov/show/NCT04393805 |
| NCT04393558 | Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms | https://ClinicalTrials.gov/show/NCT04393558 |
| NCT04396197 | Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care | https://ClinicalTrials.gov/show/NCT04396197 |
| NCT04414319 | Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly | https://ClinicalTrials.gov/show/NCT04414319 |
| NCT04410263 | Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches | https://ClinicalTrials.gov/show/NCT04410263 |
| NCT04409197 | Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network | https://ClinicalTrials.gov/show/NCT04409197 |
| NCT04401241 | How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department | https://ClinicalTrials.gov/show/NCT04401241 |
| NCT04396353 | EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04396353 |
| NCT04396210 | Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04396210 |
| NCT04395859 | Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents | https://ClinicalTrials.gov/show/NCT04395859 |
| NCT04395482 | Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury | https://ClinicalTrials.gov/show/NCT04395482 |
| NCT04394429 | Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04394429 |
| NCT04394078 | Impact of COVID-19 Pandemic on Depression and Quality of Life | https://ClinicalTrials.gov/show/NCT04394078 |
| NCT04393974 | COVID-19 and Cancer Patients | https://ClinicalTrials.gov/show/NCT04393974 |
| NCT04517682 | COVID-19 and SARS-CoV-2 Detection in Saliva | https://ClinicalTrials.gov/show/NCT04517682 |
| NCT04405466 | A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers | https://ClinicalTrials.gov/show/NCT04405466 |
| NCT04397939 | Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04397939 |
| NCT04397900 | Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes | https://ClinicalTrials.gov/show/NCT04397900 |
| NCT04397848 | Mental Health Outcomes in Healthcare Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04397848 |
| NCT04397822 | COVID-19: Study of INFLAmmasome and PLAtelets Functions | https://ClinicalTrials.gov/show/NCT04397822 |
| NCT04397588 | Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 | https://ClinicalTrials.gov/show/NCT04397588 |
| NCT04395924 | Maternal-foetal Transmission of SARS-Cov-2 | https://ClinicalTrials.gov/show/NCT04395924 |
| NCT04395755 | Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed | https://ClinicalTrials.gov/show/NCT04395755 |
| NCT04395664 | Arrhythmias in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04395664 |
| NCT04395391 | Home Usability Study of the SARS-CoV-2 (COVID-19) Test | https://ClinicalTrials.gov/show/NCT04395391 |
| NCT04395300 | Sleep Quality in Healthcare Personnel During COVID-19 | https://ClinicalTrials.gov/show/NCT04395300 |
| NCT04395885 | Sexual Function During COVID 19 Pandemic | https://ClinicalTrials.gov/show/NCT04395885 |
| NCT04394884 | Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND) | https://ClinicalTrials.gov/show/NCT04394884 |
| NCT04412460 | Echocardiography in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04412460 |
| NCT04411511 | COVID-19, Obesity and Lifestyle in Children | https://ClinicalTrials.gov/show/NCT04411511 |
| NCT04403607 | Cardiac Imaging in SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04403607 |
| NCT04402905 | Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL) | https://ClinicalTrials.gov/show/NCT04402905 |
| NCT04400812 | Attitude and Perception Towards COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04400812 |
| NCT04400461 | Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04400461 |
| NCT04397614 | Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients | https://ClinicalTrials.gov/show/NCT04397614 |
| NCT04397172 | Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04397172 |
| NCT04473105 | Optimising Resource Allocation Via Prediction of Outcomes for Covid-19 | https://ClinicalTrials.gov/show/NCT04473105 |
| NCT04427280 | Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04427280 |
| NCT04425382 | Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar | https://ClinicalTrials.gov/show/NCT04425382 |
| NCT04403035 | Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19 | https://ClinicalTrials.gov/show/NCT04403035 |
| NCT04402229 | Psychological Impact of the Covid-19 Pandemic on Student Nurses | https://ClinicalTrials.gov/show/NCT04402229 |
| NCT04401371 | Distance Learning for Dental Student During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04401371 |
| NCT04401228 | Predictive Models for Intensive Care Admission and Death of COVID-19 | https://ClinicalTrials.gov/show/NCT04401228 |
| NCT04401085 | COVID-19: Herd Immunity Study in the Czech Republic | https://ClinicalTrials.gov/show/NCT04401085 |
| NCT04400006 | Ozone Therapy in the Prevention of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04400006 |
| NCT04410939 | COVID-19 PCR Test Results in Asymptomatic Pregnants | https://ClinicalTrials.gov/show/NCT04410939 |
| NCT04409847 | COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX) | https://ClinicalTrials.gov/show/NCT04409847 |
| NCT04404062 | Validation of COVID-19 Tests | https://ClinicalTrials.gov/show/NCT04404062 |
| NCT04402853 | SARS Cov-2 in Conjunctival Secretion | https://ClinicalTrials.gov/show/NCT04402853 |
| NCT04402814 | IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing. | https://ClinicalTrials.gov/show/NCT04402814 |
| NCT04401436 | COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO) | https://ClinicalTrials.gov/show/NCT04401436 |
| NCT04401111 | One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU) | https://ClinicalTrials.gov/show/NCT04401111 |
| NCT04401098 | Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak | https://ClinicalTrials.gov/show/NCT04401098 |
| NCT04401072 | Attitude of Egyptian Population Toward COVID 19 in Ramadan | https://ClinicalTrials.gov/show/NCT04401072 |
| NCT04400877 | Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04400877 |
| NCT04403880 | Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 | https://ClinicalTrials.gov/show/NCT04403880 |
| NCT04401449 | Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons | https://ClinicalTrials.gov/show/NCT04401449 |
| NCT04413071 | Cardiac COVID-19 Health Care Workers | https://ClinicalTrials.gov/show/NCT04413071 |
| NCT04407299 | COVID-19 Impact on Rheumatic Patients | https://ClinicalTrials.gov/show/NCT04407299 |
| NCT04406545 | Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. | https://ClinicalTrials.gov/show/NCT04406545 |
| NCT04406233 | Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04406233 |
| NCT04403438 | Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04403438 |
| NCT04403061 | Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome | https://ClinicalTrials.gov/show/NCT04403061 |
| NCT04402827 | Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19. | https://ClinicalTrials.gov/show/NCT04402827 |
| NCT04556149 | imPulseâ„¢ Una Full-spectrum, Over Clothing E-stethoscope | https://ClinicalTrials.gov/show/NCT04556149 |
| NCT04403386 | Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 | https://ClinicalTrials.gov/show/NCT04403386 |
| NCT04406558 | Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents | https://ClinicalTrials.gov/show/NCT04406558 |
| NCT04404179 | Setting up a COVID-19 Care Facility at a Prison in Pakistan | https://ClinicalTrials.gov/show/NCT04404179 |
| NCT04403932 | Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency | https://ClinicalTrials.gov/show/NCT04403932 |
| NCT04403828 | Impact of COVID-19 on Personal Protection Among Dentist in Egypt | https://ClinicalTrials.gov/show/NCT04403828 |
| NCT04413435 | Clinical Characteristics of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04413435 |
| NCT04410107 | Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04410107 |
| NCT04408222 | Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04408222 |
| NCT04407143 | Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04407143 |
| NCT04406844 | Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04406844 |
| NCT04405973 | Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO | https://ClinicalTrials.gov/show/NCT04405973 |
| NCT04405869 | Thromboembolic Events in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04405869 |
| NCT04405726 | Prognostic Factors of COVID19 | https://ClinicalTrials.gov/show/NCT04405726 |
| NCT04404270 | Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) | https://ClinicalTrials.gov/show/NCT04404270 |
| NCT04404244 | Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04404244 |
| NCT04435106 | Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04435106 |
| NCT04416100 | Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04416100 |
| NCT04411576 | Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare | https://ClinicalTrials.gov/show/NCT04411576 |
| NCT04409899 | The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department | https://ClinicalTrials.gov/show/NCT04409899 |
| NCT04408170 | Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) | https://ClinicalTrials.gov/show/NCT04408170 |
| NCT04406090 | Endovascular Thrombectomy in COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04406090 |
| NCT04406038 | Study of the Spread of COVID-19 in Saint Petersburg, Russia | https://ClinicalTrials.gov/show/NCT04406038 |
| NCT04405232 | Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK | https://ClinicalTrials.gov/show/NCT04405232 |
| NCT04445259 | Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury | https://ClinicalTrials.gov/show/NCT04445259 |
| NCT04423640 | Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423640 |
| NCT04414410 | Echocardiography in Critically-ill Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04414410 |
| NCT04413058 | Menstrual Cycle Characteristics of Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04413058 |
| NCT04412473 | COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject’s Habits | https://ClinicalTrials.gov/show/NCT04412473 |
| NCT04408378 | Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients | https://ClinicalTrials.gov/show/NCT04408378 |
| NCT04408326 | Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04408326 |
| NCT04408248 | AKI Biomarkers in Coronavirus(COVID)-19 | https://ClinicalTrials.gov/show/NCT04408248 |
| NCT04407273 | STATIN THERAPY AND COVID-19 INFECTION | https://ClinicalTrials.gov/show/NCT04407273 |
| NCT04407663 | Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near | https://ClinicalTrials.gov/show/NCT04407663 |
| NCT04407585 | Testing the Accuracy of a Digital Test to Diagnose Covid-19 | https://ClinicalTrials.gov/show/NCT04407585 |
| NCT04407572 | Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women | https://ClinicalTrials.gov/show/NCT04407572 |
| NCT04407559 | COVID-SErology in Rheumatoid Arthritis (COVID-19) | https://ClinicalTrials.gov/show/NCT04407559 |
| NCT04407546 | Role of Children in Transmission of COVID-19 to Immunocompromised Patients | https://ClinicalTrials.gov/show/NCT04407546 |
| NCT04407533 | Dietary Intake and Eating Habits During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04407533 |
| NCT04407494 | Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) | https://ClinicalTrials.gov/show/NCT04407494 |
| NCT04407468 | Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04407468 |
| NCT04407429 | Vienna Versus SARS-CoV-2 Virus Study | https://ClinicalTrials.gov/show/NCT04407429 |
| NCT04407260 | The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic Patients With COVID-19. A Prospective Controlled Cohort Study. | https://ClinicalTrials.gov/show/NCT04407260 |
| NCT04407195 | COVID-19 and Mental Health | https://ClinicalTrials.gov/show/NCT04407195 |
| NCT04407117 | Appendicitis During the National Lockdown During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04407117 |
| NCT04406571 | Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer | https://ClinicalTrials.gov/show/NCT04406571 |
| NCT04425213 | Obesity and Mortality of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425213 |
| NCT04418609 | Neuro-COVID-19: Neurological Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04418609 |
| NCT04409275 | LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION | https://ClinicalTrials.gov/show/NCT04409275 |
| NCT04409249 | Prognosis in Pregnant With COVID-19 | https://ClinicalTrials.gov/show/NCT04409249 |
| NCT04408001 | Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff | https://ClinicalTrials.gov/show/NCT04408001 |
| NCT04407923 | Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment | https://ClinicalTrials.gov/show/NCT04407923 |
| NCT04416373 | COVID-19 and Pregnancy Outcomes | https://ClinicalTrials.gov/show/NCT04416373 |
| NCT04416256 | COVID-19 Pandemic and Worldwide Organ Procurement | https://ClinicalTrials.gov/show/NCT04416256 |
| NCT04412031 | Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient | https://ClinicalTrials.gov/show/NCT04412031 |
| NCT04411784 | PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT04411784 |
| NCT04411459 | Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04411459 |
| NCT04410484 | PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04410484 |
| NCT04410432 | Immune Response and Risk of Serious Infection to SARS-Cov2 | https://ClinicalTrials.gov/show/NCT04410432 |
| NCT04581070 | The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic" | https://ClinicalTrials.gov/show/NCT04581070 |
| NCT04412304 | Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04412304 |
| NCT04412278 | Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers | https://ClinicalTrials.gov/show/NCT04412278 |
| NCT04412265 | Frailty in Elderly Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04412265 |
| NCT04411147 | A Longitudinal Study of COVID-19 Sequelae and Immunity | https://ClinicalTrials.gov/show/NCT04411147 |
| NCT04448418 | The Impact of COVID-19 Outbreak on Trans-population’s Health in Italy | https://ClinicalTrials.gov/show/NCT04448418 |
| NCT04418544 | Vocal Feature Analysis Algorithm | https://ClinicalTrials.gov/show/NCT04418544 |
| NCT04416061 | The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04416061 |
| NCT04413045 | Novel COVID-19, A National Analysis | https://ClinicalTrials.gov/show/NCT04413045 |
| NCT04412746 | Covid-19 and Diabetes in West of Algeria | https://ClinicalTrials.gov/show/NCT04412746 |
| NCT04412655 | Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry | https://ClinicalTrials.gov/show/NCT04412655 |
| NCT04418193 | Patient Preference Trial for COVID-19 (PPT-COVID) | https://ClinicalTrials.gov/show/NCT04418193 |
| NCT04414657 | USZ BioResource COVID | https://ClinicalTrials.gov/show/NCT04414657 |
| NCT04418375 | Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP) | https://ClinicalTrials.gov/show/NCT04418375 |
| NCT04443075 | Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress | https://ClinicalTrials.gov/show/NCT04443075 |
| NCT04422535 | Effects on the Qt Interval of COVID-19 Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04422535 |
| NCT04422418 | Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi | https://ClinicalTrials.gov/show/NCT04422418 |
| NCT04418284 | Online Learning of Veterinary Anatomy During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04418284 |
| NCT04416438 | COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias | https://ClinicalTrials.gov/show/NCT04416438 |
| NCT04427345 | Predictive Factors COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427345 |
| NCT04424992 | The Natural History of Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424992 |
| NCT04422873 | The Impact of COVID-19 on Dialysis Users | https://ClinicalTrials.gov/show/NCT04422873 |
| NCT04422769 | Needs of Persons With Spinal Cord Injury (SCI) | https://ClinicalTrials.gov/show/NCT04422769 |
| NCT04420637 | Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases | https://ClinicalTrials.gov/show/NCT04420637 |
| NCT04420416 | Mental Health and Academic Performance in COVID-19 | https://ClinicalTrials.gov/show/NCT04420416 |
| NCT04419571 | Outcomes in Emergency Laparotomies During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04419571 |
| NCT04419545 | Covid Radiographic Images Data-set for A.I | https://ClinicalTrials.gov/show/NCT04419545 |
| NCT04418245 | CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis | https://ClinicalTrials.gov/show/NCT04418245 |
| NCT04424355 | Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection. | https://ClinicalTrials.gov/show/NCT04424355 |
| NCT04423315 | Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04423315 |
| NCT04422691 | Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04422691 |
| NCT04420312 | Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04420312 |
| NCT04420286 | Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France | https://ClinicalTrials.gov/show/NCT04420286 |
| NCT04419870 | Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04419870 |
| NCT04427969 | Early Prone Position on Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04427969 |
| NCT04425889 | COVID-19 Antibodies Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04425889 |
| NCT04424836 | HFNC Treatment in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04424836 |
| NCT04424771 | Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04424771 |
| NCT04423692 | Knowledge About Covid-19 Infection in Pregnant Women | https://ClinicalTrials.gov/show/NCT04423692 |
| NCT04422522 | Fibromyalgia During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04422522 |
| NCT04425863 | IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19 | https://ClinicalTrials.gov/show/NCT04425863 |
| NCT04425850 | USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 | https://ClinicalTrials.gov/show/NCT04425850 |
| NCT04424849 | Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424849 |
| NCT04424017 | Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04424017 |
| NCT04424004 | MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study | https://ClinicalTrials.gov/show/NCT04424004 |
| NCT04423978 | Implications of Covid-19 on the Lifestyle Changes | https://ClinicalTrials.gov/show/NCT04423978 |
| NCT04423770 | COVID-19 Related Health and Infection Control Practices Among Dentists | https://ClinicalTrials.gov/show/NCT04423770 |
| NCT04422574 | COVID 19 Serology in Pulmonologists | https://ClinicalTrials.gov/show/NCT04422574 |
| NCT04422340 | Senior-COVID-Rea Multicentric Survey | https://ClinicalTrials.gov/show/NCT04422340 |
| NCT04426266 | Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population | https://ClinicalTrials.gov/show/NCT04426266 |
| NCT04433260 | COVID19 and Physical and Emotional Wellbeing of HCP | https://ClinicalTrials.gov/show/NCT04433260 |
| NCT04427735 | Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI | https://ClinicalTrials.gov/show/NCT04427735 |
| NCT04426279 | Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants | https://ClinicalTrials.gov/show/NCT04426279 |
| NCT04426253 | Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19 | https://ClinicalTrials.gov/show/NCT04426253 |
| NCT04425044 | AiM Covid Self Monitoring | https://ClinicalTrials.gov/show/NCT04425044 |
| NCT04424446 | Saliva as Source of Detection for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04424446 |
| NCT04431414 | A Study of Immune Responses to the Virus That Causes COVID-19 | https://ClinicalTrials.gov/show/NCT04431414 |
| NCT04558437 | COVID-Impact “Psychological IMPACT of Covid-19 on AP-HP Staff” | https://ClinicalTrials.gov/show/NCT04558437 |
| NCT04438239 | Rehabilitation Needs After COVID-19 Hospital Treatment | https://ClinicalTrials.gov/show/NCT04438239 |
| NCT04431284 | Impact of COVID-19 Lockdown on Obesity and Eating Behaviors | https://ClinicalTrials.gov/show/NCT04431284 |
| NCT04430023 | Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04430023 |
| NCT04429620 | Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method | https://ClinicalTrials.gov/show/NCT04429620 |
| NCT04427358 | RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population | https://ClinicalTrials.gov/show/NCT04427358 |
| NCT04427332 | Smell and Taste Disorders in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427332 |
| NCT04427267 | Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427267 |
| NCT04427176 | Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19). | https://ClinicalTrials.gov/show/NCT04427176 |
| NCT04447222 | Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors | https://ClinicalTrials.gov/show/NCT04447222 |
| NCT04430322 | Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study | https://ClinicalTrials.gov/show/NCT04430322 |
| NCT04430062 | Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital | https://ClinicalTrials.gov/show/NCT04430062 |
| NCT04459975 | Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units | https://ClinicalTrials.gov/show/NCT04459975 |
| NCT04441502 | Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic | https://ClinicalTrials.gov/show/NCT04441502 |
| NCT04436484 | Immune Biomarkers of Outcome From COVID-19 | https://ClinicalTrials.gov/show/NCT04436484 |
| NCT04435327 | Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04435327 |
| NCT04435119 | Covid-19 and Vitamin D in Nursing-home | https://ClinicalTrials.gov/show/NCT04435119 |
| NCT04434157 | Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04434157 |
| NCT04433754 | The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection | https://ClinicalTrials.gov/show/NCT04433754 |
| NCT04433000 | Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04433000 |
| NCT04432870 | Patients’ Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study | https://ClinicalTrials.gov/show/NCT04432870 |
| NCT04431908 | Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects | https://ClinicalTrials.gov/show/NCT04431908 |
| NCT04434118 | Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients | https://ClinicalTrials.gov/show/NCT04434118 |
| NCT04433039 | COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising | https://ClinicalTrials.gov/show/NCT04433039 |
| NCT04432948 | Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management. | https://ClinicalTrials.gov/show/NCT04432948 |
| NCT04456010 | COVID-19 in ART: Perception and Experience | https://ClinicalTrials.gov/show/NCT04456010 |
| NCT04451694 | Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19 | https://ClinicalTrials.gov/show/NCT04451694 |
| NCT04438967 | Brain Health in the Time of COVID-19 | https://ClinicalTrials.gov/show/NCT04438967 |
| NCT04437342 | Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia | https://ClinicalTrials.gov/show/NCT04437342 |
| NCT04437121 | Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece | https://ClinicalTrials.gov/show/NCT04437121 |
| NCT04435080 | Physical Rehabilitation in ICU in ARDS Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04435080 |
| NCT04435028 | Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy | https://ClinicalTrials.gov/show/NCT04435028 |
| NCT04434261 | Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 | https://ClinicalTrials.gov/show/NCT04434261 |
| NCT04444609 | PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort | https://ClinicalTrials.gov/show/NCT04444609 |
| NCT04443712 | Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19) | https://ClinicalTrials.gov/show/NCT04443712 |
| NCT04441489 | Assessment of Lung Inflammation With FDG PET/CT in COVID-19 | https://ClinicalTrials.gov/show/NCT04441489 |
| NCT04438629 | Evaluation of Immune Response in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04438629 |
| NCT04435223 | Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen | https://ClinicalTrials.gov/show/NCT04435223 |
| NCT04448782 | Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04448782 |
| NCT04447209 | Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study | https://ClinicalTrials.gov/show/NCT04447209 |
| NCT04447131 | Effect of COVID-19 on Platelet Aggregation | https://ClinicalTrials.gov/show/NCT04447131 |
| NCT04441476 | Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis | https://ClinicalTrials.gov/show/NCT04441476 |
| NCT04439084 | COVID-19 in Patients With Chronic Liver Diseases | https://ClinicalTrials.gov/show/NCT04439084 |
| NCT04438954 | Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels | https://ClinicalTrials.gov/show/NCT04438954 |
| NCT04438941 | Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic | https://ClinicalTrials.gov/show/NCT04438941 |
| NCT04437940 | Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test | https://ClinicalTrials.gov/show/NCT04437940 |
| NCT04459351 | PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs | https://ClinicalTrials.gov/show/NCT04459351 |
| NCT04448717 | Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children | https://ClinicalTrials.gov/show/NCT04448717 |
| NCT04442789 | Sequelae of Sars-CoV-2 Infections | https://ClinicalTrials.gov/show/NCT04442789 |
| NCT04441814 | FOUND - Ancillary Study to Smile Protocol NCT03654105 | https://ClinicalTrials.gov/show/NCT04441814 |
| NCT04440098 | Isolated During COVID-19: Effects of COVID-19’s Social Restrictions on Loneliness and Psychosocial Symptomatology | https://ClinicalTrials.gov/show/NCT04440098 |
| NCT04438993 | The COVID-19 Disease and CARdiac Events Study | https://ClinicalTrials.gov/show/NCT04438993 |
| NCT04462120 | IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study | https://ClinicalTrials.gov/show/NCT04462120 |
| NCT04448405 | Covid-19 Lockdown and Deviant Sexual Fantasies | https://ClinicalTrials.gov/show/NCT04448405 |
| NCT04445506 | Short Term Corticosteroids in SARS-CoV2 Patients | https://ClinicalTrials.gov/show/NCT04445506 |
| NCT04444661 | Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise | https://ClinicalTrials.gov/show/NCT04444661 |
| NCT04490811 | Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children | https://ClinicalTrials.gov/show/NCT04490811 |
| NCT04446169 | COVID-19 (SARS-CoV-2) in Urine and Semen | https://ClinicalTrials.gov/show/NCT04446169 |
| NCT04443257 | REassessement After Hospitalization for Sars-COV-2 disordER | https://ClinicalTrials.gov/show/NCT04443257 |
| NCT04452682 | The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice | https://ClinicalTrials.gov/show/NCT04452682 |
| NCT04444557 | Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study | https://ClinicalTrials.gov/show/NCT04444557 |
| NCT04468308 | VRQOL in Cataract Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04468308 |
| NCT04459533 | Sparing in Neuromuscular Blockade in COVID 19 ICU | https://ClinicalTrials.gov/show/NCT04459533 |
| NCT04446338 | Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre | https://ClinicalTrials.gov/show/NCT04446338 |
| NCT04445961 | Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445961 |
| NCT04445441 | An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso | https://ClinicalTrials.gov/show/NCT04445441 |
| NCT04445233 | COVID-19 Household Transmission Study | https://ClinicalTrials.gov/show/NCT04445233 |
| NCT04444531 | Clinical Improvement and COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04444531 |
| NCT04444401 | Registry on NEN Patients and COVID-19 | https://ClinicalTrials.gov/show/NCT04444401 |
| NCT04516486 | Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04516486 |
| NCT04452422 | Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology | https://ClinicalTrials.gov/show/NCT04452422 |
| NCT04450017 | Clinical Features of Severe Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04450017 |
| NCT04449978 | TARGet Kids! COVID-19 Study of Children and Families | https://ClinicalTrials.gov/show/NCT04449978 |
| NCT04449783 | Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery | https://ClinicalTrials.gov/show/NCT04449783 |
| NCT04449731 | Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int) | https://ClinicalTrials.gov/show/NCT04449731 |
| NCT04448054 | Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas | https://ClinicalTrials.gov/show/NCT04448054 |
| NCT04447144 | Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome | https://ClinicalTrials.gov/show/NCT04447144 |
| NCT04446286 | Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19 | https://ClinicalTrials.gov/show/NCT04446286 |
| NCT04445870 | Oncology Care Pathway’s Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study | https://ClinicalTrials.gov/show/NCT04445870 |
| NCT04448145 | Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence | https://ClinicalTrials.gov/show/NCT04448145 |
| NCT04447638 | Percutaneous Tracheostomy With COVID-19 | https://ClinicalTrials.gov/show/NCT04447638 |
| NCT04493307 | The Evaluation of Hemostasis in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04493307 |
| NCT04453527 | The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04453527 |
| NCT04453501 | Anti Infective Agents Impact in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04453501 |
| NCT04451577 | Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04451577 |
| NCT04449094 | Emergence of the COVID 19 Epidemic in the City of Nice | https://ClinicalTrials.gov/show/NCT04449094 |
| NCT04449081 | Knowledge, Attitude and Practice of Dental Students About COVID-19 | https://ClinicalTrials.gov/show/NCT04449081 |
| NCT04448704 | Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04448704 |
| NCT04458337 | SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19) | https://ClinicalTrials.gov/show/NCT04458337 |
| NCT04452630 | Cardiovascular Consequences After COVID-19 | https://ClinicalTrials.gov/show/NCT04452630 |
| NCT04452617 | Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04452617 |
| NCT04451993 | Physical Activity Level in Patients With OSAS During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04451993 |
| NCT04459819 | Respiratory Physiotherapy in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04459819 |
| NCT04497779 | Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04497779 |
| NCT04474249 | Follow-up of Critical COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04474249 |
| NCT04469153 | Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19 | https://ClinicalTrials.gov/show/NCT04469153 |
| NCT04463628 | Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic | https://ClinicalTrials.gov/show/NCT04463628 |
| NCT04456075 | Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19 | https://ClinicalTrials.gov/show/NCT04456075 |
| NCT04453982 | Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b | https://ClinicalTrials.gov/show/NCT04453982 |
| NCT04453969 | Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a | https://ClinicalTrials.gov/show/NCT04453969 |
| NCT04453566 | Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes. | https://ClinicalTrials.gov/show/NCT04453566 |
| NCT04452708 | HFNC and NIV for COVID-19 Complicated by Respiratory Failure | https://ClinicalTrials.gov/show/NCT04452708 |
| NCT04452695 | Acceptability of Telehealth Triage Using Robotic Systems in COVID-19 | https://ClinicalTrials.gov/show/NCT04452695 |
| NCT04467112 | Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols | https://ClinicalTrials.gov/show/NCT04467112 |
| NCT04460664 | Coagulation Changes Associated With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04460664 |
| NCT04456933 | Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study | https://ClinicalTrials.gov/show/NCT04456933 |
| NCT04456556 | Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04456556 |
| NCT04454333 | COVID-19 in Pain Perspective | https://ClinicalTrials.gov/show/NCT04454333 |
| NCT04453280 | Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity) | https://ClinicalTrials.gov/show/NCT04453280 |
| NCT04465656 | Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04465656 |
| NCT04481516 | Yoga in NHS Health Care Workers With COVID-19 Related Stress | https://ClinicalTrials.gov/show/NCT04481516 |
| NCT04475471 | WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey | https://ClinicalTrials.gov/show/NCT04475471 |
| NCT04455451 | Intensive Care Therapy of Covid-19 Disease in Germany | https://ClinicalTrials.gov/show/NCT04455451 |
| NCT04485351 | Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes | https://ClinicalTrials.gov/show/NCT04485351 |
| NCT04459403 | Psychiatric Disturbances and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04459403 |
| NCT04457570 | Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer | https://ClinicalTrials.gov/show/NCT04457570 |
| NCT04460274 | Forecast Number of Covid-19 Cases Worldwide | https://ClinicalTrials.gov/show/NCT04460274 |
| NCT04459312 | National Covid-19 Surveillance Physicians | https://ClinicalTrials.gov/show/NCT04459312 |
| NCT04460469 | Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04460469 |
| NCT04459390 | Association of Comorbidities With COVID19 | https://ClinicalTrials.gov/show/NCT04459390 |
| NCT04522037 | Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04522037 |
| NCT04475484 | Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children | https://ClinicalTrials.gov/show/NCT04475484 |
| NCT04467931 | ACEI or ARB and COVID-19 Severity and Mortality in US Veterans | https://ClinicalTrials.gov/show/NCT04467931 |
| NCT04463706 | COVID19 Severity Prediction and Health Services Research Evaluation | https://ClinicalTrials.gov/show/NCT04463706 |
| NCT04462393 | Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19 | https://ClinicalTrials.gov/show/NCT04462393 |
| NCT04460599 | Neurological Features During COVID19 | https://ClinicalTrials.gov/show/NCT04460599 |
| NCT04460638 | SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling | https://ClinicalTrials.gov/show/NCT04460638 |
| NCT04474236 | Lung Ultrasound for COVID-19 Initial Triage and Monitoring | https://ClinicalTrials.gov/show/NCT04474236 |
| NCT04471649 | Hydroxy Chloroquine and Covid in RA Patients | https://ClinicalTrials.gov/show/NCT04471649 |
| NCT04465981 | Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins | https://ClinicalTrials.gov/show/NCT04465981 |
| NCT04468386 | Specimen Collection Study Protocol | https://ClinicalTrials.gov/show/NCT04468386 |
| NCT04466462 | Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel | https://ClinicalTrials.gov/show/NCT04466462 |
| NCT04465058 | Characteristics of Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04465058 |
| NCT04463758 | Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns | https://ClinicalTrials.gov/show/NCT04463758 |
| NCT04468802 | Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries? | https://ClinicalTrials.gov/show/NCT04468802 |
| NCT04468256 | The Heart Hive COVID-19 Study | https://ClinicalTrials.gov/show/NCT04468256 |
| NCT04468412 | Influence of COVID-19 on Vascular Endothelial Function | https://ClinicalTrials.gov/show/NCT04468412 |
| NCT04468217 | Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR | https://ClinicalTrials.gov/show/NCT04468217 |
| NCT04466982 | Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04466982 |
| NCT04466644 | COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics) | https://ClinicalTrials.gov/show/NCT04466644 |
| NCT04465552 | Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04465552 |
| NCT04476914 | Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU | https://ClinicalTrials.gov/show/NCT04476914 |
| NCT04474496 | Impact of COVID-19 on Marshallese Communities in the U.S. | https://ClinicalTrials.gov/show/NCT04474496 |
| NCT04468035 | Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04468035 |
| NCT04473365 | Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04473365 |
| NCT04474444 | Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP) | https://ClinicalTrials.gov/show/NCT04474444 |
| NCT04470323 | Functional Exhaustion of T Cells in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04470323 |
| NCT04471051 | An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04471051 |
| NCT04469660 | Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India | https://ClinicalTrials.gov/show/NCT04469660 |
| NCT04469647 | COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH | https://ClinicalTrials.gov/show/NCT04469647 |
| NCT04496128 | COVID19 Neurological Manifestation | https://ClinicalTrials.gov/show/NCT04496128 |
| NCT04496076 | COVID-19 Brain Injury | https://ClinicalTrials.gov/show/NCT04496076 |
| NCT04470583 | Evaluating Clinical Parameters of COVID-19 in Pregnancy | https://ClinicalTrials.gov/show/NCT04470583 |
| NCT04510025 | Capturing MultiORgan Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04510025 |
| NCT04484597 | Predictors of COVID-19 Infection and Disease Progression | https://ClinicalTrials.gov/show/NCT04484597 |
| NCT04475068 | Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04475068 |
| NCT04474301 | Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04474301 |
| NCT04473547 | COVID 19 Preventive Measures Among Mansoura Nursing Students | https://ClinicalTrials.gov/show/NCT04473547 |
| NCT04473300 | Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography | https://ClinicalTrials.gov/show/NCT04473300 |
| NCT04473183 | Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota | https://ClinicalTrials.gov/show/NCT04473183 |
| NCT04472013 | Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19 | https://ClinicalTrials.gov/show/NCT04472013 |
| NCT04471701 | Italian Web-based Cross-sectional Survey on COVID-19 | https://ClinicalTrials.gov/show/NCT04471701 |
| NCT04474457 | Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age | https://ClinicalTrials.gov/show/NCT04474457 |
| NCT04474288 | The COVID-19 PUI Reality Check (CPRC) Study | https://ClinicalTrials.gov/show/NCT04474288 |
| NCT04474067 | COVID-19 - Cytokine Storm | https://ClinicalTrials.gov/show/NCT04474067 |
| NCT04473157 | COVID-19 in Patients With Anosmia in Egypt | https://ClinicalTrials.gov/show/NCT04473157 |
| NCT04473131 | Immune Profiling of COVID19-patients Admitted to ICU | https://ClinicalTrials.gov/show/NCT04473131 |
| NCT04473118 | Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04473118 |
| NCT04494776 | SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study | https://ClinicalTrials.gov/show/NCT04494776 |
| NCT04477902 | Long-Term Experience and Health Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04477902 |
| NCT04476823 | European Pathology Laboratories and COVID-19 | https://ClinicalTrials.gov/show/NCT04476823 |
| NCT04476602 | Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol | https://ClinicalTrials.gov/show/NCT04476602 |
| NCT04476589 | Prognostication of Recovery in Early Disorders of Consciousness After COVID-19 | https://ClinicalTrials.gov/show/NCT04476589 |
| NCT04522310 | ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis | https://ClinicalTrials.gov/show/NCT04522310 |
| NCT04480515 | Does COVID-19 Pandemic Reduce In-hospital Mortality? | https://ClinicalTrials.gov/show/NCT04480515 |
| NCT04479982 | Microbial Infection and AMR in Hospitalized Patients With Covid 19 | https://ClinicalTrials.gov/show/NCT04479982 |
| NCT04477889 | Methodist Health System COVID-19 Patient Registry | https://ClinicalTrials.gov/show/NCT04477889 |
| NCT04477473 | Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group | https://ClinicalTrials.gov/show/NCT04477473 |
| NCT04480398 | Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients | https://ClinicalTrials.gov/show/NCT04480398 |
| NCT04480060 | Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04480060 |
| NCT04479137 | Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul | https://ClinicalTrials.gov/show/NCT04479137 |
| NCT04479293 | Post COVID-19 Functional Status in Egypt | https://ClinicalTrials.gov/show/NCT04479293 |
| NCT04479280 | Evaluation of Coagulopathy in Critically Ill COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04479280 |
| NCT04479124 | The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul | https://ClinicalTrials.gov/show/NCT04479124 |
| NCT04491214 | Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19) | https://ClinicalTrials.gov/show/NCT04491214 |
| NCT04481620 | Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT | https://ClinicalTrials.gov/show/NCT04481620 |
| NCT04480580 | Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery | https://ClinicalTrials.gov/show/NCT04480580 |
| NCT04506632 | Burden for STaff Working in the NHS | https://ClinicalTrials.gov/show/NCT04506632 |
| NCT04486729 | Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04486729 |
| NCT04483622 | Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients | https://ClinicalTrials.gov/show/NCT04483622 |
| NCT04482205 | Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures | https://ClinicalTrials.gov/show/NCT04482205 |
| NCT04495764 | Registry of Sustained Immunity to COVID-19 Among ESKD Patients | https://ClinicalTrials.gov/show/NCT04495764 |
| NCT04486521 | Clinical Outcome of Anti-IL6 vs Anti-IL6 Corticosteroid Combination in Patients With SARS-CoV-2 Cytokine Release Syndrome | https://ClinicalTrials.gov/show/NCT04486521 |
| NCT04486417 | Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19 | https://ClinicalTrials.gov/show/NCT04486417 |
| NCT04484545 | Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04484545 |
| NCT04483908 | COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses | https://ClinicalTrials.gov/show/NCT04483908 |
| NCT04492267 | Inflammatory Bowel Disease (IBD) and Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04492267 |
| NCT04488549 | Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19) | https://ClinicalTrials.gov/show/NCT04488549 |
| NCT04488510 | Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia: | https://ClinicalTrials.gov/show/NCT04488510 |
| NCT04487977 | Survey on COVID-19 Airway Management | https://ClinicalTrials.gov/show/NCT04487977 |
| NCT04485364 | Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04485364 |
| NCT04486404 | Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America | https://ClinicalTrials.gov/show/NCT04486404 |
| NCT04500652 | Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04500652 |
| NCT04500600 | Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04500600 |
| NCT04491227 | Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04491227 |
| NCT04488588 | Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt | https://ClinicalTrials.gov/show/NCT04488588 |
| NCT04488471 | Impact of Isolation in Patients With IBD During the COVID-19 Crisis | https://ClinicalTrials.gov/show/NCT04488471 |
| NCT04487951 | N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04487951 |
| NCT04487769 | Lung Ultrasound in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04487769 |
| NCT04487197 | SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets) | https://ClinicalTrials.gov/show/NCT04487197 |
| NCT04487119 | Hematology and Clinical Picture in Pediatric COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04487119 |
| NCT04570982 | Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal | https://ClinicalTrials.gov/show/NCT04570982 |
| NCT04492904 | Singapore COVID-19 Chemosensory Tracking (SCCT) Study | https://ClinicalTrials.gov/show/NCT04492904 |
| NCT04492384 | Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients | https://ClinicalTrials.gov/show/NCT04492384 |
| NCT04491318 | COVID-19 Quarantine on Musculoskeletal Status in Hemophilia | https://ClinicalTrials.gov/show/NCT04491318 |
| NCT04491201 | National Survey of the Impact of COVID-19 Pandemics | https://ClinicalTrials.gov/show/NCT04491201 |
| NCT04551690 | Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE) | https://ClinicalTrials.gov/show/NCT04551690 |
| NCT04501822 | One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04501822 |
| NCT04493268 | HYPONATREMIA IN COVID-19 PATIENTS | https://ClinicalTrials.gov/show/NCT04493268 |
| NCT04492371 | COVID-19 Infection and Multiple Myeloma | https://ClinicalTrials.gov/show/NCT04492371 |
| NCT04491292 | Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce | https://ClinicalTrials.gov/show/NCT04491292 |
| NCT04490174 | Serological Surveillance for COVID-19 in Central North Carolina | https://ClinicalTrials.gov/show/NCT04490174 |
| NCT04501432 | Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19 | https://ClinicalTrials.gov/show/NCT04501432 |
| NCT04494893 | ImmuneRACE - Immune Response Action to COVID-19 Events | https://ClinicalTrials.gov/show/NCT04494893 |
| NCT04496141 | Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19 | https://ClinicalTrials.gov/show/NCT04496141 |
| NCT04495907 | COVID-19 Progression in End-Stage Kidney Disease | https://ClinicalTrials.gov/show/NCT04495907 |
| NCT04505605 | Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04505605 |
| NCT04498299 | Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness | https://ClinicalTrials.gov/show/NCT04498299 |
| NCT04497311 | Tomographic Findings in COVID-19 and Influenza | https://ClinicalTrials.gov/show/NCT04497311 |
| NCT04498416 | CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19 | https://ClinicalTrials.gov/show/NCT04498416 |
| NCT04498507 | Psychosocial Outcomes in Families of COVID-19 ICU Patients | https://ClinicalTrials.gov/show/NCT04498507 |
| NCT04497818 | Correlation Fear of COVID-19 & Dental Treatment Anxiety | https://ClinicalTrials.gov/show/NCT04497818 |
| NCT04497636 | Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile | https://ClinicalTrials.gov/show/NCT04497636 |
| NCT04497441 | Netizens’ Perception of COVID-19 Information & Information Sources. | https://ClinicalTrials.gov/show/NCT04497441 |
| NCT04497467 | Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04497467 |
| NCT04506515 | Psychological Impact of COVID-19 Pandemic in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04506515 |
| NCT04505631 | Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04505631 |
| NCT04499300 | Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age | https://ClinicalTrials.gov/show/NCT04499300 |
| NCT04498286 | COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients | https://ClinicalTrials.gov/show/NCT04498286 |
| NCT04498091 | EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19 | https://ClinicalTrials.gov/show/NCT04498091 |
| NCT04498065 | MYocardial DOmmages Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04498065 |
| NCT04497246 | Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19) | https://ClinicalTrials.gov/show/NCT04497246 |
| NCT04503525 | Nutritional Assessment of Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04503525 |
| NCT04503447 | COVID-19 Seroprevalence Study in ITM Staff | https://ClinicalTrials.gov/show/NCT04503447 |
| NCT04500639 | Over-the-counter Medications & COVID-19 | https://ClinicalTrials.gov/show/NCT04500639 |
| NCT04507893 | Comparison Between Positive and Negative COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04507893 |
| NCT04502108 | Behavior During and After COVID-19 Crisis | https://ClinicalTrials.gov/show/NCT04502108 |
| NCT04501991 | Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes | https://ClinicalTrials.gov/show/NCT04501991 |
| NCT04509713 | Canine COVID-19 Detection | https://ClinicalTrials.gov/show/NCT04509713 |
| NCT04526405 | Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases | https://ClinicalTrials.gov/show/NCT04526405 |
| NCT04510441 | Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms | https://ClinicalTrials.gov/show/NCT04510441 |
| NCT04507230 | COVID-19 Associated Coagulopathy in Egypt | https://ClinicalTrials.gov/show/NCT04507230 |
| NCT04506229 | Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function | https://ClinicalTrials.gov/show/NCT04506229 |
| NCT04510012 | Characterizing the Immune Response and Neuronal Damage in COVID-19 | https://ClinicalTrials.gov/show/NCT04510012 |
| NCT04508777 | COVID SAFE: COVID-19 Screening Assessment for Exposure | https://ClinicalTrials.gov/show/NCT04508777 |
| NCT04508972 | The VOICE-COVID-19 | https://ClinicalTrials.gov/show/NCT04508972 |
| NCT04510623 | Host Response Mediators in Coronavirus (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04510623 |
| NCT04512300 | Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04512300 |
| NCT04512118 | CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04512118 |
| NCT04513847 | PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis | https://ClinicalTrials.gov/show/NCT04513847 |
| NCT04521010 | Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04521010 |
| NCT04514016 | Cross Sectional CFAR HIV/COVID Study | https://ClinicalTrials.gov/show/NCT04514016 |
| NCT04514003 | The Corona and COVID-19 Study in Telemark and Agder | https://ClinicalTrials.gov/show/NCT04514003 |
| NCT04517695 | Blood Volume Assessment in COVID-19 ICU Patients - BVAC19 | https://ClinicalTrials.gov/show/NCT04517695 |
| NCT04517097 | Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic | https://ClinicalTrials.gov/show/NCT04517097 |
| NCT04515108 | Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies | https://ClinicalTrials.gov/show/NCT04515108 |
| NCT04514874 | Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020 | https://ClinicalTrials.gov/show/NCT04514874 |
| NCT04516928 | Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel | https://ClinicalTrials.gov/show/NCT04516928 |
| NCT04544072 | Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards | https://ClinicalTrials.gov/show/NCT04544072 |
| NCT04517136 | Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions | https://ClinicalTrials.gov/show/NCT04517136 |
| NCT04516824 | Experience of Orthopaedic and Spine Center Pakistan During COVID-19 | https://ClinicalTrials.gov/show/NCT04516824 |
| NCT04519372 | SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting | https://ClinicalTrials.gov/show/NCT04519372 |
| NCT04522076 | Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia | https://ClinicalTrials.gov/show/NCT04522076 |
| NCT04519502 | Maternal Morbidity and Mortality During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04519502 |
| NCT04519398 | Investigating the Involvement of ACE and Angiotensinogen Genes’ Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events | https://ClinicalTrials.gov/show/NCT04519398 |
| NCT04519307 | Evaluation of Newborns Presenting With Suspected COVID 19 | https://ClinicalTrials.gov/show/NCT04519307 |
| NCT04519255 | Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT | https://ClinicalTrials.gov/show/NCT04519255 |
| NCT04518735 | Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study) | https://ClinicalTrials.gov/show/NCT04518735 |
| NCT04531735 | Respiratory Syncytial Virus Infection May be More Dangerous in Neonate | https://ClinicalTrials.gov/show/NCT04531735 |
| NCT04525911 | Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital | https://ClinicalTrials.gov/show/NCT04525911 |
| NCT04524520 | COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery | https://ClinicalTrials.gov/show/NCT04524520 |
| NCT04527497 | Clinical Course and Treatment of COVID-19 Inpatients in Hospital | https://ClinicalTrials.gov/show/NCT04527497 |
| NCT04525287 | Prediction Models for Diagnosis and Prognosis of Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04525287 |
| NCT04523051 | Rehabilitation After Admission in Intensive Care Unit for COVID-19 | https://ClinicalTrials.gov/show/NCT04523051 |
| NCT04523012 | COVID-19 and HIV Patients | https://ClinicalTrials.gov/show/NCT04523012 |
| NCT04525716 | The Effect of Covid-19 on Patient Outcomes Among Operated Patients | https://ClinicalTrials.gov/show/NCT04525716 |
| NCT04525443 | Endothelial Function and COVID-19 | https://ClinicalTrials.gov/show/NCT04525443 |
| NCT04524754 | Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04524754 |
| NCT04524234 | Cardiac Dysfunction in Critically Ill Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04524234 |
| NCT04531254 | Back to School COVID-19 Simulation Study | https://ClinicalTrials.gov/show/NCT04531254 |
| NCT04527458 | Case Fatalities in Hospitalised COVID-19 Patients in the UK | https://ClinicalTrials.gov/show/NCT04527458 |
| NCT04559542 | Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes | https://ClinicalTrials.gov/show/NCT04559542 |
| NCT04532411 | COVID-19 Testing Sample Acquisition Throughput and Efficiency | https://ClinicalTrials.gov/show/NCT04532411 |
| NCT04531111 | Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt | https://ClinicalTrials.gov/show/NCT04531111 |
| NCT04528901 | Study of seroPREvalence Vis-Ã -vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital) | https://ClinicalTrials.gov/show/NCT04528901 |
| NCT04527601 | Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments | https://ClinicalTrials.gov/show/NCT04527601 |
| NCT04534400 | Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04534400 |
| NCT04531501 | COVID-19 Saliva Test Research Study | https://ClinicalTrials.gov/show/NCT04531501 |
| NCT04530500 | COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression | https://ClinicalTrials.gov/show/NCT04530500 |
| NCT04530461 | Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases | https://ClinicalTrials.gov/show/NCT04530461 |
| NCT04529447 | Response of Korean Medicine Hospital to COVID-19 | https://ClinicalTrials.gov/show/NCT04529447 |
| NCT04529408 | EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up | https://ClinicalTrials.gov/show/NCT04529408 |
| NCT04537559 | Impact of COVID-19 Outbreak on Non-COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04537559 |
| NCT04536285 | Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt | https://ClinicalTrials.gov/show/NCT04536285 |
| NCT04531319 | Immune Cell Subgroups in Covid 19 Patients | https://ClinicalTrials.gov/show/NCT04531319 |
| NCT04549636 | COVID-19 Related Lung Ventilation and Perfusion Injury | https://ClinicalTrials.gov/show/NCT04549636 |
| NCT04535154 | Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19 | https://ClinicalTrials.gov/show/NCT04535154 |
| NCT04534569 | Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF) | https://ClinicalTrials.gov/show/NCT04534569 |
| NCT04535297 | Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke | https://ClinicalTrials.gov/show/NCT04535297 |
| NCT04534608 | COVID-19 Child Health Investigation of Latent Disease in Hamburg | https://ClinicalTrials.gov/show/NCT04534608 |
| NCT04534595 | Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire | https://ClinicalTrials.gov/show/NCT04534595 |
| NCT04539834 | Electrolyte State in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04539834 |
| NCT04542044 | Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04542044 |
| NCT04540029 | Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure | https://ClinicalTrials.gov/show/NCT04540029 |
| NCT04537117 | Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19 | https://ClinicalTrials.gov/show/NCT04537117 |
| NCT04578197 | NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04578197 |
| NCT04544605 | Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04544605 |
| NCT04540484 | COVID-19 IgG Formation in Physicians at ALGH and Their Household Members | https://ClinicalTrials.gov/show/NCT04540484 |
| NCT04538586 | Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening) | https://ClinicalTrials.gov/show/NCT04538586 |
| NCT04544033 | IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients | https://ClinicalTrials.gov/show/NCT04544033 |
| NCT04554251 | Global Impact of COVID-19 on Pulmonology Special Units | https://ClinicalTrials.gov/show/NCT04554251 |
| NCT04548908 | Prevalence Of COVID-19 Among Health-workers in a French General Hospital | https://ClinicalTrials.gov/show/NCT04548908 |
| NCT04541472 | Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery) | https://ClinicalTrials.gov/show/NCT04541472 |
| NCT04552340 | Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV. | https://ClinicalTrials.gov/show/NCT04552340 |
| NCT04549350 | Sleep Quality Among HCWs | https://ClinicalTrials.gov/show/NCT04549350 |
| NCT04544150 | Gastrointestinal Manifestations Among Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04544150 |
| NCT04542200 | Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment | https://ClinicalTrials.gov/show/NCT04542200 |
| NCT04542226 | Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04542226 |
| NCT04546776 | COVID-19 Persistence in Stool | https://ClinicalTrials.gov/show/NCT04546776 |
| NCT04545047 | Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19 | https://ClinicalTrials.gov/show/NCT04545047 |
| NCT04544176 | COVID-19 Risk From Attending Outpatient Appointments | https://ClinicalTrials.gov/show/NCT04544176 |
| NCT04556565 | MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain | https://ClinicalTrials.gov/show/NCT04556565 |
| NCT04550403 | Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes | https://ClinicalTrials.gov/show/NCT04550403 |
| NCT04576351 | The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19 | https://ClinicalTrials.gov/show/NCT04576351 |
| NCT04549831 | Genetic Bases of COVID-19 Clinical Variability | https://ClinicalTrials.gov/show/NCT04549831 |
| NCT04547218 | Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population | https://ClinicalTrials.gov/show/NCT04547218 |
| NCT04547114 | Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects | https://ClinicalTrials.gov/show/NCT04547114 |
| NCT04554979 | COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience | https://ClinicalTrials.gov/show/NCT04554979 |
| NCT04550312 | The Impact of Lifestyle Changes on Non-COVID Deaths | https://ClinicalTrials.gov/show/NCT04550312 |
| NCT04555954 | Determining the Physical Activity Level of Healthy Adults During Pandemic | https://ClinicalTrials.gov/show/NCT04555954 |
| NCT04550390 | Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19. | https://ClinicalTrials.gov/show/NCT04550390 |
| NCT04551378 | The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors | https://ClinicalTrials.gov/show/NCT04551378 |
| NCT04557358 | Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04557358 |
| NCT04556513 | Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status | https://ClinicalTrials.gov/show/NCT04556513 |
| NCT04555187 | Cardiovascular Risk Stratification in Covid-19 | https://ClinicalTrials.gov/show/NCT04555187 |
| NCT04569292 | COVID-19 Infection in Cancer Pantients | https://ClinicalTrials.gov/show/NCT04569292 |
| NCT04560855 | Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home | https://ClinicalTrials.gov/show/NCT04560855 |
| NCT04555109 | Convalescent Plasma for COVID-19 Research Donor Study | https://ClinicalTrials.gov/show/NCT04555109 |
| NCT04558307 | Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations | https://ClinicalTrials.gov/show/NCT04558307 |
| NCT04556604 | Surgical Consent During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04556604 |
| NCT04568018 | Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04568018 |
| NCT04567927 | Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04567927 |
| NCT04558645 | Evaluation of Physical Activity and Quality of Life of Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04558645 |
| NCT04556318 | Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04556318 |
| NCT04558320 | COVID-19 and Lactating Mothers | https://ClinicalTrials.gov/show/NCT04558320 |
| NCT04558385 | Seroconversion in COVID-19 Recovered Population | https://ClinicalTrials.gov/show/NCT04558385 |
| NCT04563247 | Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs | https://ClinicalTrials.gov/show/NCT04563247 |
| NCT04560413 | Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients | https://ClinicalTrials.gov/show/NCT04560413 |
| NCT04561102 | Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population | https://ClinicalTrials.gov/show/NCT04561102 |
| NCT04561089 | Evaluation of the COVIDSeq Test in Saliva Specimens From Illumina Personnel | https://ClinicalTrials.gov/show/NCT04561089 |
| NCT04565782 | Corona Virus Infection Among Liver Transplant Recipients | https://ClinicalTrials.gov/show/NCT04565782 |
| NCT04562285 | Sustained Immunity to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04562285 |
| NCT04562246 | SARS-CoV-2 IgG and IgM Serologic Assays | https://ClinicalTrials.gov/show/NCT04562246 |
| NCT04561193 | Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04561193 |
| NCT04561024 | Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm | https://ClinicalTrials.gov/show/NCT04561024 |
| NCT04560530 | The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients | https://ClinicalTrials.gov/show/NCT04560530 |
| NCT04567836 | Screening of Health-care Workers in an University Hospital for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04567836 |
| NCT04563156 | Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04563156 |
| NCT04568044 | Evaluation of Humoral Immunity Following COVID-19 in Pregnancy | https://ClinicalTrials.gov/show/NCT04568044 |
| NCT04565106 | Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04565106 |
| NCT04566965 | Serology to Covid for Recording Exposures and Evaluating Needs | https://ClinicalTrials.gov/show/NCT04566965 |
| NCT04568551 | COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor | https://ClinicalTrials.gov/show/NCT04568551 |
| NCT04575571 | MAVIPAN: My Life and the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04575571 |
| NCT04565080 | Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson’s Disease (PD) | https://ClinicalTrials.gov/show/NCT04565080 |
| NCT04565067 | Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans | https://ClinicalTrials.gov/show/NCT04565067 |
| NCT04564287 | An Observational Study of Neurologic Function After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04564287 |
| NCT04564274 | COV2Base-A Rare Disease by COVID Study | https://ClinicalTrials.gov/show/NCT04564274 |
| NCT04567979 | Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico. | https://ClinicalTrials.gov/show/NCT04567979 |
| NCT04569344 | COVID-19 and Venous Thromboembolism Risk | https://ClinicalTrials.gov/show/NCT04569344 |
| NCT04568655 | The Noninvasive Ventilation to COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04568655 |
| NCT04576299 | Health Care Workers’ Perception of Patient Safety During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04576299 |
| NCT04572438 | A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy | https://ClinicalTrials.gov/show/NCT04572438 |
| NCT04573335 | Diabetes Outcomes in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04573335 |
| NCT04581577 | Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders | https://ClinicalTrials.gov/show/NCT04581577 |
| NCT04573634 | A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition | https://ClinicalTrials.gov/show/NCT04573634 |
| NCT04575532 | Detection of COVID-19 Decompensation | https://ClinicalTrials.gov/show/NCT04575532 |
| NCT04579289 | Managerial and Environmental Risk in French Long Term Care Institutions | https://ClinicalTrials.gov/show/NCT04579289 |
| NCT04573062 | Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health | https://ClinicalTrials.gov/show/NCT04573062 |
| NCT04577105 | Risk Factors and Computed Tomography Findings in COVID-19. | https://ClinicalTrials.gov/show/NCT04577105 |
| NCT04578132 | Description of the Population With Genitourinary Tumors and COVID-19 | https://ClinicalTrials.gov/show/NCT04578132 |
| NCT04581044 | Impact of COVID-19 on Psoriasis Practice | https://ClinicalTrials.gov/show/NCT04581044 |
| NCT04579627 | Facial Hair, PPE and COVID-19 | https://ClinicalTrials.gov/show/NCT04579627 |
| NCT04579471 | Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study | https://ClinicalTrials.gov/show/NCT04579471 |
| NCT04579458 | Assessment of COVID-19 in Tearfilm | https://ClinicalTrials.gov/show/NCT04579458 |
| NCT04583865 | Feasibility and Quality of TeleConsultation in Pediatric Anesthesia | https://ClinicalTrials.gov/show/NCT04583865 |
| NCT04582331 | Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis | https://ClinicalTrials.gov/show/NCT04582331 |
| NCT04581083 | Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04581083 |
| NCT04583345 | Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04583345 |
| NCT04582903 | Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence | https://ClinicalTrials.gov/show/NCT04582903 |
Registrires
| nct_id | brief_title | link |
|---|---|---|
| NCT04314271 | The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04314271 |
| NCT04318314 | COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04318314 |
| NCT04315870 | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. | https://ClinicalTrials.gov/show/NCT04315870 |
| NCT04323592 | Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome | https://ClinicalTrials.gov/show/NCT04323592 |
| NCT04319016 | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy | https://ClinicalTrials.gov/show/NCT04319016 |
| NCT04320472 | Acute Encephalopathy in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04320472 |
| NCT04321811 | Behavior, Environment And Treatments for Covid-19 | https://ClinicalTrials.gov/show/NCT04321811 |
| NCT04323839 | COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) | https://ClinicalTrials.gov/show/NCT04323839 |
| NCT04325412 | Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY | https://ClinicalTrials.gov/show/NCT04325412 |
| NCT04327570 | In-depth Immunological Investigation of COVID-19. | https://ClinicalTrials.gov/show/NCT04327570 |
| NCT04327479 | Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04327479 |
| NCT04327674 | The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19 | https://ClinicalTrials.gov/show/NCT04327674 |
| NCT04329559 | COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study | https://ClinicalTrials.gov/show/NCT04329559 |
| NCT04336956 | Covid-19 Pediatric Observatory | https://ClinicalTrials.gov/show/NCT04336956 |
| NCT04331574 | Renin-Angiotensin System Inhibitors and COVID-19 | https://ClinicalTrials.gov/show/NCT04331574 |
| NCT04331171 | Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients’ Triage | https://ClinicalTrials.gov/show/NCT04331171 |
| NCT04333953 | COVID-19 in Patients With HIV | https://ClinicalTrials.gov/show/NCT04333953 |
| NCT04341766 | Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 | https://ClinicalTrials.gov/show/NCT04341766 |
| NCT04334291 | International COVID19 Clinical Evaluation Registry, | https://ClinicalTrials.gov/show/NCT04334291 |
| NCT04333875 | Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis | https://ClinicalTrials.gov/show/NCT04333875 |
| NCT04336345 | Outcomes of Patients With COVID-19 in the Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04336345 |
| NCT04347278 | Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04347278 |
| NCT04335773 | COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology | https://ClinicalTrials.gov/show/NCT04335773 |
| NCT04345536 | Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital | https://ClinicalTrials.gov/show/NCT04345536 |
| NCT04337346 | Evaluation of Covid 19 Anxiety in Endometriosis Patients | https://ClinicalTrials.gov/show/NCT04337346 |
| NCT04354519 | The United Kingdom Multiple Sclerosis Register Covid-19 Substudy | https://ClinicalTrials.gov/show/NCT04354519 |
| NCT04340479 | The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation | https://ClinicalTrials.gov/show/NCT04340479 |
| NCT04353583 | Renal Outcome in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04353583 |
| NCT04340466 | French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study | https://ClinicalTrials.gov/show/NCT04340466 |
| NCT04358042 | PSYCHIATRIC Disorders and Covid-19 | https://ClinicalTrials.gov/show/NCT04358042 |
| NCT04344249 | Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04344249 |
| NCT04344002 | LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) | https://ClinicalTrials.gov/show/NCT04344002 |
| NCT04349982 | ICU Trial in Critical Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04349982 |
| NCT04348227 | How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country’s ICU? | https://ClinicalTrials.gov/show/NCT04348227 |
| NCT04344912 | Impact of COVID19 Outbreak in Cardiac Acute Care | https://ClinicalTrials.gov/show/NCT04344912 |
| NCT04347993 | A Prospective “Universal” Observational Database for COVID-19 | https://ClinicalTrials.gov/show/NCT04347993 |
| NCT04347798 | IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT | https://ClinicalTrials.gov/show/NCT04347798 |
| NCT04348942 | A COVID-19 Symptom, Exposure and Immune Response Registry | https://ClinicalTrials.gov/show/NCT04348942 |
| NCT04378452 | Assessment of the Psycho-social Impact of COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04378452 |
| NCT04357275 | The RIsk Stratification in COVID-19 Patients in the ICU Registry | https://ClinicalTrials.gov/show/NCT04357275 |
| NCT04354818 | Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) | https://ClinicalTrials.gov/show/NCT04354818 |
| NCT04354701 | COVID-19 and Cancer Consortium Registry | https://ClinicalTrials.gov/show/NCT04354701 |
| NCT04352764 | ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings | https://ClinicalTrials.gov/show/NCT04352764 |
| NCT04351529 | Austrian COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04351529 |
| NCT04356586 | Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms | https://ClinicalTrials.gov/show/NCT04356586 |
| NCT04366206 | Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est | https://ClinicalTrials.gov/show/NCT04366206 |
| NCT04357639 | Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ) | https://ClinicalTrials.gov/show/NCT04357639 |
| NCT04380766 | Covid-19 Pandemic and Pancreatic Surgery in Italy | https://ClinicalTrials.gov/show/NCT04380766 |
| NCT04359927 | Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04359927 |
| NCT04359602 | COVID-19 Recovered Volunteer Research Participant Pool Registry | https://ClinicalTrials.gov/show/NCT04359602 |
| NCT04374110 | Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374110 |
| NCT04361591 | COVID-19 in Liver Transplant Recipients | https://ClinicalTrials.gov/show/NCT04361591 |
| NCT04361500 | Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter | https://ClinicalTrials.gov/show/NCT04361500 |
| NCT04366986 | International Registry of Coronavirus (COVID-19) Exposure in Pregnancy | https://ClinicalTrials.gov/show/NCT04366986 |
| NCT04364984 | ARB, ACEi, DRi in COVID-19 | https://ClinicalTrials.gov/show/NCT04364984 |
| NCT04363632 | Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04363632 |
| NCT04433871 | COVID-19 in Pediatric Oncology and Hematology Centers in France | https://ClinicalTrials.gov/show/NCT04433871 |
| NCT04365322 | Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04365322 |
| NCT04393142 | Serologic Testing of Household Contacts of Confirmed Cases of COVID-19 | https://ClinicalTrials.gov/show/NCT04393142 |
| NCT04368975 | ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04368975 |
| NCT04368234 | Duke COVID-19 Shared Data and Specimen Repository | https://ClinicalTrials.gov/show/NCT04368234 |
| NCT04368143 | COVID-19 Immune Repertoire Sequencing | https://ClinicalTrials.gov/show/NCT04368143 |
| NCT04367714 | Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 | https://ClinicalTrials.gov/show/NCT04367714 |
| NCT04367207 | African Covid-19 Critical Care Outcomes Study | https://ClinicalTrials.gov/show/NCT04367207 |
| NCT04370821 | COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers | https://ClinicalTrials.gov/show/NCT04370821 |
| NCT04380727 | Almitrine and COVID-19 Related Hypoxemia | https://ClinicalTrials.gov/show/NCT04380727 |
| NCT04370067 | HUNgarian COronaVirus Disease-19 Epidemiological Research | https://ClinicalTrials.gov/show/NCT04370067 |
| NCT04369300 | Anxiety And Depression During COVID-19 IN INDIA | https://ClinicalTrials.gov/show/NCT04369300 |
| NCT04368065 | Registry to Study Factors That May Impact COVID-19 Occurrence and Severity | https://ClinicalTrials.gov/show/NCT04368065 |
| NCT04367857 | ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04367857 |
| NCT04367350 | Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement | https://ClinicalTrials.gov/show/NCT04367350 |
| NCT04372199 | SEVERITY SCORE FOR COVID-19 PNEUMONIA | https://ClinicalTrials.gov/show/NCT04372199 |
| NCT04371328 | Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04371328 |
| NCT04373759 | Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs | https://ClinicalTrials.gov/show/NCT04373759 |
| NCT04371744 | QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 | https://ClinicalTrials.gov/show/NCT04371744 |
| NCT04374045 | Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study | https://ClinicalTrials.gov/show/NCT04374045 |
| NCT04379440 | Geriatric Population COVID-19 Observational Study (GEROCOVIDobs) | https://ClinicalTrials.gov/show/NCT04379440 |
| NCT04383457 | Covid-19 Triage Using Camera-based AI | https://ClinicalTrials.gov/show/NCT04383457 |
| NCT04379544 | Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04379544 |
| NCT04376398 | Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals | https://ClinicalTrials.gov/show/NCT04376398 |
| NCT04390555 | The Global PCHF-COVICAV Registry | https://ClinicalTrials.gov/show/NCT04390555 |
| NCT04388605 | Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic | https://ClinicalTrials.gov/show/NCT04388605 |
| NCT04385797 | Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia | https://ClinicalTrials.gov/show/NCT04385797 |
| NCT04388436 | Post Covid-19 Cardiopulmonary and Immunological Changes | https://ClinicalTrials.gov/show/NCT04388436 |
| NCT04386265 | Compassionate Use of Hyperbaric Oxygen Therapy | https://ClinicalTrials.gov/show/NCT04386265 |
| NCT04389996 | COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey | https://ClinicalTrials.gov/show/NCT04389996 |
| NCT04388631 | Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health. | https://ClinicalTrials.gov/show/NCT04388631 |
| NCT04391920 | Registry of CytoSorb Therapy in COVID-19 ICU Patients | https://ClinicalTrials.gov/show/NCT04391920 |
| NCT04397575 | The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients | https://ClinicalTrials.gov/show/NCT04397575 |
| NCT04391946 | Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04391946 |
| NCT04387929 | Detection of Anti-COVID-19 Antibody Levels in an Hospital Population | https://ClinicalTrials.gov/show/NCT04387929 |
| NCT04389554 | D-dimer Levels in Pregnant With COVID-19 | https://ClinicalTrials.gov/show/NCT04389554 |
| NCT04490837 | Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID) | https://ClinicalTrials.gov/show/NCT04490837 |
| NCT04391686 | Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context | https://ClinicalTrials.gov/show/NCT04391686 |
| NCT04394000 | Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 | https://ClinicalTrials.gov/show/NCT04394000 |
| NCT04393324 | The Critical Care Response to the COVID-19 Pandemic in Madrid | https://ClinicalTrials.gov/show/NCT04393324 |
| NCT04497194 | Registry of COVID-19 Patients at AOUI Verona | https://ClinicalTrials.gov/show/NCT04497194 |
| NCT04394390 | Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients? | https://ClinicalTrials.gov/show/NCT04394390 |
| NCT04395781 | Pediatric Acute and Critical Care COVID-19 Registry of Asia | https://ClinicalTrials.gov/show/NCT04395781 |
| NCT04413955 | Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA | https://ClinicalTrials.gov/show/NCT04413955 |
| NCT04408339 | COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking | https://ClinicalTrials.gov/show/NCT04408339 |
| NCT04395794 | SARS-CoV-2 Disguise Study | https://ClinicalTrials.gov/show/NCT04395794 |
| NCT04398264 | Characteristics of COVID-19 Infection Among PREGnant Women | https://ClinicalTrials.gov/show/NCT04398264 |
| NCT04401033 | Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) | https://ClinicalTrials.gov/show/NCT04401033 |
| NCT04453748 | The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications | https://ClinicalTrials.gov/show/NCT04453748 |
| NCT04401540 | Characteristics of Neonatal Covid-19 in Turkey | https://ClinicalTrials.gov/show/NCT04401540 |
| NCT04403672 | Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus | https://ClinicalTrials.gov/show/NCT04403672 |
| NCT04411563 | Epigenetic Tools as Prognostic Predictors in Covid19 | https://ClinicalTrials.gov/show/NCT04411563 |
| NCT04412382 | Covid-19: Possible Role of Neutrophil Extracellular Traps | https://ClinicalTrials.gov/show/NCT04412382 |
| NCT04410471 | Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients | https://ClinicalTrials.gov/show/NCT04410471 |
| NCT04412317 | Use of PCR-Sars-CoV-2 in Children | https://ClinicalTrials.gov/show/NCT04412317 |
| NCT04416009 | Extracellular Water in Covid 19 Pneumonia | https://ClinicalTrials.gov/show/NCT04416009 |
| NCT04412551 | Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 | https://ClinicalTrials.gov/show/NCT04412551 |
| NCT04488562 | Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands | https://ClinicalTrials.gov/show/NCT04488562 |
| NCT04435457 | Cardiovascular Implications of COVID-19 | https://ClinicalTrials.gov/show/NCT04435457 |
| NCT04418557 | COVID-19 and Obstetric Transmission | https://ClinicalTrials.gov/show/NCT04418557 |
| NCT04422444 | Post Intensive Care Syndrome in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04422444 |
| NCT04422587 | Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea | https://ClinicalTrials.gov/show/NCT04422587 |
| NCT04425759 | Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19) | https://ClinicalTrials.gov/show/NCT04425759 |
| NCT04423003 | Endoscopic Interventions in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423003 |
| NCT04422470 | Registry of Patients With Hematologic Disease and COVID-19 in Russia | https://ClinicalTrials.gov/show/NCT04422470 |
| NCT04434144 | A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh | https://ClinicalTrials.gov/show/NCT04434144 |
| NCT04429477 | Cerebral Compliance Impairment in COVID-19 | https://ClinicalTrials.gov/show/NCT04429477 |
| NCT04426084 | Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study | https://ClinicalTrials.gov/show/NCT04426084 |
| NCT04503434 | Patients’ Experiences in a Medicalized Hotel for COVID-19 Acute Care Support | https://ClinicalTrials.gov/show/NCT04503434 |
| NCT04431869 | In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers | https://ClinicalTrials.gov/show/NCT04431869 |
| NCT04430374 | Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf | https://ClinicalTrials.gov/show/NCT04430374 |
| NCT04433364 | COPE - COVID-19 in Pregnancy and Early Childhood | https://ClinicalTrials.gov/show/NCT04433364 |
| NCT04435041 | Remote-by-Default Care in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04435041 |
| NCT04444310 | Antibody Responses in Contacts of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04444310 |
| NCT04443140 | Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic? | https://ClinicalTrials.gov/show/NCT04443140 |
| NCT04449042 | The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry | https://ClinicalTrials.gov/show/NCT04449042 |
| NCT04445402 | Pediatrics HOT COVID-19 Database in NY Tristate | https://ClinicalTrials.gov/show/NCT04445402 |
| NCT04466306 | Pediatric Acute Kidney Injury in COVID-19 | https://ClinicalTrials.gov/show/NCT04466306 |
| NCT04450277 | Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04450277 |
| NCT04460170 | COVID-19 Follow up Intensive Care Studies | https://ClinicalTrials.gov/show/NCT04460170 |
| NCT04453579 | Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health | https://ClinicalTrials.gov/show/NCT04453579 |
| NCT04457505 | One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04457505 |
| NCT04455347 | Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked | https://ClinicalTrials.gov/show/NCT04455347 |
| NCT04521088 | Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic | https://ClinicalTrials.gov/show/NCT04521088 |
| NCT04459689 | COVID-19 in PID Survey | https://ClinicalTrials.gov/show/NCT04459689 |
| NCT04465474 | Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP) | https://ClinicalTrials.gov/show/NCT04465474 |
| NCT04459364 | The Prevalence of Pulmonary Hypertension in Patients With COVID-19. | https://ClinicalTrials.gov/show/NCT04459364 |
| NCT04460196 | Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments | https://ClinicalTrials.gov/show/NCT04460196 |
| NCT04463862 | COVID - AirPollution | https://ClinicalTrials.gov/show/NCT04463862 |
| NCT04472078 | Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina | https://ClinicalTrials.gov/show/NCT04472078 |
| NCT04479488 | Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil) | https://ClinicalTrials.gov/show/NCT04479488 |
| NCT04479150 | Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04479150 |
| NCT04481646 | Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool | https://ClinicalTrials.gov/show/NCT04481646 |
| NCT04511429 | COVID-19 in Immunosuppressed Children | https://ClinicalTrials.gov/show/NCT04511429 |
| NCT04498546 | Mask Usage and Exercise During the COVÄ°D-19 Pandemic | https://ClinicalTrials.gov/show/NCT04498546 |
| NCT04503057 | Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04503057 |
| NCT04515199 | Home Management of Adult Egyptian Mild COVID-19 Cases | https://ClinicalTrials.gov/show/NCT04515199 |
| NCT04508920 | A Survey to Assess Effects of Covid-19 on Cardiovascular Patients | https://ClinicalTrials.gov/show/NCT04508920 |
| NCT04506528 | The C3I COVID-19 Project | https://ClinicalTrials.gov/show/NCT04506528 |
| NCT04505709 | Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19 | https://ClinicalTrials.gov/show/NCT04505709 |
| NCT04508959 | The McMaster Multi-Regional COVID-19 Hospital Case Registry | https://ClinicalTrials.gov/show/NCT04508959 |
| NCT04517630 | Renal Biomarkers in AKI and COVID-19 | https://ClinicalTrials.gov/show/NCT04517630 |
| NCT04527315 | COVID-19 Survivorship Registry | https://ClinicalTrials.gov/show/NCT04527315 |
| NCT04531202 | CORE Study COVID-19 | https://ClinicalTrials.gov/show/NCT04531202 |
| NCT04533360 | Prevalence of COVID-19 Antibodies Kingman AZ | https://ClinicalTrials.gov/show/NCT04533360 |
| NCT04532632 | Taste and Smell Impairment in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04532632 |
| NCT04535128 | COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications | https://ClinicalTrials.gov/show/NCT04535128 |
| NCT04544878 | Pediatric Intensive Care and COVID-19 | https://ClinicalTrials.gov/show/NCT04544878 |
| NCT04542954 | Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East | https://ClinicalTrials.gov/show/NCT04542954 |
| NCT04560608 | Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04560608 |
| NCT04546191 | Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland | https://ClinicalTrials.gov/show/NCT04546191 |
| NCT04553055 | Antibiotic Misuse During COVID-19 Pandemic: A Cross-sectional Survey Addressed to Community Pharmacists | https://ClinicalTrials.gov/show/NCT04553055 |
| NCT04553575 | CoViD-19 Patient in Reims University Hospital in March to April 2020 | https://ClinicalTrials.gov/show/NCT04553575 |
| NCT04581135 | Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04581135 |
| NCT04558996 | Spanish Registry of Pregnant Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04558996 |
| NCT04558203 | The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice | https://ClinicalTrials.gov/show/NCT04558203 |
| NCT04568421 | Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04568421 |
| NCT04568005 | Evaluation of Lymphedema Patients Status During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04568005 |
| NCT04573868 | National Study “AEC COVID-19” | https://ClinicalTrials.gov/show/NCT04573868 |
| NCT04583566 | Differential Expression of Cytokines, Transcriptome and miRNA in COVID-19 Egyptian’s Patients | https://ClinicalTrials.gov/show/NCT04583566 |
| NCT04581096 | Mapping COVID-19 Spread in a Tertiary Hospital | https://ClinicalTrials.gov/show/NCT04581096 |
| NCT04583306 | The Salivary Raman COVID-19 Fingerprint | https://ClinicalTrials.gov/show/NCT04583306 |